10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended June 30, 2026

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period From              to

Commission file number: 001-34666

MaxLinear, Inc.

(Exact name of registrant as specified in its charter)

Delaware			14-1896129
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)
5966 La Place Court, Suite 100,	Carlsbad	California	92008
(Address of principal executive offices)			(Zip Code)

(760) 692-0711

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock	MXL	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☑   No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☑    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☑	Accelerated filer	☐	Emerging growth company	☐
Non-accelerated filer	☐	Smaller reporting company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☑ 

As of July 16, 2026, the registrant had 90,693,191 shares of common stock, par value $0.0001, outstanding.

MAXLINEAR, INC.

QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

		Page
Note About Forward-Looking Statements		3
Part I	FINANCIAL INFORMATION	5
Item 1.	Financial Statements (unaudited)	6
	Consolidated Balance Sheets as of June 30, 2026 and December 31, 2025	6
	Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2026 and 2025	7
	Consolidated Statements of Comprehensive Loss for the Three and Six Months Ended June 30, 2026 and 2025	8
	Consolidated Statements of Stockholders’ Equity for the Fiscal Quarters Ended June 30, 2026 and 2025	9
	Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2026 and 2025	11
	Notes to Consolidated Financial Statements	12
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	36
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	46
Item 4.	Controls and Procedures	46
Part II	OTHER INFORMATION	48
Item 1.	Legal Proceedings	48
Item 1A.	Risk Factors	48
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	48
Item 3.	Defaults Upon Senior Securities	48
Item 4.	Mine Safety Disclosures	48
Item 5.	Other Information	48
Item 6.	Exhibits	49
	Signatures	50

2

Note About Forward-Looking Statements

As used herein, "MaxLinear," "Company," "we," "us," "our," and similar terms include MaxLinear, Inc. and its subsidiaries, unless the context indicates otherwise.

This Quarterly Report on Form 10-Q, or Form 10-Q, including any information that may be incorporated by reference herein, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, referred to as the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. In some cases, you can identify forward-looking statements by terms such as “anticipate,” “believe,” “continue,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “potential,” “predict,” “should,” “will” or the negative of these terms or other comparable terminology. These statements involve known and unknown risks, uncertainties and situations that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these statements. Factors that could cause or contribute to such differences include those discussed in Part I, Item 2, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in this Form 10-Q and Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (our “2025 Annual Report”), as updated (if applicable) in this Form 10-Q and other documents we file with the SEC. Such factors include but are not limited to:

•our terminated merger with Silicon Motion and related arbitration and class action complaint and the risks related to potential payment of damages;

•the effect of intense and increasing competition;

•increased tariffs, export controls or imposition of additional trade barriers; impacts of global economic conditions;

•the cyclical nature of the semiconductor industry;

•a significant variance in our operating results and its impact on the volatility of our stock price, and our ability to sustain our current level of revenue, which has previously declined, and/or manage future growth effectively;

•escalating trade wars, military conflicts and other geopolitical and economic tensions among the countries in which we conduct business;

•international geopolitical and military conflicts;

•our ability to obtain or retain government authorization to export certain of our products or technology;

•the loss of, or a significant reduction in, orders from major customers;

•legal proceedings or potential violations of regulations;

•information technology failures;

• a potential future decrease in the average selling prices of our products;

•failure to penetrate new applications and markets;

•development delays and consolidation trends in our industry;

•inability to make substantial and productive research and development investments;

•delays or expenses caused by undetected defects or bugs in our products;

•substantial quarterly and annual fluctuations in our revenue and operating results;

•failure to timely develop and introduce new or enhanced products;

•order and shipment uncertainties and differences between our estimates of customer demand and product mix and our actual results;

•failure to accurately predict our future revenue and appropriately budget expenses; lengthy and expensive customer qualification processes;

•customer product plan cancellations;

•failure to maintain compliance with government regulations;

•failure to attract and retain qualified personnel;

•any adverse impact of rising interest rates on us, our customers, and our distributors and related demand;

•risks related to compliance with privacy, data protection and cybersecurity laws and regulations;

•risks related to conforming our products to industry standards;

•risks related to business acquisitions and investments;

•claims of intellectual property infringement;

•our ability to protect our intellectual property;

•security vulnerabilities of our products;

•use of open source software in our products;

•failure to manage our relationships with, or negative impacts from, third parties; and

3

•future decisions relating to our stock repurchase program.

Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also adversely affect our business, financial condition, results of operations or the market price of our common stock. We encourage investors to review these factors carefully. We may from time to time make additional disclosures that may amend, supplement or supersede the risks and uncertainties disclosed herein, including those made in our 2025 Annual Report. However, we do not undertake to update any forward-looking statement that may be made from time to time by or on behalf of us, whether as a result of new information, future events, or otherwise, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.

4

PART I — FINANCIAL INFORMATION

5

ITEM 1.    FINANCIAL STATEMENTS

MAXLINEAR, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands, except par value amounts)

	June 30, 2026		December 31, 2025
Assets	(unaudited)
Current assets:
Cash and cash equivalents	$	64,814	$	72,806
Short-term restricted cash	1,492		1,419
Accounts receivable, net	51,037		46,122
Inventory	105,490		78,104
Prepaid expenses and other current assets	75,829		50,390
Total current assets	298,662		248,841
Long-term restricted cash	27,426		27,187
Property and equipment, net	41,207		48,873
Leased right-of-use assets	19,724		15,506
Intangible assets, net	43,780		48,892
Goodwill	318,588		318,588
Deferred tax assets	62,361		77,268
Other long-term assets	10,823		11,241
Total assets	$	822,571	$	796,396
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$	40,401	$	37,916
Accrued price protection liability	31,192		26,493
Accrued expenses and other current liabilities	58,244		72,392
Accrued compensation	38,287		49,219
Total current liabilities	168,124		186,020
Long-term lease liabilities	15,465		12,313
Long-term debt	123,926		123,618
Other long-term liabilities	30,216		22,550
Total liabilities	337,731		344,501
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding	—		—
Common stock, $0.0001 par value; 550,000 shares authorized; 90,692 shares issued and outstanding at June 30, 2026 and 86,451 shares issued and outstanding at December 31, 2025	9		9
Additional paid-in capital	1,027,265		951,262
Accumulated other comprehensive income	1,349		1,030
Accumulated deficit	(543,783)		(500,406)
Total stockholders’ equity	484,840		451,895
Total liabilities and stockholders’ equity	$	822,571	$	796,396

See accompanying notes.

6

MAXLINEAR, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited; in thousands, except per share data)

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Net revenue	$	168,847	$	108,813	$	306,035	$	204,746
Cost of net revenue	71,184		47,288		129,488		89,390
Gross profit	97,663		61,525		176,547		115,356
Operating expenses:
Research and development	56,033		47,199		109,195		102,656
Selling, general and administrative	45,751		33,361		88,208		69,950
Restructuring charges	64		5,580		538		13,459
Total operating expenses	101,848		86,140		197,941		186,065
Loss from operations	(4,185)		(24,615)		(21,394)		(70,709)
Interest income	474		812		1,107		1,676
Interest expense	(2,269)		(2,512)		(4,466)		(5,016)
Other income (expense), net	(570)		(4,386)		(449)		(5,654)
Total other income (expense), net	(2,365)		(6,086)		(3,808)		(8,994)
Loss before income taxes	(6,550)		(30,701)		(25,202)		(79,703)
Income tax provision (benefit)	(8,310)		(4,115)		18,175		(3,404)
Net income (loss)	$	1,760	$	(26,586)	$	(43,377)	$	(76,299)
Net income (loss) per share:
Basic	$	0.02	$	(0.31)	$	(0.49)	$	(0.89)
Diluted	$	0.02	$	(0.31)	$	(0.49)	$	(0.89)
Shares used to compute net income (loss) per share:
Basic	90,043		86,626		88,826		85,952
Diluted	97,333		86,626		88,826		85,952

See accompanying notes.

7

MAXLINEAR, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(unaudited; in thousands)

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Net income (loss)	$	1,760	$	(26,586)	$	(43,377)	$	(76,299)
Other comprehensive income, net of tax:
Foreign currency translation adjustments, net of tax benefit of $10 and $34 for the three and six months ended June 30, 2026, respectively, and net of tax expense of $264 for the three months ended June 30, 2025 and net of tax benefit of $259 for the six months ended June 30, 2025, respectively.	1,228		6,300		319		7,157
Total comprehensive income (loss)	$	2,988	$	(20,286)	$	(43,058)	$	(69,142)

See accompanying notes.

8

MAXLINEAR, INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

FISCAL QUARTERS ENDED JUNE 30, 2026

(unaudited; in thousands)

	Common Stock			Additional Paid-In Capital		Accumulated Other Comprehensive Income (Loss)		Accumulated Deficit		Total Stockholders’ Equity
	Shares	Amount
Balance at December 31, 2025	86,451	$	9	$	951,262	$	1,030	$	(500,406)	$	451,895
Common stock issued pursuant to equity awards, net	3,078	—		28,360		—		—		28,360
Stock-based compensation	—	—		19,982		—		—		19,982
Other comprehensive loss	—	—		—		(909)		—		(909)
Net loss	—	—		—		—		(45,137)		(45,137)
Balance at March 31, 2026	89,529	9		999,604		121		(545,543)		454,191
Common stock issued pursuant to equity awards, net	989	—		(1,758)		—		—		(1,758)
Employee stock purchase plan	174	—		1,961		—		—		1,961
Stock-based compensation	—	—		27,458		—		—		27,458
Other comprehensive income	—	—		—		1,228		—		1,228
Net income	—	—		—		—		1,760		1,760
Balance at June 30, 2026	90,692	$	9	$	1,027,265	$	1,349	$	(543,783)	$	484,840

9

MAXLINEAR, INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

FISCAL QUARTERS ENDED JUNE 30, 2025

(unaudited; in thousands)

	Common Stock			Additional Paid-In Capital		Accumulated Other Comprehensive Income (Loss)		Accumulated Deficit		Total Stockholders’ Equity
	Shares	Amount
Balance at December 31, 2024	84,613	$	8	$	886,823	$	(6,823)	$	(363,725)	$	516,283
Common stock issued pursuant to equity awards, net	1,761	1		2,876		—		—		2,877
Stock-based compensation	—	—		22,871		—		—		22,871
Other comprehensive income	—	—		—		857		—		857
Net loss	—	—		—		—		(49,713)		(49,713)
Balance at March 31, 2025	86,374	9		912,570		(5,966)		(413,438)		493,175
Common stock issued pursuant to equity awards, net	331	—		—		—		—		—
Employee stock purchase plan	202	—		2,178		—		—		2,178
Stock-based compensation	—	—		13,264		—		—		13,264
Other comprehensive income	—	—		—		6,300		—		6,300
Net loss	—	—		—		—		(26,586)		(26,586)
Balance at June 30, 2025	86,907	$	9	$	928,012	$	334	$	(440,024)	$	488,331

See accompanying notes.

10

MAXLINEAR, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited; in thousands)

	Six Months Ended June 30,
	2026		2025
Operating Activities
Net loss	$	(43,377)	$	(76,299)
Adjustments to reconcile net loss to cash provided by (used in) operating activities:
Amortization and depreciation	18,130		18,582
Amortization of debt issuance costs and accretion of discounts	839		1,001
Stock-based compensation	47,506		36,024
Deferred income taxes	14,902		(6,355)
Loss on disposal of property and equipment	200		900
Reduction in the carrying amount of leased right-of-use assets	3,615		3,784
Impairment of leased right-of-use assets	233		427
Gain on extinguishment of lease liabilities	(328)		—
Loss on foreign currency	247		5,461
Excess tax benefits on stock-based awards	(10,615)		(2,274)
Changes in operating assets and liabilities:
Accounts receivable	(4,915)		(20,354)
Inventory	(27,386)		4,312
Prepaid expenses and other assets	(22,501)		4,480
Accounts payable, accrued expenses and other current liabilities	(709)		29,141
Accrued compensation	21,211		11,849
Accrued price protection liability	4,699		(3,881)
Lease liabilities	(5,485)		(5,777)
Other long-term liabilities	(329)		(1,932)
Net cash used in operating activities	(4,063)		(911)
Investing Activities
Purchases of property and equipment	(3,722)		(3,161)
Purchases of intangible assets	(1,665)		(6,207)
Proceeds from convertible notes receivable	(2,000)		—
Net cash used in investing activities	(7,387)		(9,368)
Financing Activities
Proceeds from borrowings under revolving credit facility	20,000		—
Repayment of borrowings under revolving credit facility	(20,000)		—
Payment of debt issuance costs	(479)		—
Proceeds from funding arrangement	8,000		—
Net proceeds from issuance of common stock, net of costs	3,804		2,140
Minimum tax withholding paid on behalf of employees for restricted stock units	(7,438)		(2,201)
Net cash provided by (used in) financing activities	3,887		(61)
Effect of exchange rate changes on cash and cash equivalents	(117)		990
Decrease in cash, cash equivalents and restricted cash	(7,680)		(9,350)
Cash, cash equivalents and restricted cash at beginning of period	101,412		119,603
Cash, cash equivalents and restricted cash at end of period	$	93,732	$	110,253
Supplemental disclosures of cash flow information:
Cash paid for interest	$	3,984	$	4,322
Cash paid for income taxes, net of refunds	$	(2,116)	$	2,994
Supplemental disclosures of non-cash activities:
Issuance of shares for payment of bonuses	$	32,205	$	5,163

See accompanying notes.

11

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

1. Organization and Summary of Significant Accounting Policies

Description of Business

MaxLinear, Inc. was incorporated in Delaware in September 2003. MaxLinear, Inc., together with its directly and indirectly wholly-owned subsidiaries, collectively referred to as MaxLinear, or the Company, is a provider of communications systems-on-chips, or SoCs, solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. MaxLinear is a fabless integrated circuit design company whose products integrate all or substantial portions of a high-speed communication system, including radio frequency, or RF, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management. MaxLinear’s customers primarily include electronics distributors, module makers, original equipment manufacturers, or OEMs, and original design manufacturers, or ODMs, which incorporate the Company’s products in a wide range of electronic devices. Examples of such devices include radio transceivers and modems for 4G/5G base-station and backhaul infrastructure; optical transceivers targeting hyperscale data centers; Wi-Fi and wireline routers for home networking; broadband modems compliant with Data Over Cable Service Interface Specifications, or DOCSIS, passive optical network, or PON, and digital subscriber line, or DSL; as well as power management and interface products used in these and many other markets.

Basis of Presentation and Principles of Consolidation

The accompanying unaudited consolidated financial statements include the accounts of MaxLinear, Inc. and its directly and indirectly wholly-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. All intercompany transactions and investments have been eliminated in consolidation.

In the opinion of management, the Company’s unaudited consolidated interim financial statements contain adjustments, including normal recurring accruals necessary to present fairly the Company’s consolidated financial position, results of operations, comprehensive loss, stockholders’ equity, and cash flows.

The consolidated balance sheet as of December 31, 2025 was derived from the Company’s audited consolidated financial statements at that date. The accompanying unaudited consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2025 included in the Company’s Annual Report on Form 10-K filed by the Company with the Securities and Exchange Commission, or the SEC, on January 29, 2026, or the Annual Report. Interim results for the six months ended June 30, 2026 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2026.

The functional currency of certain foreign subsidiaries is the local currency. Accordingly, assets and liabilities of these foreign subsidiaries are translated at the current exchange rate at the balance sheet date and historical rates for equity. Revenue and expense components are translated at weighted average exchange rates in effect during the period. Gains and losses resulting from foreign currency translation are included as a component of stockholders’ equity. Foreign currency transaction gains and losses are included in the results of operations, and to date, have not been material.

Use of Estimates and Significant Risks and Uncertainties

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes to the consolidated financial statements. Actual results could differ from those estimates.

The Company is not aware of any specific event or circumstance that would require an update to its estimates or adjustments to the carrying value of its assets and liabilities as of July 23, 2026, the issuance date of this Quarterly Report on Form 10-Q. Actual results could differ from those estimates.

Summary of Significant Accounting Policies

Refer to the Company’s Annual Report for a summary of significant accounting policies. There have been no material changes to the Company’s significant accounting policies during the six months ended June 30, 2026.

12

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

Recently Adopted Accounting Pronouncements

In September 2025, the FASB issued ASU No. 2025-07, Derivatives and Hedging (Topic 815) and Revenue from Contracts with Customers (Topic 606)—Derivatives Scope Refinements and Scope Clarification for Share-Based Noncash Consideration from a Customer in a Revenue Contract, or ASU No. 2025-07. The amendments in this update exclude from derivative accounting non-exchange-traded contracts with underlyings that are based on operations or activities specific to one of the parties to the contract and clarify the accounting for receipt of share-based noncash consideration from a customer for the transfer of goods or services. These amendments are effective for the Company for annual and interim periods in 2027 and may be applied prospectively to new contracts entered into on or after the date of adoption, or on a modified retrospective basis via a cumulative-effect adjustment to the opening balance of retained earnings for existing contracts, with early adoption permitted. The Company adopted the amendments in this update prospectively in 2026. The impact of the adoption of the amendments in this update was not material to the Company’s consolidated financial position and results of operations as of and for the three and six months ended June 30, 2026.

In July 2025, the FASB issued ASU No. 2025-05, Financial Instruments – Credit Losses (Topic 326), to allow entities to elect a practical expedient that assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset when estimating expected credit losses for current accounts receivable and current contract assets. These amendments are effective for the Company for annual and interim periods in 2026 applied prospectively, with early adoption permitted. The Company adopted the amendments in this update prospectively in 2026. The impact of the adoption of the amendments in this update was not material to the Company’s consolidated financial position and results of operations.

Recently Issued, Not Yet Adopted Accounting Pronouncements

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements, to clarify and reorganize GAAP interim reporting guidance to improve navigability, applicability, and consistency without changing the fundamental nature or volume of required interim disclosures. This amendment clarifies when ASC 270 is applicable, establishes a disclosure principle requiring disclosure of material events or changes occurring since the most recent annual reporting period, and consolidates into ASC Topic 270 a comprehensive list of interim disclosures required by other Codification Topics. The amendment also clarifies the form and content of interim financial statements, including guidance for condensed interim reporting. The amendment is effective for the Company for interim periods in 2028, with early adoption permitted. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations.

In December 2025, the FASB issued ASU 2025‑10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities, to establish specific guidance for the recognition, measurement, presentation, and disclosure of government grants received to reduce diversity and increase consistency amongst business entities in accounting for such grants. This amendment amends ASC Topic 832 to require that a government grant received by a business entity should not be recognized as income until it is probable that a business entity will comply with the conditions attached to the grant and the grant will be received, with any grant related to an asset to be purchased, constructed or acquired such as long-lived assets or inventory to be recognized on the balance sheet as either deferred income or as an adjustment to the cost basis of the related asset, or the cost accumulation approach, as such costs are incurred. Any grant income or deferred income shall be recognized in earnings on a systematic and rational basis over the periods in which a business entity recognizes as expenses the costs for which the grant is intended to compensate, whereas any grants accounted for using the cost accumulation approach will not have a direct subsequent recognition in earnings, but rather reduced depreciation or amortization in accounting for the related asset. Entities are also required to present grants recognized in earnings separately under other income or deducted from the related expense, and provide disclosures of the nature of the government grant received, the accounting policies used to account for the grant, and the significant terms and conditions of the grant.

The amendment is effective for the Company for annual and interim periods in 2029, with early adoption and multiple transition methods permitted. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations as it does not differ materially from the Company’s current practice in accounting for government grants.

In September 2025, the FASB issued ASU No. 2025-06, Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, to update the accounting for software developed for internal use to better align with software development as it has evolved from a sequential development method to incremental and iterative development methods. The amendments in this update require an entity to begin capitalizing internal-use software costs when management has authorized and committed to funding the software project and it is probable that the project will be completed and the software will be used to perform the function intended. These amendments are effective for the Company for annual and interim periods in 2028, applied either prospectively, retrospectively, or by a modified approach,

13

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

with early adoption permitted. As the Company does not currently have a material amount of software developed for internal use, the impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations.

In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses, to improve the disclosures about a public business entity’s expenses and address requests from investors for more detailed information about the types of expenses including purchases of inventory, employee compensation, depreciation and intangible asset amortization in commonly presented expense captions such as cost of sales, selling, general and administrative expense, and research and development. These amendments are effective for the Company for annual periods in 2027, applied prospectively, with early adoption permitted, and interim periods beginning in 2028. The Company intends to adopt the amendments in this update prospectively in 2027 for annual periods and in 2028 for interim periods. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations, as the requirements only require more detailed disclosures in the footnotes to the Company’s consolidated financial statements.

2. Net Income (Loss) Per Share

Basic earnings per share, or EPS, is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted EPS is computed by dividing net income (loss) by the weighted-average number of common shares outstanding for the period and the weighted-average number of dilutive common stock equivalents outstanding for the period determined using the treasury-stock method. For purposes of this calculation, stock options and restricted stock units are considered to be common stock equivalents and are only included in the calculation of diluted EPS when their effect is dilutive. In periods in which the Company has a net loss, dilutive common stock equivalents are excluded from the calculation of diluted EPS.

The table below presents the computation of basic and diluted EPS:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
	(in thousands, except per share amounts)
Numerator:
Net income (loss)	$	1,760	$	(26,586)	$	(43,377)	$	(76,299)
Denominator:
Weighted average common shares outstanding—basic	90,043		86,626		88,826		85,952
Dilutive common stock equivalents	7,290		—		—		—
Weighted average common shares outstanding—diluted	97,333		86,626		88,826		85,952
Net income (loss) per share:
Basic	$	0.02	$	(0.31)	$	(0.49)	$	(0.89)
Diluted	$	0.02	$	(0.31)	$	(0.49)	$	(0.89)

For the three months ended June 30, 2026 and 2025, the Company excluded common stock equivalents for outstanding stock-based awards, which represented potentially dilutive securities of 144 thousand and 7.8 million, respectively, from the calculation of diluted net income (loss) per share due to their anti-dilutive nature.

For the six months ended June 30, 2026 and 2025, the Company excluded common stock equivalents for outstanding stock-based awards, which represented potentially dilutive securities of 7.4 million and 6.4 million, respectively, from the calculation of diluted net loss per share due to their anti-dilutive nature.

3. Business Combinations

Terminated Silicon Motion Merger

On May 5, 2022, MaxLinear entered into an Agreement and Plan of Merger, or the Merger Agreement, with Silicon Motion Technology Corporation, or Silicon Motion, an exempted company with limited liability incorporated under the laws of the Cayman Islands, pursuant to which, among other things and subject to the terms and conditions thereof, MaxLinear agreed to acquire Silicon Motion pursuant to a statutory merger, under the laws of the Cayman Islands, of Shark Merger Sub, a wholly-owned subsidiary of MaxLinear, with and into Silicon Motion, with Silicon Motion surviving the merger as a wholly-owned

14

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

subsidiary of MaxLinear. Silicon Motion is a provider of NAND flash controllers for solid state drives, or SSDs, and other solid state storage devices.

On July 26, 2023, MaxLinear terminated the Merger Agreement and notified Silicon Motion that MaxLinear was relieved of its obligations to close because, among other reasons, (i) certain conditions to closing set forth in the Merger Agreement were not satisfied and were incapable of being satisfied, (ii) Silicon Motion had suffered a Material Adverse Effect that was continuing, (iii) Silicon Motion was in material breach of representations, warranties, covenants, and agreements in the Merger Agreement that gave rise to the right of the Company to terminate, and (iv) in any event, the First Extended Outside Date had passed and was not automatically extended because certain conditions in Article 6 of the Merger Agreement were not satisfied or waived as of May 5, 2023. For these same reasons, under the terms of the Merger Agreement, MaxLinear was not required to pay a break-up fee or other fee to Silicon Motion as a result of the termination of the Merger Agreement. Undefined capitalized terms in this paragraph have the same meaning as in the Merger Agreement. On August 16, 2023, Silicon Motion delivered to MaxLinear a notice, which Silicon Motion publicly disclosed, that it was purporting to terminate the Merger Agreement and that Silicon Motion would be commencing an arbitration to seek damages from MaxLinear arising from MaxLinear's alleged breaches of the Merger Agreement.

On October 5, 2023, Silicon Motion filed a Notice of Arbitration with the Singapore International Arbitration Centre alleging that MaxLinear breached the Merger Agreement. See Note 14 for more information on legal matters related to the termination of the Merger Agreement.

4. Restructuring Activity

From time to time, the Company approves and implements restructuring plans as a result of internal resource alignment and cost saving measures. Such restructuring plans may include terminating employees, vacating certain leased facilities, and cancelling certain contracts.

The following table presents the activity related to the restructuring plans, which is included in restructuring charges in the consolidated statements of operations:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
	(in thousands)
Employee separation expenses	$	218	$	4,561	$	323	$	6,158
Lease related charges	(176)		933		182		935
Other	22		86		33		6,366
	$	64	$	5,580	$	538	$	13,459

The following table presents a roll-forward of the Company’s restructuring liability for the six months ended June 30, 2026. The restructuring liability is included in accrued expenses and other current liabilities and other long-term liabilities in the consolidated balance sheets.

	Employee Separation Expenses		Lease Related Charges		Other		Total
	(in thousands)
Liability as of December 31, 2025	$	2,857	$	858	$	11,243	$	14,958
Restructuring charges	323		182		33		538
Cash payments	(2,707)		(172)		(8,818)		(11,697)
Non-cash charges and adjustments	(254)		101		138		(15)
Liability as of June 30, 2026	219		969		2,596		3,784
Less: current portion as of June 30, 2026	(219)		(969)		(1,175)		(2,363)
Long-term portion as of June 30, 2026	$	—	$	—	$	1,421	$	1,421

15

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

5. Goodwill and Intangible Assets

Goodwill

Goodwill arises from the acquisition method of accounting for business combinations and represents the excess of the purchase price over the fair value of the net assets and other identifiable intangible assets acquired. The fair values of net tangible assets and intangible assets acquired are based upon preliminary valuations and the Company’s estimates and assumptions are subject to change within the measurement period (potentially up to one year from the acquisition date).

There were no changes in the carrying amount of goodwill for the six months ended June 30, 2026 and 2025.

The Company performs an annual goodwill impairment assessment on October 31st each year, using a quantitative assessment comparing the fair value of each reporting unit, which the Company has determined to be the entity itself, with its carrying amount, including goodwill. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recorded. As a result of the Company’s impairment assessment, no goodwill impairment was recognized as of October 31, 2025.

In addition to its annual review, the Company performs a test of impairment when indicators of impairment are present. During the six months ended June 30, 2026 and 2025, there were no indications of impairment of the Company’s goodwill balances.

Acquired Intangibles

Finite-lived Intangible Assets

The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which are amortized over their estimated useful lives:

		June 30, 2026						December 31, 2025
	Weighted Average Useful Life (in Years)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
		(in thousands)
Licensed technology	6.9	$	33,523	$	(4,917)	$	28,606	$	31,858	$	(3,663)	$	28,195
Developed technology	6.9	311,261		(298,872)		12,389		311,261		(293,761)		17,500
Trademarks and trade names	6.2	14,800		(14,633)		167		14,800		(14,562)		238
Patents	7.0	4,780		(2,162)		2,618		4,780		(1,821)		2,959
	6.0	$	364,364	$	(320,584)	$	43,780	$	362,699	$	(313,807)	$	48,892

The following table sets forth amortization expense associated with finite-lived intangible assets, which is included in the consolidated statements of operations as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
	(in thousands)
Cost of net revenue	$	3,213	$	2,844	$	6,342	$	5,673
Selling, general and administrative	229		591		435		1,183
	$	3,442	$	3,435	$	6,777	$	6,856

Amortization of finite-lived intangible assets in cost of net revenue in the consolidated statements of operations results primarily from acquired developed technology.

16

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

The following table sets forth the activity related to finite-lived intangible assets:

	Six Months Ended June 30,
	2026		2025
	(in thousands)
Beginning balance	$	48,892	$	55,008
Additions	1,665		6,207
Amortization	(6,777)		(6,856)
Ending balance	$	43,780	$	54,359

The Company regularly reviews the carrying amount of its long-lived assets subject to depreciation and amortization, as well as the related useful lives, to determine whether indicators of impairment may exist that warrant adjustments to carrying values or estimated useful lives. An impairment loss is recognized when the sum of the expected future undiscounted net cash flows is less than the carrying amount of the asset. Should impairment exist, the impairment loss is measured based on the excess of the carrying amount of the asset over the asset’s fair value.

During each of the three and six months ended June 30, 2026 and 2025, no impairment losses related to finite-lived intangible assets were recognized.

The following table presents future amortization of the Company’s finite-lived intangible assets at June 30, 2026:

	Amount
	(in thousands)
2026 (6 months)	$	7,427
2027	11,834
2028	6,388
2029	5,297
2030	4,167
Thereafter	8,667
Total	$	43,780

6. Financial Instruments

The composition of financial instruments is as follows:

	Fair Value
	June 30, 2026		December 31, 2025
	(in thousands)
Liabilities
Contingent consideration	$	2,600	$	2,600

The fair value of the Company’s financial instruments is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants and is recorded using a hierarchical disclosure framework based upon the level of subjectivity of the inputs used in measuring assets and liabilities. The levels are described below:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.

Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

Level 3: Unobservable inputs are used when little or no market data is available.

17

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

The Company classifies its financial instruments that are categorized within Level 1 or Level 2 of the fair value hierarchy on the basis of valuations using quoted market prices or alternate pricing sources and models utilizing market observable inputs, respectively.

The contingent consideration liability of $2.6 million as of June 30, 2026 and December 31, 2025 is associated with an acquisition in January 2023. The contingent consideration liability is classified as a Level 3 (significant unobservable inputs) financial instrument. The contingent consideration as it relates to the acquisition was subject to the acquired business’ satisfaction of certain personnel objectives by June 17, 2024, but remains unpaid pending resolution of certain matters. The fair value of the contingent consideration was based on (1) applying the Monte Carlo simulation method, with underlying forecast mathematics based on Geometric Brownian motion in a risk-neutral framework, to forecast achievement of the acquired business’ financial objectives, if applicable, under various possible contingent consideration events and (2) a probability based methodology using management’s inputs and assumptions to forecast achievement of the acquired business’ personnel objectives which included an assumption of total payments up to $2.6 million to the acquiree. Key inputs in the valuation include forecasted revenue, revenue volatility, discount rate and discount term as it relates to the financial objectives and probability of achievement, discount term and discount rate as it relates to the personnel objectives.

There was no activity in the Level 3 fair value hierarchy categories of financial instruments for the six months ended June 30, 2026 and 2025.

There were no transfers between Level 1, Level 2, or Level 3 fair value hierarchy categories of financial instruments for the six months ended June 30, 2026 and 2025.

Financial Instruments Not Recorded at Fair Value on a Recurring Basis

Some of the Company’s financial instruments are recorded at amounts that approximate fair value due to their liquid or short-term nature. Such financial assets and financial liabilities include: cash and cash equivalents, restricted cash, net receivables, certain other assets, accounts payable, accrued price protection liability, accrued expenses, accrued compensation costs, and other current liabilities.

The Company’s long-term debt is not recorded at fair value on a recurring basis but is measured at fair value for disclosure purposes (Note 8).

7. Balance Sheet Details

Cash, cash equivalents and restricted cash consist of the following:

	June 30, 2026		December 31, 2025
	(in thousands)
Cash and cash equivalents	$	64,814	$	72,806
Short-term restricted cash	1,492		1,419
Long-term restricted cash	27,426		27,187
Total cash, cash equivalents and restricted cash	$	93,732	$	101,412

As of June 30, 2026 and December 31, 2025, cash and cash equivalents included money market funds of approximately $2.0 million and $19.2 million, respectively. As of June 30, 2026 and December 31, 2025, the Company had restricted cash of approximately $28.9 million and $28.6 million, respectively. The cash is restricted in connection with guarantees for certain import duties, office leases and purchase obligations.

Inventory consists of the following:

	June 30, 2026		December 31, 2025
	(in thousands)
Work-in-process	$	79,012	$	47,598
Finished goods	26,478		30,506
	$	105,490	$	78,104

18

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

Property and equipment, net consists of the following:

	Useful Life (in Years)	June 30, 2026		December 31, 2025
		(in thousands)
Furniture and fixtures	5	$	4,101	$	4,006
Machinery and equipment	3-5	88,929		87,043
Masks and production equipment	5	68,028		66,044
Software	3	11,253		11,498
Leasehold improvements	1-5	36,127		35,632
Construction in progress	N/A	1,315		2,516
		209,753		206,739
Less: accumulated depreciation and amortization		(168,546)		(157,866)
		$	41,207	$	48,873

Depreciation expense for the three months ended June 30, 2026 and 2025 was $5.6 million and $5.9 million, respectively. Depreciation expense for the six months ended June 30, 2026 and 2025 was $11.4 million and $11.7 million, respectively.

As of June 30, 2026, the Company held a note receivable from a supplier of $8.0 million with annual repayments of $2.0 million per year due annually by March 31, from 2027 through 2030, provided that certain production utilization targets are met. The long-term portion of the note receivable of $6.0 million is included in other long-term assets as of June 30, 2026 and December 31, 2025, respectively.

On January 5, 2026, the Company entered into a convertible note receivable of $2.0 million with a privately-held entity. The convertible note receivable bears interest at an annual rate of 3.87%, compounded annually. The note is due and payable at any time on or after the maturity date of January 5, 2029, unless earlier converted. The outstanding principal and any unpaid accrued interest are convertible into shares of the entity or repayable under certain conditions. Conversion occurs automatically upon the closing of the investee’s next equity financing of at least $10.0 million, provided the entity has achieved a specified milestone prior to such financing, or conversion may be elected by the Company under certain conditions. If the entity fails to achieve the milestone prior to the maturity date, the Company may, at any time on or after maturity, elect either repayment of the outstanding principal and accrued interest or conversion into shares of the entity. The convertible note receivable of $2.0 million is included in other long-term assets as of June 30, 2026.

The following table sets forth activity related to the accrued price protection liability:

	Six Months Ended June 30,
	2026		2025
	(in thousands)
Beginning balance	$	26,493	$	43,401
Charged as a reduction of revenue	15,890		14,353
Revisions to accrued rebates	(2,440)		(12,170)
Payments	(8,751)		(6,064)
Ending balance	$	31,192	$	39,520

19

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

Accrued expenses and other current liabilities consist of the following:

	June 30, 2026		December 31, 2025
	(in thousands)
Accrued technology license payments	$	3,627	$	3,687
Accrued professional fees	5,198		6,882
Accrued engineering and production costs	11,496		8,469
Accrued restructuring	2,363		13,390
Short-term lease liabilities	8,806		9,096
Accrued customer credits	5,197		6,398
Income tax liability	432		511
Customer contract liabilities	397		4,222
Accrued obligations to customers for price adjustments	10,420		11,922
Accrued obligations to customers for stock rotation rights	247		222
Contingent consideration - current portion	2,600		2,600
Other	7,461		4,993
	$	58,244	$	72,392

The following table summarizes the change in balances of accumulated other comprehensive income (loss) by component:

	Cumulative Translation Adjustments		Pension and Other Defined Benefit Plan Obligation		Total
	(in thousands)
Balance at December 31, 2025	$	(327)	$	1,357	$	1,030
Other comprehensive loss before reclassifications, net of tax	319		—		319
Balance at June 30, 2026	$	(8)	$	1,357	$	1,349

8. Debt and Other Long-Term Liabilities

Debt

The carrying amount of the Company’s long-term debt consists of the following:

	June 30, 2026		December 31, 2025
	(in thousands)
Principal balance:
Initial term loan under the June 23, 2021 credit agreement	$	125,000	$	125,000
Total principal balance	125,000		125,000
Less:
Unamortized debt discount	(258)		(320)
Unamortized debt issuance costs	(816)		(1,062)
Net carrying amount of long-term debt	123,926		123,618
Less: current portion of long-term debt	—		—
Long-term debt, non-current portion	$	123,926	$	123,618

As of June 30, 2026 and December 31, 2025, the weighted average effective interest rate on aggregate debt was approximately 6.4% and 6.9%, respectively.

During the three months ended June 30, 2026 and 2025, the Company recognized total amortization of debt discount and debt issuance costs of $0.2 million and $0.2 million, respectively, to interest expense. During the six months ended June 30,

20

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

2026 and 2025, the Company recognized total amortization of debt discount and debt issuance costs of $0.3 million and $0.3 million, respectively, to interest expense.

The approximate aggregate fair value of the term loans outstanding as of June 30, 2026 and December 31, 2025 was $123.3 million and $124.7 million, respectively, which was estimated on the basis of inputs that are observable in the market and which is considered a Level 2 measurement method in the fair value hierarchy (Note 6).

As of June 30, 2026, the outstanding principal balance of $125.0 million is due in full on June 23, 2028, upon maturity of the loan.Initial Term Loan and Revolving Facility under the June 23, 2021 Credit Agreement

On June 23, 2021, the Company entered into a Credit Agreement, or the June 23, 2021 Credit Agreement, by and among the Company, the lenders from time to time party thereto, and Wells Fargo Bank, National Association, as administrative agent and collateral agent, or “Agent”, that provides for a senior secured term B loan facility, or the Initial Term Loan under the June 23, 2021 Credit Agreement, in an aggregate principal amount of $350.0 million and a senior secured revolving credit facility, or the Revolving Facility, in an aggregate principal amount of up to $100.0 million. The proceeds of the Initial Term Loan under the June 23, 2021 Credit Agreement were used (i) to repay in full all outstanding indebtedness under that certain Credit Agreement dated May 12, 2017, by and among the Company, MUFG Bank Ltd., as administrative agent and MUFG Union Bank, N.A., as collateral agent and the lenders from time to time party thereto (as amended by Amendment No. 1, dated July 31, 2020) and (ii) to pay fees and expenses incurred in connection therewith. The remaining proceeds of the Initial Term Loan under the June 23, 2021 Credit Agreement are available for general corporate purposes and the proceeds of the Revolving Facility may be used to finance the working capital needs and other general corporate purposes of the Company and its subsidiaries. Under the terminated amended and restated commitment letter with Wells Fargo Bank and other lenders entered into in connection with the previously pending (now terminated) merger with Silicon Motion (Note 3), the Company had expected to repay the remaining outstanding term loans under such agreement upon closing of the merger.

The June 23, 2021 Credit Agreement permits the Company to request incremental loans in an aggregate principal amount not to exceed the sum of an amount equal to the greater of (x) $175.0 million and (y) 100% of consolidated EBITDA, plus the amount of certain voluntary prepayments, plus an unlimited amount that is subject to pro forma compliance with certain first lien net leverage ratio, secured net leverage ratio and total net leverage ratio tests. Incremental loans are subject to certain additional conditions, including obtaining additional commitments from the lenders then party to the June 23, 2021 Credit Agreement or new lenders.

Under the June 23, 2021 Credit Agreement, the Initial Term Loan bears interest, at the Company’s option, at a per annum rate equal to either (i) a base rate equal to the highest of (x) the federal funds rate, plus 0.50%, (y) the prime rate then in effect and (z) an adjusted Term SOFR rate determined on the basis of a one-month interest period plus 1.00%, in each case, plus an applicable margin of 1.25% or (ii) an adjusted Term SOFR rate, subject to a floor of 0.50%, plus an applicable margin of 2.25%. Loans under the Revolving Facility initially bear interest, at a per annum rate equal to either (i) a base rate (as calculated above) plus an applicable margin of 0.00%, or (ii) an adjusted Term SOFR rate (as calculated above) plus an applicable margin of 1.00%. Following delivery of financial statements for the Company’s fiscal quarter ending June 30, 2021, the applicable margin for loans under the Revolving Facility will range from 0.00% to 0.75% in the case of base rate loans and 1.00% to 1.75% in the case of Term SOFR rate loans, in each case, depending on the Company’s secured net leverage ratio as of the most recently ended fiscal quarter. The Company is required to pay commitment fees of 0.25% per annum on the daily undrawn commitments under the Revolving Facility, depending on the Company’s secured net leverage ratio as of the most recently ended fiscal quarter. The Initial Term Loan under the June 23, 2021 Credit Agreement was initially set to amortize in equal quarterly installments from September 30, 2021 equal to 0.25% of the original principal amount of the Initial Term Loan under the June 23, 2021 Credit Agreement, with the balance payable on the maturity date. Due to prepayments of the principal made to date, the remaining principal balance of $125.0 million is payable on the June 23, 2028 maturity date. The June 23, 2021 Credit Agreement was amended on June 29, 2023 to implement a benchmark replacement.

On April 22, 2026, the Company entered into an amendment with the lenders party thereto and the Agent, or the Second Amendment. The Second Amendment amended the June 23, 2021 Credit Agreement to, among other things, (i) extend the maturity date applicable to the Revolving Facility from June 23, 2026 to March 23, 2028, (ii) provide for $30 million in incremental revolving commitments under the Revolving Facility and a $10.0 million Letter of Credit Commitment,, (iii) increase the applicable margin for loans under the Revolving Facility to (x) 2.25% per annum for Term SOFR loans, and (y) 1.25% per annum for base rate loans, and (iv) increase the applicable commitment fee rate to 0.25% per annum. Further, the financial covenant was modified to require that the Company maintain (a) a total net leverage ratio of not greater than 3.50:1.00

21

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

and (b) unrestricted cash plus available and undrawn commitments under the Revolving Facility in an amount not to exceed 100% of the Consolidated EBITDA for the most recently ended Test Period, in each case, tested as of the last day of any fiscal quarter of the Company. The proceeds of the Revolving Facility may be used to finance the working capital needs and other general corporate purposes of the Company and its subsidiaries. As of June 30, 2026, there were no borrowings outstanding under the Revolving Facility.

The Company is required to make mandatory prepayments of the outstanding principal amount of term loans under the June 23, 2021 Credit Agreement, or as amended by the Second Amendment, the Amended Credit Agreement, with the net cash proceeds from the disposition of certain assets and the receipt of insurance proceeds upon certain casualty and condemnation events, in each case, to the extent not reinvested within a specified time period, from excess cash flow beyond stated threshold amounts, and from the incurrence of certain indebtedness. The Company has the right to prepay its term loans under the Amended Credit Agreement, in whole or in part, at any time without premium or penalty, subject to certain limitations and a 1.0% soft call premium applicable during the first six months following the closing date of the Amended Credit Agreement. The Initial Term Loan under the June 23, 2021 Credit Agreement will mature on June 23, 2028, at which time all outstanding principal and accrued and unpaid interest on the Initial Term Loan under the June 23, 2021 Credit Agreement must be repaid. The Revolving Facility will mature on March 23, 2028, at which time all outstanding principal and accrued and unpaid interest under the Revolving Facility must be repaid. The Company is also obligated to pay fees customary for a credit facility of this size and type.

The Company’s obligations under the Amended Credit Agreement are required to be guaranteed by certain of its domestic subsidiaries meeting materiality thresholds set forth in the Amended Credit Agreement. Such obligations, including the guaranties, are secured by substantially all of the assets of the Company and the subsidiary guarantors pursuant to a Security Agreement, dated as of June 23, 2021, by and among the Company, the subsidiary guarantors from time to time party thereto, and Wells Fargo Bank, National Association, as collateral agent.

The Amended Credit Agreement contains customary affirmative and negative covenants, including covenants limiting the ability of the Company and its restricted subsidiaries to, among other things, incur debt, grant liens, undergo certain fundamental changes, make investments, make certain restricted payments, and sell assets, in each case, subject to limitations and exceptions set forth in the Amended Credit Agreement. The Revolving Facility also prohibits the Company from having a secured net leverage ratio in excess of 3.50:1.00 (subject to a temporary increase to 3.75:1.00 following the consummation of certain material permitted acquisitions) as of the last day of any fiscal quarter of the Company (commencing with the fiscal quarter ending September 30, 2021) if the aggregate borrowings under the Revolving Facility exceed 1% of the aggregate commitments thereunder (subject to certain exceptions set forth in the Amended Credit Agreement) as of such date. As of June 30, 2026, the Company was in compliance with such covenants. The Amended Credit Agreement also contains customary events of default that include, among other things, certain payment defaults, cross defaults to other indebtedness, covenant defaults, change in control defaults, judgment defaults, and bankruptcy and insolvency defaults. If an event of default exists, the lenders may require immediate payment of all obligations under the Amended Credit Agreement and may exercise certain other rights and remedies provided for under the Amended Credit Agreement, the other loan documents and applicable law.

The debt is carried at its principal amount, net of unamortized debt discount and issuance costs, and is not adjusted to fair value each period. The issuance date fair value of the liability component of the debt in the amount of $350.2 million was determined using a discounted cash flow analysis, in which the projected interest and principal payments were discounted back to the issuance date of the term loan at a market interest rate for nonconvertible debt of 3.4%, which represents a Level 2 fair value measurement. The debt discount of $0.9 million and debt issuance costs of $2.9 million associated with the Initial Term Loan under the Amended Credit Agreement are being amortized to interest expense using the effective interest method over its seven-year term through June 23, 2028. Debt issuance costs of $0.4 million associated with the Revolving Facility are being amortized to interest expense over its five-year original term through June 23, 2026, with the portion for incremental debt issuance costs of $0.5 million associated with the Second Amendment amortized to interest expense over the period from the date incurred through March 23, 2028.

Sale Arrangement

In March 2026, the Company entered into an agreement to sell an interest in certain claims for an amount not to exceed $10.0 million. The proceeds of this sale of $8.0 million were used to pay certain costs and expenses in connection with such claims, and are reflected as a long-term liability as of June 30, 2026. This liability is expected to be derecognized upon settlement or other resolution of the specified claims. Management does not believe that any additional potential payments that are contingent on the outcome of the claims are estimable as of June 30, 2026.

22

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

9. Stock-Based Compensation

Common Stock

Each share of common stock is entitled to one vote per share and holders of the common stock vote as a single class of stock on any matter that is submitted to a vote of stockholders.

Employee Stock-Based Compensation Plans

At June 30, 2026, the Company had stock-based compensation awards outstanding under the following plans: the 2010 Equity Incentive Plan, as amended, or 2010 Plan, the 2010 Employee Stock Purchase Plan, or ESPP, and the 2024 Inducement Equity Incentive Plan, or the Inducement Plan. Refer to the Company’s Annual Report for a summary of these plans.

On May 20, 2026, an amendment and restatement of the 2010 Plan, or the Restated 2010 Plan, and an amendment and restatement of the ESPP, or the Restated ESPP, became effective upon approval by the Company’s stockholders. Concurrently, on May 20, 2026, the Company terminated the Inducement Plan. The Restated Incentive Plan reserves an aggregate of 18,791,651 shares of the Company’s common stock for issuance under the plan, expires in May 2036, and (1) requires stockholder approval to increase the maximum number of shares reserved and available for issuance under the Restated 2010 Plan, (2) prohibits share recycling, or add back to shares available for issuance under the Restated 2010 Plan, of shares of stock used to pay the exercise or purchase price of an award or to satisfy tax withholding obligations, (3) prohibits option exchanges, re-pricings or cash buyouts of out-of-the money stock options. The Restated ESPP will remain in effect until it is terminated. The amendment and restatement of the ESPP also removes the annual automatic increase of the number of shares reserved and available for sale thereunder. As of June 30, 2026, the number of shares of common stock available for future issuance under the Restated 2010 Plan was 17,032,561 shares, including stock options and restricted stock unit awards outstanding at June 30, 2026 of 11,910,556 shares.

As of June 30, 2026, the number of shares of common stock available for future issuance under the ESPP was 7,766,912 shares.

As of June 30, 2026, the 713,220 shares subject to restricted stock unit awards outstanding as of June 30, 2026 remain available for future issuance under the terminated Inducement Plan.

Employee Incentive Bonus

The Company’s Executive Incentive Bonus Plan permits the settlement of awards under the plan in any combination of cash or shares of its common stock. The Company settles a majority of bonus awards for its employees, including executives, in shares of common stock under the Restated 2010 Plan. When bonus awards are settled in common stock issued under the Restated 2010 Plan, the number of shares issuable to plan participants is determined based on the closing price of the Company’s common stock as determined in trading on the applicable stock exchange, on a date approved by the Board of Directors. In connection with the Company’s bonus programs, in February 2026, the Company issued 1.5 million freely-tradable (subject to certain restrictions for affiliates) shares of the Company’s common stock in settlement of bonus awards to employees, including executives, for the 2025 performance period. At June 30, 2026, the Company has an accrual of $18.0 million for bonus awards for employees for year-to-date achievement in the 2026 performance period, which the Company intends to settle primarily in shares of its common stock, unless otherwise required to be settled in cash due to local laws or agreements. The Company’s compensation committee retains discretion to effect payment of employee bonus awards in cash, stock, or a combination of cash and stock.

23

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

Stock-Based Compensation

The Company recognizes stock-based compensation in the consolidated statements of operations, based on the department to which the related employee reports, as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
	(in thousands)
Cost of net revenue	$	131	$	155	$	281	$	437
Research and development	10,535		7,625		20,210		22,281
Selling, general and administrative	16,813		5,333		27,015		13,306
	$	27,479	$	13,113	$	47,506	$	36,024

The total unrecognized compensation cost related to unvested restricted stock units as of June 30, 2026 was $99.7 million, and the weighted average period over which these equity awards are expected to vest is 2.15 years.

The total unrecognized compensation cost related to unvested performance-based restricted stock units as of June 30, 2026 was $9.2 million, and the weighted average period over which these equity awards are expected to vest is 1.35 years. Actual levels of future performance under performance-based restricted stock units for the unvested periods may differ from the Company’s current estimates.

The total unrecognized compensation cost related to unvested stock options as of June 30, 2026 was $12.9 million, and the weighted average period over which these equity awards are expected to vest is 1.64 years.

Restricted Stock Units

A summary of the Company’s restricted stock unit activity for all equity plans is as follows:

	Number of Shares (in thousands)	Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 2025	7,649	$	19.89
Granted1	4,096	21.06
Vested2	(4,127)	19.99
Canceled3	(389)	18.92
Outstanding at June 30, 2026	7,229	$	20.55

____________
(1) Includes approximately 148 thousand shares granted under the Inducement Plan at a weighted-average grant-date fair value per share of $18.47.

(2) Includes approximately 38 thousand shares vested under the Inducement Plan at a weighted-average grant-date fair value per share of $14.00.

(3) Includes approximately 70 thousand shares canceled under the Inducement Plan at a weighted-average grant-date fair value per share of $15.35.

Performance-Based Restricted Stock Units

Performance-based restricted stock units are eligible to vest at the end of each year in a three-year performance period based on certain financial metrics as defined in the underlying agreement.

2025 and Subsequent Performance-Based Restricted Stock Units

For performance-based restricted stock units granted in 2025 and 2026, the award is divided into four approximately equal tranches each representing 25% of the target number of performance-based restricted stock units subject to the award. Each tranche has one or more performance goals that must be achieved in order for any restricted stock units subject to the tranche to become eligible to vest. For the first tranche, which covers one fiscal year in a three-year period, restricted stock units are eligible to vest based upon the achievement of certain net revenue and non-GAAP operating income targets. For two

24

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

of the four tranches, each of which cover one fiscal year in a three-year period, restricted stock units are eligible to vest when the Company’s annual growth rate in net revenue and non-GAAP operating income over baseline results equal or exceed target growth rates, as defined in the underlying agreement. For each of these three tranches, 50% of each performance-based award is subject to the net revenue metric for the performance period and 50% is subject to the non-GAAP operating income metric for the respective performance period. If the Company’s baseline results, or growth rate in each of these metrics relative to the baseline results, are below a determined threshold for a performance period for a particular performance metric and tranche, no shares in the performance metric and tranche will vest. The number of shares vesting is based on meeting minimum threshold, target, or maximum pre-determined baseline for the first year, and growth rate relative to the baseline thereafter, up to a maximum 200% of target; however, any shares above target (100%) will only become eligible to vest with continued service through the end of year three.

The fourth tranche of performance-based restricted stock units is measured over a three-year performance period, and shares are eligible to vest for this tranche based on the Company’s relative percentile rank in growth rate in net revenue for the third year over baseline results relative to the growth rates for companies in the Russell 3000 index for the same metric and periods. The Company’s relative percentile rank in net revenue is determined by ranking the individual companies in the Russell 3000 (including MaxLinear) in order of largest to smallest according to their revenue growth for the third year over baseline results, then calculating the percentile ranking of MaxLinear relative to other Russell 3000 companies. If the Company’s relative percentile rank for revenue growth at the end of the third year versus baseline is less than the predetermined threshold, as defined in the underlying agreement, no shares will vest. The target number of shares are eligible to vest when the Company’s relative percentile rank equals or exceeds the 50th percentile. The maximum shares that may be achieved is 200% of target shares for performance at or above the 75th percentile.

2024 and Prior Performance-Based Restricted Stock Units

For previous performance-based restricted stock units granted prior to 2025, the target number of units (100%) are eligible to vest when the annual growth rate in net revenue and non-GAAP diluted earnings per share (subject to certain adjustments) over baseline results relative to the growth rates for a peer group of companies for the same metrics and periods, equals or exceeds the 50th percentile.

The Company’s relative percentile rank in net revenue and non-GAAP diluted earnings per share is determined by ranking the designated peer group companies (including MaxLinear) from the highest to the lowest according to their annual growth rate in each metric for the performance year, then calculating the percentile ranking of MaxLinear relative to other companies in the designated peer group. If the Company’s relative percentile rank for each metric at year-end is less than the 25th percentile, no shares will vest. If the Company’s relative percentile rank for these metrics is greater than or equal to the 25th percentile, vesting may range from 50% up to a maximum 250% of target; such maximum may only vest at the end of year three for performance achieved at or above the 75th percentile.

For the performance-based restricted stock units granted prior to 2025, 60% of each performance-based award is subject to the net revenue metric for the performance period and 40% is subject to the non-GAAP diluted earnings per share metric for the performance period. The maximum percentage for a particular metric is 250% of the target number of units subject to the award related to that metric, however, vesting of the performance stock units is capped at 30% and 100%, respectively, of the target number of units subject to the award in years one and two, respectively, of the three-year performance period. The number of shares granted is based on the maximum percentage achievable (250%) in the performance-based restricted stock unit award, in order to reserve an adequate number of shares for any potential future vesting.

As of June 30, 2026, achievement to date under the performance metrics specified in the respective award agreements are based on its expected metric results over the performance periods and calculated growth rates relative to baseline based on data available, as defined in the respective award agreements. To the extent any prior achievement levels are no longer probable, any compensation expense recorded is adjusted to the revised achievement levels.

25

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

A summary of the Company’s performance-based restricted stock unit activity is as follows:

	Number of Shares (in thousands)	Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 2025	3,333	$	19.58
Granted	623	18.47
Released	(83)	15.19
Canceled1	(1,021)	25.46
Outstanding at June 30, 2026	2,852	$	17.36

________________

(1) Includes shares canceled due to achievement below threshold amounts from shares granted which were previously reserved at the maximum achievable (250%). No shares were eligible to vest for the 2025 performance period under the 2023 and 2024 performance-based restricted stock unit grants due to achievement below the 25th percentile.

Employee Stock Purchase Rights and Stock Options

Employee Stock Purchase Rights

During the six months ended June 30, 2026 and 2025, there were 174,470 and 201,877 shares of common stock purchased under the ESPP at a weighted average price of $11.24 and $10.79, respectively.

The fair values of employee stock purchase rights were estimated using the Black-Scholes option pricing model at their respective grant date using the following assumptions:

	Six Months Ended June 30,
	2026		2025
Weighted-average grant date fair value per share	$4.22 to $43.36		$5.24 to $6.00
Risk-free interest rate	3.77% to 3.81%		4.29% to 4.44%
Dividend yield	—	%	—	%
Expected life (in years)	0.49 to 0.51		0.50 to 0.51
Volatility	59.07% to 113.93%		92.19% to 95.74%

The risk-free interest rate assumption was based on rates for United States (U.S.) Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued. The assumed dividend yield was based on the Company’s expectation of not paying dividends in the foreseeable future. The expected term is the duration of the offering period for each grant date. In addition, the estimated volatility incorporates the historical volatility over the expected term based on the Company’s daily closing stock prices.

Stock Options

A summary of the Company’s stock options activity is as follows:

	Number of Options (in thousands)	Weighted-Average Exercise Price		Weighted-Average Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2025	2,718	$	19.39
Exercised	(100)	18.76
Canceled	(200)	$	18.76
Outstanding at June 30, 2026	2,418	$	19.48	6.9	$	262,464
Vested and expected to vest at June 30, 2026	2,330	$	19.47	6.9	$	252,979
Exercisable at June 30, 2026	949	$	19.22	5.7	$	103,303

No options were granted during the six months ended June 30, 2026 and 2025.

26

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

The intrinsic value of stock options exercised was $2.9 million and $0 in the three months ended June 30, 2026 and 2025, respectively. The intrinsic value of stock options exercised was $2.9 million and $0 in the six months ended June 30, 2026 and 2025, respectively.

Cash received from exercise of stock options was $3.1 million during each of the three and six months ended June 30, 2026 and negligible during each of the three and six months ended June 30, 2025.

The tax benefit from stock options exercised was $0.6 million and $0 during the three months ended June 30, 2026 and 2025, respectively. The tax benefit from stock options exercised was $0.6 million and $0 during the six months ended June 30, 2026 and 2025, respectively.

10. Income Taxes

The provision for income taxes primarily relates to projected federal, state, and foreign income taxes. To determine the quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is generally based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates. In addition, the tax effects of certain significant or unusual items are recognized discretely in the quarter during which they occur and can be a source of variability in the effective tax rates from quarter to quarter.

The Company utilizes the asset and liability method of accounting for income taxes, under which deferred tax assets and liabilities are determined based on temporary differences between the financial statement and tax basis of assets and liabilities using enacted tax rates expected to be in effect during the years in which the temporary differences reverse. The Company records a valuation allowance to reduce its deferred taxes to the amount it believes is more likely than not to be realized. In making such determination, the Company considers all available positive and negative evidence quarterly, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, and recent financial performance. Forming a conclusion that a valuation allowance is not required is difficult when there is negative evidence such as cumulative losses in recent years. Based upon the Company’s review of all positive and negative evidence, the Company continues to have a valuation allowance on its state deferred tax assets, certain of its federal deferred tax assets, and certain foreign deferred tax assets in jurisdictions where the Company has cumulative losses or otherwise is not expected to utilize certain tax attributes. The Company does not incur expense or benefit in certain tax-free jurisdictions in which it operates.

The Company recorded an income tax benefit of $8.3 million in the three months ended June 30, 2026 and an income tax benefit of $4.1 million in the three months ended June 30, 2025. The Company recorded an income tax provision of $18.2 million in the six months ended June 30, 2026 and an income tax benefit of $3.4 million in the six months ended June 30, 2025.

The difference between the Company’s effective tax rate and the 21.0% United States federal statutory rate for the six months ended June 30, 2026 primarily related to the mix of pre-tax income among jurisdictions, permanent tax items including a tax on net controlled foreign corporation tested income, or NCTI, stock-based compensation, and the impact of the valuation allowance against the Company’s Singapore deferred tax assets.

The difference between the Company’s effective tax rate and the 21.0% U.S. federal statutory rate for the six months ended June 30, 2025 primarily related to the mix of pre-tax income among jurisdictions, permanent tax items, and stock-based compensation and the impact of the valuation allowance against the Company's Singapore deferred tax assets.

Income tax positions must meet a more-likely-than-not threshold to be recognized. Income tax positions that previously failed to meet the more-likely-than-not threshold are recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not threshold are de-recognized in the first financial reporting period in which that threshold is no longer met. The Company records potential penalties and interest accrued related to unrecognized tax benefits within the consolidated statements of operations as income tax expense.

During the six months ended June 30, 2026, the Company’s unrecognized tax benefits increased by $1.0 million. The Company does not expect its unrecognized tax benefits to change significantly over the next 12 months. Accrued interest and penalties associated with uncertain tax positions as of June 30, 2026 were approximately $0 and $0, respectively.

The Company is subject to federal and state income tax in the United States and is also subject to income tax in certain other foreign tax jurisdictions. At June 30, 2026, the statutes of limitations for the assessment of federal, state, and foreign income taxes are closed for the years before 2022, 2021, and 2018, respectively.

27

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

The Company’s subsidiary in Singapore operates under certain tax incentives in Singapore, which are generally effective through March 2027, and are conditional upon meeting certain employment and investment thresholds in Singapore. Under the incentives, qualifying income derived from certain sales of the Company’s integrated circuits is taxed at a concessionary rate over the incentive period, and there are reduced Singapore withholding taxes on certain intercompany royalties during the incentive period. During the quarter ended December 31, 2024, the Company recorded a full valuation allowance against its Singapore deferred tax assets. No deferred tax benefit was recognized on the Singapore net loss and deductible temporary differences for the three and six months ended June 30, 2026 and 2025 due to the valuation allowance.

11. Concentration of Credit Risk, Significant Customers and Geographic Information

Concentration of Credit Risk

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents and accounts receivable. Collateral is generally not required for customer receivables. The Company limits its exposure to credit loss by placing its cash with high credit quality financial institutions. At times, such deposits may be in excess of insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents.

Significant Customers

The Company markets its products and services to manufacturers of a wide range of electronic devices (Note 1). The Company sells its products both directly to end-customers and through third-party distributors, both of which are referred to as the Company’s customers (Note 12). Revenue is also generated from sales of intellectual property, and the recipients of such intellectual property are also referred to as the Company’s customers. The Company makes periodic evaluations of the credit worthiness of its customers.

Customers comprising 10% or greater of net revenues for each of the periods presented are as follows:

	Three Months Ended June 30,			Six Months Ended June 30,
	2026	2025		2026		2025
Percentage of total net revenue
Customer A	*	16	%	11	%	16	%
Customer B	*	16	%	*		14	%

____________________________

*    Represents less than 10% of the net revenue for the respective period.

The following table presents balances that are 10% or greater of gross accounts receivable, based on the Company’s billings to its customers.

	June 30, 2026		December 31, 2025
Percentage of gross accounts receivable
Customer C	20	%	*
Customer D	12	%	26	%
Customer E	12	%	*
Customer F	*		14	%
Customer G	*		10	%
Customer H	*		10	%

____________________________

*    Represents less than 10% of the gross accounts receivable for the respective period.

28

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

Significant Suppliers

Suppliers comprising 10% or greater of total inventory purchases are as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Vendor A	57	%	29	%	54	%	32	%
Vendor B	13	%	23	%	15	%	21	%
Vendor C	*		14	%	*		14	%

____________________________

*    Represents less than 10% of the total inventory purchases for the respective period.

Geographic Information

The Company’s consolidated net revenues by geographic area based on ship-to location are as follows (dollars in thousands):

	Three Months Ended June 30,								Six Months Ended June 30,
	2026				2025				2026				2025
	Amount		% of total net revenue		Amount		% of total net revenue		Amount		% of total net revenue		Amount		% of total net revenue
Asia	$	143,795	85	%	$	87,118	80	%	$	249,180	81	%	$	162,379	80	%
Europe	15,028		9	%	16,101		15	%	31,317		10	%	31,055		15	%
United States	9,498		6	%	5,223		5	%	23,489		8	%	10,752		5	%
Rest of world	526		—	%	371		—	%	2,049		1	%	560		—	%
Total	$	168,847	100	%	$	108,813	100	%	$	306,035	100	%	$	204,746	100	%

The products shipped to individual countries or territories representing 10% or greater of total net revenue for each of the periods presented are as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Percentage of total net revenue
Hong Kong	48	%	50	%	48	%	49	%
Mainland China	13	%	*		12	%	*
Vietnam	13	%	10	%	10	%	10	%

____________________________

*    Represents less than 10% of total net revenue for the respective period.

The determination of which country a particular sale is allocated to is based on the destination of the product shipment. No other individual country accounted for more than 10% of net revenue during these periods. Although a large percentage of the Company’s products is shipped to Asia, and in particular, Hong Kong, mainland China, and Vietnam, the Company believes that a significant number of the systems designed by customers and incorporating the Company’s semiconductor products are subsequently sold outside Asia to Europe, Middle East, and Africa markets and North American markets.

Long-lived assets, which consist of property and equipment, net, leased right-of-use assets, intangible assets, net, and goodwill by geographic area are as follows (dollars in thousands):

	June 30, 2026				December 31, 2025
	Amount		% of total		Amount		% of total
United States	$	320,820	75	%	$	319,478	74	%
Singapore	83,142		20	%	92,519		21	%
Rest of world	19,337		5	%	19,862		5	%
Total	$	423,299	100	%	$	431,859	100	%

29

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

12. Revenue from Contracts with Customers

Revenue by Market

The table below presents disaggregated net revenues by market (dollars in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
Infrastructure	$	85,016		$	34,709		$	147,830		$	61,270
% of net revenue	50		%	32		%	48		%	30		%
Broadband	44,882			47,556			88,508			88,439
% of net revenue	27		%	44		%	29		%	43		%
Connectivity	23,968			20,741			42,563			40,976
% of net revenue	14		%	19		%	14		%	20		%
Industrial and multi-market	14,981			5,807			27,134			14,061
% of net revenue	9		%	5		%	9		%	7		%
Total net revenue	$	168,847		$	108,813		$	306,035		$	204,746

Revenues from sales through the Company’s distributors accounted for 48% and 31% of net revenue for the three months ended June 30, 2026 and 2025, respectively. Revenues from sales through the Company’s distributors accounted for 47% and 33% of net revenue for the six months ended June 30, 2026 and 2025, respectively.

Contract Liabilities

As of June 30, 2026 and December 31, 2025, customer contract liabilities were approximately $0.4 million and $4.2 million, respectively, and consisted primarily of advance payments received for which performance obligations have not been completed. The decrease in customer contract liabilities was due to recognition of revenue in the six months ended June 30, 2026, which was previously in the contract liability balance as of the beginning of the period.

Obligations to Customers for Price Adjustments and Returns and Assets for Right-of-Returns

As of June 30, 2026 and December 31, 2025, obligations to customers consisting of estimates of price protection rights offered to the Company’s end customers totaled $31.2 million and $26.5 million, respectively, and are included in accrued price protection liability in the consolidated balance sheets. For activity in this account, including amounts included in net revenue, refer to Note 7.

Other obligations to customers representing estimates of price adjustments to be claimed by distributors upon sell-through of their inventory to their end customer and estimates of stock rotation returns to be claimed by distributors on products sold as of June 30, 2026 were $10.4 million and $0.2 million, respectively, and as of December 31, 2025 were $11.9 million and $0.2 million, respectively, and are included in accrued expenses and other current liabilities in the consolidated balance sheets (Note 7).

As of June 30, 2026 and December 31, 2025, right of return assets under customer contracts representing the estimates of product inventory the Company expects to receive from customers in stock rotation returns were approximately $0.1 million and $0.1 million, respectively. Right of return assets are included in inventory in the consolidated balance sheets.

As of June 30, 2026 and December 31, 2025, there were no credit losses recorded on customer accounts receivable.

13. Leases

Operating Leases

Operating lease arrangements primarily consist of office leases expiring in various years through 2033. These leases have original terms of approximately 2 to 8 years and some contain options to extend the lease up to 5 years or terminate the lease, which are included in right-of-use assets and lease liabilities when the Company is reasonably certain it will renew the underlying leases. Since the implicit rate of such leases is unknown and the Company is not reasonably certain to renew its leases, the Company has elected to apply a collateralized incremental borrowing rate to facility leases on the original lease term in calculating the present value of future lease payments. As of June 30, 2026 and December 31, 2025, the weighted average

30

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

discount rate for operating leases was 4.3% and 4.6%, respectively, and the weighted average remaining lease term for operating leases was 3.6 years and 2.7 years, respectively, as of the end of each of these periods.

The table below presents aggregate future minimum payments due under leases, reconciled to total lease liabilities included in the consolidated balance sheet as of June 30, 2026:

	Operating Leases
	(in thousands)
2026 (6 months)	$	5,000
2027	8,937
2028	4,850
2029	3,660
2030	1,939
Thereafter	2,650
Total minimum payments	27,036
Less: imputed interest	(2,763)
Less: unrealized translation loss	(2)
Total lease liabilities	24,271
Less: short-term lease liabilities	(8,806)
Long-term lease liabilities	$	15,465

Operating lease cost was $2.1 million and $2.2 million for the three months ended June 30, 2026 and 2025, respectively. Operating lease cost was $4.3 million and $4.6 million for the six months ended June 30, 2026 and 2025, respectively.

Short-term lease costs for the three and six months ended June 30, 2026 and 2025 were not material.

There were $0 and $0.3 million of right-of-use assets obtained in exchange for new lease liabilities for the three months ended June 30, 2026 and 2025, respectively. There were $8.1 million and $2.0 million of right-of-use assets obtained in exchange for new lease liabilities for the six months ended June 30, 2026 and 2025, respectively.

14. Commitments and Contingencies

Inventory Purchase and Other Contractual Obligations

As of June 30, 2026, future minimum payments under inventory purchase and other obligations are as follows (in thousands):

	Inventory Purchase Obligations		Other Obligations		Total
2026 (6 months)	$	165,109	$	22,424	$	187,533
2027	56,227		25,925		82,152
2028	—		21,846		21,846
2029	—		10,898		10,898
2030	—		647		647
Thereafter	—		2,790		2,790
Total minimum payments	$	221,336	$	84,530	$	305,866

Other obligations consist primarily of contractual payments due for software licenses. Total inventory purchase and other contractual obligations increased from $209.6 million as of December 31, 2025 to $305.9 million as of June 30, 2026 driven by increased sales demand, which resulted in incremental purchase orders, and incremental software licenses.

Jointly Funded Research and Development

From time to time, the Company enters into contracts for jointly funded research and development projects to develop technology that may be commercialized into a product in the future and receives payments as milestones under the contracts are

31

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

met. If the Company is required to repay all or a portion of the funds provided by the other parties under certain conditions, the Company defers such funds in other long-term liabilities. As of June 30, 2026, funds of $15.0 million received from the other parties have been deferred in other long-term liabilities. The Company de-recognizes the liabilities when the contingencies associated with the repayment conditions have been resolved.

Dispute with Silicon Motion

As previously disclosed, on July 26, 2023, MaxLinear terminated the Merger Agreement on multiple grounds (Note 3). On August 16, 2023, Silicon Motion delivered to MaxLinear a notice, which Silicon Motion publicly disclosed, that it was purporting to terminate the Merger Agreement and that Silicon Motion would be commencing an arbitration before the Singapore International Arbitration Centre to seek damages from MaxLinear arising from MaxLinear’s alleged breaches of the Merger Agreement. Silicon Motion’s position is that MaxLinear’s Willful and Material Breaches (as such term is defined in the Merger Agreement) of the Merger Agreement prevented the Merger from being completed by August 7, 2023, and that MaxLinear is consequently liable for substantial monetary damages in excess of the termination fee as provided in the Merger Agreement.

On October 5, 2023, Silicon Motion filed a Notice of Arbitration with the Singapore International Arbitration Centre alleging that MaxLinear breached the Merger Agreement. Silicon Motion seeks payment of the termination fee, additional damages, fees, and costs. The arbitration is confidential.

MaxLinear believes that it properly terminated the Merger Agreement. MaxLinear remains confident in its decision and will vigorously defend its right to terminate the Silicon Motion transaction without penalty.

Silicon Motion Stockholder Litigation

MaxLinear and certain of its officers have been named as defendants in three lawsuits brought by stockholders of Silicon Motion.

On August 31, 2023, a Silicon Motion stockholder filed a putative class action complaint in the United States District Court for the Southern District of California captioned Water Island Event-Driven Fund v. MaxLinear, Inc., No. 23-cv-01607 (S.D. Cal.), against MaxLinear and certain of its current officers. The complaint included two claims: (1) an alleged violation of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder; and (2) an alleged violation of Section 20(a) of the Exchange Act. On December 20, 2023, the court appointed the lead plaintiffs, who filed the Consolidated Complaint on February 15, 2024. The Consolidated Complaint alleged that the defendants made false and misleading statements and/or omitted material facts that MaxLinear had a duty to disclose, concerning the Company’s intention to close the merger with Silicon Motion. On August 28, 2024, the court granted the defendants’ motion to dismiss, holding that the plaintiffs lacked standing to sue MaxLinear and its officers. The case was dismissed without prejudice.

On September 18, 2024, the plaintiffs filed an Amended Consolidated Complaint, or the Amended Complaint. The Amended Complaint includes the same two claims as alleged in the Consolidated Complaint and makes similar factual allegations against the MaxLinear defendants, but added Silicon Motion and certain of its officers as additional defendants. On July 15, 2025, the court dismissed the Amended Complaint, “with prejudice”. The plaintiffs cannot amend the Amended Complaint.

On August 8, 2025, the plaintiffs filed a Notice of Appeal to the United States Court of Appeals for the Ninth Circuit. On November 6, 2025, the plaintiffs filed their opening brief with the Court of Appeals, and on January 22, 2026, the MaxLinear defendants filed their answering brief with the Court of Appeals. The plaintiffs filed their reply brief on April 13, 2026.

On June 13, 2024, HBK Master Fund L.P. and HBK Merger Strategies Master Fund L.P., stockholders of Silicon Motion, or collectively, the HBK Plaintiffs, filed an additional complaint in the United States District Court for the Southern District of California captioned HBK Master Fund L.P. v. MaxLinear, Inc., No. 24-cv-01033 (S.D. Cal.), against MaxLinear and certain of its current officers, which also alleges violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder, and Section 20(a) of the Exchange Act, and other violations. The complaint alleges that the defendants concealed their intention to terminate the merger with Silicon Motion from Silicon Motion’s shareholders. The complaint seeks compensatory damages, including interest, costs and expenses, punitive damages, and such other equitable or injunctive relief that the court deems appropriate. On January 2, 2025, the court granted the defendants’ motion to dismiss holding that the plaintiffs lacked standing to sue MaxLinear and its officers. The case was dismissed without prejudice.

On January 17, 2025, the HBK Plaintiffs filed an amended complaint, including the same two claims as alleged previously with similar factual allegations. The amended complaint seeks compensatory damages, including interest, costs and expenses, punitive damages, and such other relief that the court deems appropriate. On February 18, 2025, the MaxLinear

32

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

defendants filed a motion to dismiss this amended complaint. On September 17, 2025, the court dismissed all but one claim under the plaintiffs' amended complaint. MaxLinear intends to continue to vigorously defend its position.

On May 14, 2026, the HBK Plaintiffs filed a complaint and jury demand in the Superior Court of California, County of San Diego captioned HBK Master Fund L.P. and HBK Merger Strategies Master Fund L.P. vs. MaxLinear, Inc., Kishore Seendripu, Steven Litchfield, and Leslie Green, Case No. 26CL026719N (Superior Court of CA). These are the same plaintiffs suing based on the same set of facts as the case that was filed in the United States District Court for the Southern District of California, arising from the terminated merger with Silicon Motion. The complaint alleges that the defendants falsely assured the plaintiffs and other investors that they would complete the merger upon regulatory approval despite their internal plans otherwise. The complaint alleges common law fraud, statutory fraud pursuant to Civil Code sections 1709, 1710, and 1711, negligent misrepresentation, tortious interference with prospective economic advantage, and negligent interference with prospective economic advantage. The plaintiffs request compensatory damages, punitive damages, attorneys' fees and costs, and such other relief as the court may deem just and proper. MaxLinear intends to vigorously defend these claims.

MaxLinear Stockholder Litigation

On February 12, 2025, the plaintiff, Joshua M. Steffens, brought a shareholder derivative action on behalf of MaxLinear in the United States District Court for the Southern District of California, against current and former members of MaxLinear’s Board of Directors and certain of its executive officers. The complaint alleges breach of fiduciary duties and violation of federal securities laws. This is a follow-on derivative lawsuit alleging that the defendants concealed their intention to terminate the merger with Silicon Motion, leading to the filing of the Silicon Motion stockholder lawsuits referenced above, thereby causing harm to MaxLinear. The complaint seeks money damages, directing the individual defendants to account for all damages caused by them and all profits, special benefits and unjust enrichment they have obtained as a result of their unlawful conduct, including all salaries, bonuses, fees, stock award, options and common stock sale proceeds, and imposing a constructive trust thereon, punitive damages, costs and expenses, and such other relief that the court deems appropriate. This matter is stayed pending resolution of the Silicon Motion stockholder lawsuits referenced above.

Comcast Litigation

On December 1, 2023, MaxLinear filed claims against Comcast Management, LLC and Comcast Cable Communications, LLC, or together, Comcast, in the United States District Court for the Southern District of New York. MaxLinear alleges that in 2020, MaxLinear shared its proprietary design and know-how for a full-duplex, or FDX, amplifier with Comcast in the hope of securing future business with Comcast. MaxLinear shared its design and know-how on several occasions, all pursuant to a non-disclosure agreement between MaxLinear and Comcast, with the expectation that Comcast would keep the information confidential. MaxLinear alleges that Comcast needed this technology in order to effectively compete with fiber-optic internet providers. Instead of engaging MaxLinear to develop the FDX amplifier, Comcast allegedly shared MaxLinear’s proprietary designs with MaxLinear’s direct competitor. Comcast allegedly then worked with MaxLinear’s competitor to develop the FDX-amplifier technology. MaxLinear brought claims for trade secret misappropriation, unfair competition, and breach of the parties’ non-disclosure agreement, and it sought an unspecified amount of compensatory damages, punitive damages, pre-judgment and post-judgment interest, costs, expenses, and attorney fees as well as an injunction against Comcast’s use or disclosure of MaxLinear’s trade secrets.

On March 19, 2024, Comcast amended its claims for declaratory judgments, indemnification, and breach of the implied covenant of good faith and fair dealing, and on April 3, 2024, MaxLinear moved to dismiss all claims against it. On September 19, 2024, the court granted the motion to dismiss with respect to certain claims for declaratory judgment claim and denied the motion to dismiss with respect to the remaining claims. On September 23, 2024, Comcast filed amended claims for declaratory judgment, indemnification, and breach of the implied covenant of good faith and fair dealing, and on October 14, 2024, MaxLinear amended and refiled its trade secret and related claims. MaxLinear intends to continue to vigorously prosecute its claims and defend its position.

Dish Litigation

On February 10, 2023, Entropic Communications, LLC, or Entropic, filed claims for patent infringement against Dish Network Corporation, Dish Network LLC, Dish Network Service, LLC, and Dish Network California Service Corporation in the United States District Court for the Central District of California. At that time, MaxLinear was not a party to the action. On September 21, 2023, Dish Network California Service Corporation, or Dish California, filed four counterclaims against MaxLinear. The four claims are declaratory judgment, breach of contract, fraud and negligent misrepresentation, and civil conspiracy.

On January 31, 2024, the Dish defendants, together with DISH Technologies L.L.C., or collectively, Dish, filed eight counterclaims (amended counterclaims for Dish California) against MaxLinear. The eight counterclaims were (1) breach of

33

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

contract, (2) fraud and negligent misrepresentation, (3) fraud arising from a civil conspiracy, (4) quasi-contract for restitution/unjust enrichment, (5) combination in restraint of trade, (6) violation of the Cartwright Act (by Dish California only), (7) patent misuse, and (8) violation of Cal. Bus. & Prof. Code § 17200 et seq. Dish’s eight counterclaims revolve around a core allegation that MaxLinear is a member of the Multimedia over Coax Alliance (MoCA) and that MaxLinear violated its obligation under MoCA’s Intellectual Property Rights Policy, or IPR Policy, by acting with Entropic to rid the asserted patents of the RAND encumbrances. Dish seeks an unspecified amount of compensatory damages, disgorgement, attorneys’ fees, experts’ fees, and costs.

On February 14, 2025, the court dismissed with prejudice six of the eight counterclaims against MaxLinear, as follows: (1) fraud arising from a civil conspiracy, (2) quasi-contract for restitution/unjust enrichment, (3) combination in restraint of trade, (4) violation of the Cartwright Act (by Dish California only), (5) patent misuse, and (6) violation of Cal. Bus. & Prof. Code § 17200 et seq.

On July 2, 2026, Dish filed a Notice of Bankruptcy Filing and Automatic Stay of Proceedings in this pending litigation. The bankruptcy filing automatically stays Entropic's claims against Dish, but not Dish's counterclaims against MaxLinear.

MaxLinear intends to continue to vigorously defend its position against Dish’s remaining two counterclaims.

Cox Litigations

On February 10, 2023, Entropic sued Cox Communications, Inc., CoxCom, LLC, and Cox Communications California, LLC, or together, Cox, in two separate actions in the United States District Court for the Central District of California. On October 6, 2023, Cox filed counterclaims against MaxLinear in each of the two actions.

In the first action, Cox alleges that when MaxLinear assigned certain patents to Entropic, MaxLinear violated its obligations under MoCA’s IPR Policy by assigning these patents and by allegedly failing to ensure that Cox would be offered a FRAND license for these patents. Cox amended its counterclaims on January 9, 2024 and asserted claims of breach of contract, unjust enrichment, and declaratory judgment against MaxLinear. Cox seeks an unspecified amount of compensatory damages, equitable relief, attorneys’ fees, expenses, and costs. MaxLinear moved to dismiss Cox’s amended counterclaims on February 6, 2024.

On February 14, 2025, the court dismissed with prejudice the unjust enrichment counterclaim against MaxLinear.

In the second action, in response to Entropic suing Cox for patent infringement, Cox filed counterclaims against MaxLinear. Cox alleges that MaxLinear granted CableLabs a non-exclusive, royalty-free license to all patents essential for compliance with DOCSIS specifications. It further alleges that MaxLinear breached this agreement when MaxLinear assigned certain patents to Entropic. Cox amended its counterclaims on January 9, 2024 and asserted claims for breach of contract, unjust enrichment, and declaratory judgment. Cox seeks an unspecified amount of compensatory damages, equitable relief, attorneys’ fees, expenses, and costs. MaxLinear moved to dismiss Cox’s amended counterclaims on February 6, 2024.

On February 14, 2025, the court dismissed with prejudice all the counterclaims against MaxLinear in this matter.

MaxLinear intends to continue to vigorously defend its position against Cox’s remaining two counterclaims.

DIRECTV Litigation

On November 7, 2023, Entropic filed an amended complaint against DIRECTV, LLC, AT&T, Inc., AT&T Services, Inc., and AT&T Communications, LLC, in the Central District of California, for infringement of twelve patents. DIRECTV, LLC, or DIRECTV, filed its answer to the amended complaint on March 28, 2025. DIRECTV’s answer asserted five counterclaims against MaxLinear. The counterclaims against MaxLinear include two separate breach of contract claims, failure to negotiate in good faith, and declaratory judgment that MaxLinear’s transfer of patents to Entropic was void. MaxLinear intends to vigorously defend its position against these counterclaims.

*    *    *

The Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. As of June 30, 2026, no material loss contingencies have been accrued for litigation and other legal claims in the consolidated financial statements, since the Company’s management currently does not believe that the ultimate outcome of any of the matters described above is probable. An unfavorable outcome of these matters may be reasonably possible in excess of recorded amounts; however, a reasonable estimate of the amount or range of such loss cannot be made at this time.

34

Table of Contents MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

Other Matters

From time to time, the Company is subject to threats of litigation or actual litigation in the ordinary course of business as described above, some of which may be material. Results of litigation and claims are inherently unpredictable. Regardless of the outcome, litigation and claims can have an adverse impact on the Company because of defense and settlement costs, diversion of management resources, and other factors.

15. Segment Reporting

The following table presents segment revenue, gross profit, and net income (loss) for the periods presented (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Net revenue	$	168,847	$	108,813	$	306,035	$	204,746
Cost of net revenue	71,184		47,288		129,488		89,390
Gross profit	97,663		61,525		176,547		115,356
Less:
Employee related	76,501		55,643		143,670		122,746
Depreciation and amortization	3,853		4,541		7,869		9,004
Design and prototype expenses	12,866		10,177		24,700		19,848
Professional fees	4,494		5,983		12,984		12,494
Occupancy expenses	4,070		4,216		8,180		8,514
Restructuring expenses	64		5,580		538		13,459
Interest and other (income) expense, net	2,365		6,086		3,808		8,994
Income tax expense (benefit)	(8,310)		(4,115)		18,175		(3,404)
Segment net income (loss)	$	1,760	$	(26,586)	$	(43,377)	$	(76,299)

16. Stock Repurchases

On November 20, 2025, the Company’s board of directors authorized a plan to repurchase up to $75.0 million of the Company’s common stock over a period ending November 20, 2028. The amount and timing of repurchases are subject to a variety of factors including liquidity, share price, market conditions, and legal requirements. Any purchases have been and will be funded from available working capital and may be effected through open market purchases, block transactions, and privately negotiated transactions. The share repurchase program does not obligate the Company to make any repurchases and may be modified, suspended, or terminated by the Company at any time without prior notice.

During the year ended December 31, 2025, the Company repurchased and retired 1,143,891 shares of its common stock at a weighted average price of $17.46 per share at an aggregate value of approximately $20.0 million under the repurchase program. During the six months ended June 30, 2026, the Company did not repurchase any of its common stock under the repurchase program. As of June 30, 2026, approximately $55.0 million remained available for repurchase under the program.

35

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

The following discussion and analysis of the financial condition and results of our operations should be read in conjunction with the consolidated financial statements and related notes included elsewhere in this report. This discussion contains forward-looking statements that involve a number of risks, uncertainties, and assumptions that could cause our actual results to differ materially from those discussed below. Factors that could cause or contribute to such differences include, but are not limited to, those identified below, and those discussed in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (our “2025 Annual Report”) and Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 in the section titled “Risk Factors.”

Overview

We are a provider of communications systems-on-chips, or SoCs, solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. We are a fabless integrated circuit design company whose products integrate all or substantial portions of a high-speed communication system, including radio frequency, or RF, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management. Our ability to design analog and mixed-signal circuits in complementary metal-oxide-semiconductors, or CMOS, allows us to efficiently combine analog functionality and complex digital signal processing logic in the same integrated circuit. As a result, we believe our solutions have exceptional levels of functional integration and performance, low manufacturing cost, and reduced power consumption versus competition. These solutions also enable shorter design cycles, significant design flexibility and low system-level cost across a range of markets.

Our customers primarily include electronics distributors, module makers, original equipment manufacturers, or OEMs, and original design manufacturers, or ODMs, which incorporate our products in a wide range of electronic devices. Examples of such devices include radio transceivers and modems for 4G/5G base-station and backhaul infrastructure; optical transceivers targeting hyperscale data centers; Wi-Fi and wireline routers for home networking; broadband modems compliant with Data Over Cable Service Interface Specifications, or DOCSIS, passive optical network, or PON, and digital subscriber line, or DSL; as well as power management and interface products used in these and many other markets. In addition, we generate revenue from certain intellectual property sale agreements.

In the six months ended June 30, 2026, net revenue was $306.0 million, which was derived in part from sales of high-speed optical interconnect solutions sold into optical modules for data-center, metro and long-haul networks, RF receivers and RF receiver SoC and connectivity solutions into broadband operator voice and data modems and gateways and connectivity adapters, global analog and digital RF receiver products, radio and modem solutions into wireless carrier access and backhaul infrastructure platforms, and high-performance interface and power management solutions into a broad range of communications, industrial, automotive and multi-market applications. We have experienced growth in sales demand across our infrastructure, connectivity, and industrial and multi-market end markets driven by new product wins and market growth. We continue to develop and innovate with new products for new solutions in advanced semiconductor process nodes such as 16nm and 5nm and beyond, while addressing opportunities capturing and processing high-speed optical interconnect signals and high quality broadband communications.

Products shipped to Asia accounted for 81% and 79% of net revenue during the six months ended June 30, 2026 and 2025, respectively, including 48% from products shipped to Hong Kong, 12% from products shipped to mainland China, and 10% from products shipped to Vietnam during the six months ended June 30, 2026 and 49% from products shipped to Hong Kong and 10% from products shipped to Vietnam during the six months ended June 30, 2025. Although a large percentage of our products is shipped to Asia, we believe that a significant number of the systems designed by these customers and incorporating our semiconductor products are then sold outside Asia. For example, revenue generated from sales of our products during the six months ended June 30, 2026 and 2025 related principally to sales to Asian ODMs and contract manufacturers delivering products into European and North American markets. To date, all of our sales have been denominated in United States dollars.

A significant portion of our net revenue has historically been generated by a limited number of customers through sales of our products. Sales of products to customers comprise both direct sales to customers and indirect sales through distributors. In the six months ended June 30, 2026, one customer accounted for 11% of our net revenue, and our ten largest customers collectively accounted for 55% of our net revenue. For certain customers, we sell multiple products into disparate end user applications such as PON outdoor units, or PON ODUs, Wi-Fi routers, broadband gateways, and cable modems.

36

Our business depends on winning competitive bid selection processes, known as design wins, to develop integrated circuits for use in our customers’ products. These selection processes are typically lengthy, and as a result, our sales cycles will vary based on the specific market served, whether the design win is with an existing or a new customer and whether our product being designed in our customer’s device is a first generation or subsequent generation product. Our customers’ products can be complex and, if our engagement results in a design win, can require significant time to move into volume production. Because the sales cycle for our products is long, we can incur significant design and development expenditures in circumstances where we do not ultimately recognize any revenue. We do not have any long-term purchase commitments with any of our customers, all of whom purchase our products on a purchase order basis. Once one of our products is incorporated into a customer’s design, however, we believe that our product is likely to remain a component of the customer’s product for its life cycle because of the time and expense associated with redesigning the product or substituting an alternative chip. Product life cycles in our target markets will vary by application. For example, in the broadband data modem and gateway sectors, a design-in can have a product life cycle of 24 to 60 months. In the industrial and wired and wireless infrastructure markets, a design-in can have a product life cycle of 24 to 84 months and beyond.

Terminated Silicon Motion Merger

On May 5, 2022, we entered into an agreement and plan of merger, or the Merger Agreement, with Silicon Motion Technology Corporation, or Silicon Motion, an exempted company with limited liability incorporated under the Law of the Cayman Islands, pursuant to which, subject to the terms and conditions thereof, we agreed to acquire Silicon Motion pursuant to a statutory merger of Shark Merger Sub, a wholly-owned subsidiary of MaxLinear, with and into Silicon Motion, with Silicon Motion surviving the merger as a wholly-owned subsidiary of MaxLinear. Silicon Motion is a provider of NAND flash controllers for solid state drives and other solid state storage devices.

On July 26, 2023, we terminated the Merger Agreement and notified Silicon Motion that we were relieved of our obligations to close because, among other reasons, (i) certain conditions to closing set forth in the Merger Agreement were not satisfied and were incapable of being satisfied, (ii) Silicon Motion had suffered a Material Adverse Effect that was continuing, (iii) Silicon Motion was in material breach of representations, warranties, covenants, and agreements in the Merger Agreement that gave rise to the right of the Company to terminate, and (iv) in any event, the First Extended Outside Date had passed and was not automatically extended because certain conditions in Article 6 of the Merger Agreement were not satisfied or waived as of May 5, 2023. Under the terms of the Merger Agreement, MaxLinear was not required to pay a break-up fee or other fee as a result of the termination of the Merger Agreement on these grounds. On August 16, 2023, Silicon Motion delivered a notice to us, which Silicon Motion publicly disclosed, that it was purporting to terminate the Merger Agreement and that Silicon Motion would be commencing an arbitration to seek damages from us arising from our alleged breaches of the Merger Agreement. Undefined capitalized terms in this paragraph have the same meaning as in the Merger Agreement.

On October 5, 2023, Silicon Motion filed a Notice of Arbitration with the Singapore International Arbitration Centre alleging that we breached the Merger Agreement. See Note 14, Commitments and Contingencies of the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for more information on legal proceedings related to the termination of the Merger Agreement.

Critical Accounting Policies and Estimates

Management’s discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements which are prepared in accordance with accounting principles that are generally accepted in the United States of America. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities, related disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. We continually evaluate our estimates and judgments, the most critical of which are those related to business combinations, revenue recognition, inventory valuation, production masks, goodwill and other intangible assets valuation, and income taxes. We base our estimates and judgments on historical experience and other factors that we believe to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional information becomes known.

We believe that the accounting policies and estimates we have identified as critical involve a greater degree of judgment and complexity than our other accounting policies and estimates. Accordingly, those are the policies and estimates we believe are the most critical to understanding and evaluating our consolidated financial condition and results of operations.

For a summary of our critical accounting policies and estimates, refer to Management’s Discussion and Analysis section of our Annual Report on Form 10-K for the year ended December 31, 2025, which we filed with the Securities and Exchange

37

Commission, or SEC, on January 29, 2026, or our Annual Report. There have been no material changes to our critical accounting policies and estimates during the six months ended June 30, 2026.

Recently Adopted Accounting Pronouncements

See Note 1 to our consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for recently adopted accounting pronouncements as of the date of this report, if any.

Recently Issued Accounting Pronouncements

See Note 1 to our consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for recently issued accounting pronouncements not yet adopted as of the date of this report, if any.

Results of Operations

The following describes the line items set forth in our unaudited consolidated statements of operations.

Net Revenue. Net revenue is generated from sales of radio-frequency, analog, digital, and mixed-signal integrated circuits and intellectual property for access and connectivity, wired and wireless infrastructure, and industrial and multi-market applications, as well as patent and intellectual property licenses. A significant portion of our sales is to distributors, who then resell our products.

Cost of Net Revenue. Cost of net revenue includes the cost of finished silicon wafers processed by third-party foundries; costs associated with our outsourced packaging and assembly, test and shipping; costs of personnel, including salaries, benefits, and stock-based compensation; equipment associated with manufacturing support, logistics and quality assurance; amortization of acquired developed technology and purchased licensed technology intangible assets; inventory fair value adjustments, if any; amortization of certain production mask costs and CAD software license costs; cost of production load boards and sockets; and an allocated portion of our occupancy costs.

Research and Development. Research and development, or R&D, expense includes personnel-related expenses, including salaries and benefits and stock-based compensation, new product engineering mask costs, prototype integrated circuit packaging and test costs, CAD software license costs, intellectual property license costs, reference design development costs, development testing and evaluation costs, depreciation expense, and allocated occupancy costs, partially offset by income from joint R&D projects and/or governmental R&D grants, if any. Research and development activities include the design of new products, refinement of existing products and design of test methodologies to ensure compliance with required specifications. All research and development costs are expensed as incurred. Income from joint R&D projects and governmental R&D grants are reflected as a credit to research and development expense when such income has been earned and any contingencies associated with retaining such income have been resolved.

Selling, General and Administrative. Selling, general and administrative expense includes personnel-related expenses, including salaries and benefits and stock-based compensation, amortization of certain acquired intangible assets, merger, acquisition and integration costs, if any, third-party sales commissions, field application engineering support, travel costs, professional and consulting fees, legal fees, depreciation expense and allocated occupancy costs.

Restructuring Charges. Restructuring charges consist of severance, lease and leasehold impairment charges, and other charges related to restructuring plans.

Interest and Other Income (Expense), Net. Interest and other income (expense), net includes interest income, interest expense and other income (expense). Interest income consists of interest earned on our cash, cash equivalents and restricted cash balances. Interest expense consists of interest accrued on debt and amortization of discounts on debt and other liabilities. Other income (expense) generally consists of income (expense) generated from non-operating transactions.

Income Tax Provision (Benefit). We make certain estimates and judgments in determining income taxes for financial statement purposes. These estimates and judgments occur in the calculation of certain tax assets and liabilities, which arise from differences in the timing of recognition of revenue and expenses for tax and financial statement purposes and the realizability of assets in future years.

38

The following table sets forth our consolidated statement of operations data as a percentage of net revenue for the periods indicated:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Net revenue	100	%	100	%	100	%	100	%
Cost of net revenue	42		43		42		44
Gross profit	58		57		58		56
Operating expenses:
Research and development	33		43		36		50
Selling, general and administrative	27		31		29		34
Restructuring charges	—		5		—		7
Total operating expenses	60		79		65		91
Loss from operations	(2)		(23)		(7)		(35)
Interest income	—		1		—		1
Interest expense	(1)		(2)		(1)		(2)
Other income (expense), net	—		(4)		—		(3)
Total other income (expense), net	(1)		(6)		(1)		(4)
Loss before income taxes	(4)		(28)		(8)		(39)
Income tax provision (benefit)	(5)		(4)		6		(2)
Net income (loss)	1	%	(24)	%	(14)	%	(37)	%

Net Revenue

	Three Months Ended June 30,										Six Months Ended June 30,
	2026			2025			$ Change		% Change		2026			2025			$ Change		% Change
	(dollars in thousands)										(dollars in thousands)
Infrastructure	$	85,016		$	34,709		$	50,307	145	%	$	147,830		$	61,270		$	86,560	141	%
% of net revenue	50		%	32		%					48		%	30		%
Broadband	44,882			47,556			(2,674)		0%		88,508			88,439			69		0%
% of net revenue	27		%	44		%					29		%	43		%
Connectivity	23,968			20,741			3,227		16	%	42,563			40,976			1,587		4	%
% of net revenue	14		%	19		%					14		%	20		%
Industrial and multi-market	14,981			5,807			9,174		158	%	27,134			14,061			13,073		93	%
% of net revenue	9		%	5		%					9		%	7		%
Total net revenue	$	168,847		$	108,813		$	60,034	55	%	$	306,035		$	204,746		$	101,289	49	%

Net revenue increased $60.0 million to $168.8 million for the three months ended June 30, 2026, as compared to $108.8 million for the three months ended June 30, 2025, driven by increased demand in our infrastructure, industrial and multi-market and connectivity categories, partially offset by declines in the volume of sales in broadband markets. The increase in infrastructure net revenue of $50.3 million was driven by increases in the volume of shipments of optical, high-performance analog, and wireless backhaul products. The decrease in broadband net revenue of $2.7 million was driven by a decrease in the volume of cable data shipments in this category, partially offset by an increase in broadband SoC shipments. The increase in industrial and multi-market net revenue of $9.2 million was driven by increased volume of shipments of component and high-performance analog products in this category. The increase in connectivity net revenue of $3.2 million was driven by increases in the volume of Wi-Fi product shipments. Price changes did not have a material impact to revenues period over period.

39

Net revenue increased $101.3 million to $306.0 million for the six months ended June 30, 2026, as compared to $204.7 million for the six months ended June 30, 2025, driven by increased demand in our infrastructure and industrial and multi-market categories. The increase in infrastructure net revenue of $86.6 million was driven by increases in the volume of shipments of optical, high-performance analog, and wireless backhaul and access products. The increase in broadband net revenue of $0.1 million was driven by an increase in the volume of broadband SoC shipments in this category, partially offset by decreases in the volume of cable data shipments. The increase in industrial and multi-market net revenue of $13.1 million was driven by increased volume of shipments of high-performance analog and component products in this category. The increase in connectivity net revenue of $1.6 million was driven by increases in the volume of Wi-Fi product shipments, partially offset by decreases in the volume of ethernet and MoCA products. Price changes did not have a material impact to revenues period over period.

We currently expect that revenue will fluctuate in the future, from period-to-period, consistent with the cyclical nature of our industry.

Cost of Net Revenue and Gross Profit

	Three Months Ended June 30,										Six Months Ended June 30,
	2026			2025			$ Change		% Change		2026			2025			$ Change		% Change
	(dollars in thousands)										(dollars in thousands)
Cost of net revenue	$	71,184		$	47,288		$	23,896	51	%	$	129,488		$	89,390		$	40,098	45	%
% of net revenue	42		%	43		%					42		%	44		%
Gross profit	97,663			61,525			36,138		59	%	176,547			115,356			61,191		53	%
% of net revenue	58		%	57		%					58		%	56		%

Cost of net revenue increased $23.9 million to $71.2 million for the three months ended June 30, 2026, as compared to $47.3 million for the three months ended June 30, 2025. The increase was driven by an increase in the volume of sales as described above under “Net Revenue”. Gross profit percentage improved for the three months ended June 30, 2026, as compared to the three months ended June 30, 2025, due to product mix.

Cost of net revenue increased $40.1 million to $129.5 million for the six months ended June 30, 2026, as compared to $89.4 million for the six months ended June 30, 2025. The increase was driven by an increase in the volume of sales as described above under “Net Revenue”. Gross profit percentage improved for the six months ended June 30, 2026, as compared to the six months ended June 30, 2025, due to product mix.

We currently expect that gross profit percentage will fluctuate in the future, from period-to-period, based on changes in product mix, average selling prices, and average manufacturing costs.

Research and Development

	Three Months Ended June 30,										Six Months Ended June 30,
	2026			2025			$ Change		% Change		2026			2025			$ Change		% Change
	(dollars in thousands)										(dollars in thousands)
Research and development	$	56,033		$	47,199		$	8,834	19	%	$	109,195		$	102,656		$	6,539	6	%
% of net revenue	33		%	43		%					36		%	50		%

Research and development expense increased $8.8 million to $56.0 million for the three months ended June 30, 2026, as compared to $47.2 million for the three months ended June 30, 2025. The increase was driven by increases in stock-based compensation of $2.9 million, bonus expense of $2.5 million, prototype expenses of $1.2 million, and payroll and benefits expense of $1.1 million, and the impact of a decrease in income from joint R&D projects and governmental grants of $1.0 million. The increases in stock-based compensation and bonus expense are due to increased engineering headcount and improved financial performance over the prior period. The increase in payroll and benefit expenses is also due to the increased engineering headcount. The increase in prototype expenses is due to timing of projects. The amount of income from research and development funded by others varies from period to period depending on availability of such funding, including governmental grants.

Research and development expense increased $6.5 million to $109.2 million for the six months ended June 30, 2026, as compared to $102.7 million for the six months ended June 30, 2025. The increase was driven by increases in bonus expense of $4.4 million, and the impact of a decrease in income from joint R&D projects and governmental grants of $4.0 million. These increases were partially offset by the impact of a decrease in stock-based compensation of $2.1 million. The increase in bonus

40

expense is due to improved financial performance over the prior period. The decrease in stock-based compensation related to timing of expense pertaining to equity retention grants made to employees in late 2024. The amount of income from research and development funded by others varies from period to period depending on availability of such funding, including governmental grants.

We have aligned our research and development spending with current project demands and expect our research and development expenses to increase in future years as we develop products to drive future growth.

Selling, General and Administrative

	Three Months Ended June 30,										Six Months Ended June 30,
	2026			2025			$ Change		% Change		2026			2025			$ Change		% Change
	(dollars in thousands)										(dollars in thousands)
Selling, general and administrative	$	45,751		$	33,361		$	12,390	37	%	$	88,208		$	69,950		$	18,258	26	%
% of net revenue	27		%	31		%					29		%	34		%

Selling, general and administrative expense increased $12.4 million to $45.8 million for the three months ended June 30, 2026, as compared to $33.4 million for the three months ended June 30, 2025. The increase was driven by increases in stock-based compensation of $11.5 million, payroll and benefits expense of $1.5 million, and bonus expense of $1.3 million. These increases were partially offset by a decrease in professional fees of $1.9 million. The increase in stock-based compensation and bonus expense is due to increased headcount and improved financial performance over the prior period. The increase in payroll and benefits expenses is also due to increased headcount over the prior period. The decrease in professional fees of $1.9 million is attributable to lower legal fees related to ongoing litigation compared to the prior period.

Selling, general and administrative expense increased $18.3 million to $88.2 million for the six months ended June 30, 2026, as compared to $70.0 million for the six months ended June 30, 2025. The increase was driven by increases in stock-based compensation of $13.7 million, bonus expense of $2.6 million, and payroll and benefits expense of $1.9 million. The increase in stock-based compensation and bonus expense is due to increased headcount and improved financial performance over the prior period. The increase in payroll and benefits is also due to increased headcount over the prior period.

Our selling, general and administrative expenses have increased over the prior year due to the factors described above. We expect selling, general and administrative expenses to increase in future years with incremental growth in our sales and marketing organization to expand into existing and new markets.

Restructuring Charges

	Three Months Ended June 30,										Six Months Ended June 30,
	2026			2025			$ Change		% Change		2026			2025			$ Change		% Change
	(dollars in thousands)										(dollars in thousands)
Restructuring charges	$	64		$	5,580		$	(5,516)	(99)	%	$	538		$	13,459		$	(12,921)	(96)	%
% of net revenue	—		%	5		%					—		%	7		%

Restructuring charges decreased $5.5 million to $0.1 million for the three months ended June 30, 2026, compared to $5.6 million for the three months ended June 30, 2025. Restructuring charge for the three months ended June 30, 2026 were negligible. Restructuring charges for the three months ended June 30, 2025 included $4.6 million in severance and related expenses and $0.9 million in charges related to the reduction of space leased for office facilities in connection with a workforce reduction.

Restructuring charges decreased $12.9 million to $0.5 million for the six months ended June 30, 2026, compared to $13.5 million for the six months ended June 30, 2025. Restructuring charges for the six months ended June 30, 2026 included $0.2 million in lease related charges. Restructuring charges for the six months ended June 30, 2025 included $6.4 million in charges under contracts associated with CAD tool licenses which we ceased using, $6.2 million in employee severance and related charges, and $0.9 million in charges related to reduction of space leased for office facilities in connection with a workforce reduction.

41

    Interest and Other Income (Expense)

	Three Months Ended June 30,										Six Months Ended June 30,
	2026			2025			$ Change		% Change		2026			2025			$ Change		% Change
	(dollars in thousands)										(dollars in thousands)
Interest and other income (expense), net	$	(2,365)		$	(6,086)		$	3,721	(61)	%	$	(3,808)		$	(8,994)		$	5,186	(58)	%
% of net revenue	(1)		%	(6)		%					(1)		%	(4)		%

Interest and other income (expense), net changed by $3.7 million from an expense of $6.1 million in the three months ended June 30, 2025 to an expense of $2.4 million for the three months ended June 30, 2026. The change was driven by currency exchange gains of $3.8 million.

Interest and other income (expense), net changed by $5.2 million from an expense of $9.0 million in the six months ended June 30, 2025 to an expense of $3.8 million for the six months ended June 30, 2026. The change was driven by currency exchange gains of $5.2 million.

Income Tax Provision (Benefit)

	Three Months Ended June 30,								Six Months Ended June 30,
	2026		2025		$ Change		% Change		2026		2025		$ Change		% Change
	(dollars in thousands)								(dollars in thousands)
Income tax benefit	$	(8,310)	$	(4,115)	$	(4,195)	102	%	$	18,175	$	(3,404)	$	21,579	(634)	%

The income tax benefit for the three months ended June 30, 2026 was $8.3 million compared to an income tax benefit of $4.1 million for the three months ended June 30, 2025.

The income tax provision for the six months ended June 30, 2026 was $18.2 million compared to an income tax benefit of $3.4 million for the six months ended June 30, 2025.

The difference between our effective tax rate and the 21.0% U.S. federal statutory rate for the six months ended June 30, 2026 primarily related to the mix of pre-tax income among jurisdictions, permanent tax items including a tax on net controlled foreign corporation tested income, or NCTI, stock-based compensation, and the impact of the valuation allowance against the Company’s Singapore deferred tax assets.

The difference between our effective tax rate and the 21.0% U.S. federal statutory rate for the six months ended June 30, 2025 primarily related to the mix of pre-tax income among jurisdictions, permanent tax items, stock-based compensation, and the impact of the valuation allowance against the Company’s Singapore deferred tax assets.

We continue to maintain a valuation allowance to offset state and certain federal and foreign deferred tax assets, as realization of such assets does not meet the more-likely-than-not threshold required under accounting guidelines. In making such determination, we consider all available positive and negative evidence quarterly, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, and recent financial performance. Based upon our review of all positive and negative evidence, we continue to have a valuation allowance on state deferred tax assets, certain federal deferred tax assets, and certain foreign deferred tax assets in jurisdictions where we have cumulative losses or otherwise are not expected to utilize certain tax attributes. We do not incur income tax expense or benefit in certain tax-free jurisdictions in which we operate.

Our subsidiary in Singapore operates under certain tax incentives in Singapore, which are effective through March 2027. Under these incentives, qualifying income derived from certain sales of our integrated circuits is taxed at a concessionary rate over the incentive period. We also receive a reduced withholding tax rate on certain intercompany royalty payments made by our Singapore subsidiary during the incentive period. During the quarter ended December 31, 2024, we recorded a full valuation allowance against our Singapore deferred tax assets. Due to this Singapore valuation allowance position, no income tax provision was recorded in Singapore for the six months ended June 30, 2026 and 2025. The incentives are conditional upon our meeting certain minimum employment and investment thresholds within Singapore over time, and we may be required to return certain tax benefits in the event we do not achieve compliance related to that incentive period. We currently believe that we will be able to satisfy these conditions without material risk.

42

Liquidity and Capital Resources

As of June 30, 2026, we had cash and cash equivalents of $64.8 million, restricted cash of $28.9 million and net accounts receivable of $51.0 million. Additionally, as of June 30, 2026, our working capital, which we define as current assets less current liabilities, was $130.5 million. Financial instruments, which potentially subject us to concentrations of credit risk, consist primarily of cash and cash equivalents and accounts receivable. Collateral is generally not required for customer receivables. We limit our exposure to credit loss by placing our cash with high credit quality financial institutions. At times, such deposits may be in excess of insured limits. We have not experienced any losses on our deposits of cash and cash equivalents.

Our primary uses of cash are to fund operating expenses and purchases of inventory, property and equipment, and from time to time, the acquisition of, or investments in, businesses. In May 2022, we entered into the Merger Agreement to acquire Silicon Motion. However, on July 26, 2023, we terminated the Merger Agreement and were relieved of our obligations to close.

From time to time, we may also use cash to pay down outstanding debt and/or make investments. As of June 30, 2026, $125.0 million of principal was outstanding under a senior secured term B loan facility or the “Initial Term Loan under the June 23, 2021 Credit Agreement.” The Company also has available, subject to the terms and conditions of the agreement, a senior secured revolving credit facility, in an aggregate principal amount of up to $130.0 million which remained undrawn as of June 30, 2026. The proceeds of the revolving facility may be used to finance the working capital needs and other general corporate purposes of the Company and its subsidiaries.

Commencing on September 30, 2021, the Initial Term Loan under the June 23, 2021 Credit Agreement was initially set to amortize in equal quarterly installments equal to 0.25% of the original principal amount of the Initial Term Loan under the June 23, 2021 Credit Agreement, with the balance payable on the June 23, 2028 maturity date. We could be subject to substantial variable interest rate risk because our interest rate under term loans typically vary based on a fixed margin over an indexed rate or an adjusted base rate. If interest rates were to further increase substantially, it could have a material adverse effect on our operating results and could affect our ability to service the indebtedness.

Our future capital requirements will depend on many factors, including changes in revenue, the expansion or contraction of our engineering, sales and marketing activities, the timing and extent of our expansion into new territories, the timing of introductions of new products and enhancements to existing products, the continuing market acceptance of our products, any damages from legal proceedings related to the termination of the Merger Agreement with Silicon Motion or any alleged breaches of the Merger Agreement that we are required to pay, or any amounts we agree to pay in any settlement and any other potential material investments in, or acquisitions of, complementary businesses, services or technologies. Additional funds may not be available on terms favorable to us or at all. If we are unable to raise additional funds when needed, we may not be able to sustain our operations or execute our strategic plans.

Our cash and cash equivalents are impacted by the timing of when we pay expenses as reflected in the change in our outstanding accounts payable and accrued expenses. Cash used to fund operating expenses in our consolidated statements of cash flows excludes the impact of non-cash items such as, but not limited to, amortization and depreciation of acquired intangible assets and leased right-of-use assets and property and equipment, stock-based compensation, and any impairment of assets. Cash used to fund capital purchases and acquisitions of businesses and investments is included in investing activities in our consolidated statements of cash flows. Cash paid to satisfy minimum tax withholdings on behalf of employees for restricted stock units, cash proceeds from issuance of common stock and debt, and cash used to pay down outstanding debt or repurchase stock, if any, are included in financing activities in our consolidated statements of cash flows.

43

As of June 30, 2026, our material cash requirements include long-term debt, non-cancelable operating leases, inventory purchase obligations and other obligations, which primarily consist of contractual payments due for CAD software licenses, as follows:

	Payments due
	Total		Less than 1 year		1-3 years		3-5 years		More than 5 years
	(in thousands)
Long-term debt obligations	$	125,000	$	—	$	125,000	$	—	$	—
Operating lease obligations	27,036		5,000		13,787		5,599		2,650
Purchase obligations	221,336		165,109		56,227		—		—
Other obligations	84,530		22,424		47,771		11,545		2,790
Total	$	457,902	$	192,533	$	242,785	$	17,144	$	5,440

Total inventory purchase and other contractual obligations increased from $209.6 million as of December 31, 2025 to $305.9 million as of June 30, 2026 driven by increased sales demand, which resulted in incremental purchase orders, and incremental software licenses.

Our planned capital expenditures as of June 30, 2026 are expected to increase to support our production needs. Our consolidated balance sheet at June 30, 2026 included $4.0 million in other long-term liabilities for uncertain tax positions, some of which may result in cash payment and $15.0 million received from other parties for jointly funded research and development projects which will be recognized into income when the contingencies associated with the repayment conditions have been resolved. The future payments related to uncertain tax positions recorded as other long-term liabilities have not been presented in the table above due to the uncertainty of the amounts and timing of cash settlement with the taxing authorities.

Our primary sources of cash are cash receipts on accounts receivable from our shipment of products to distributors and direct customers, and on occasion, proceeds that we receive under certain intellectual property sale agreements. Aside from the amounts billed to our customers, net cash collections of accounts receivable are impacted by the efficiency of our cash collections process, which can vary from period to period depending on the payment cycles of our major distributor customers, and relative linearity of shipments period-to-period.

The June 23, 2021 Credit Agreement, under which we entered into a senior secured term B loan facility and a revolving credit facility, permits us to request incremental loans in an aggregate principal amount not to exceed the sum of an amount equal to the greater of (x) $175.0 million and (y) 100% of “Consolidated EBITDA” (as defined in such agreement), plus the amount of certain voluntary prepayments, plus an unlimited amount that is subject to pro forma compliance with certain first lien net leverage ratio, secured net leverage ratio and total net leverage ratio tests.

The following is a summary of our working capital, cash and cash equivalents, and restricted cash for the periods indicated:

	June 30, 2026		December 31, 2025
	(in thousands)
Working capital	$	130,538	$	62,821
Cash and cash equivalents	$	64,814	$	72,806
Short-term restricted cash	1,492		1,419
Long-term restricted cash	27,426		27,187
Total cash, cash equivalents, and restricted cash	$	93,732	$	101,412

We believe that our $64.8 million of cash and cash equivalents at June 30, 2026 will be sufficient to fund our projected operating requirements for at least the next twelve months. As of June 30, 2026, our indebtedness totaled $125.0 million, which consists of outstanding principal under the Initial Term Loan under the June 23, 2021 Credit Agreement. The June 23, 2021 Credit Agreement also provides the Company with the Revolving Facility which was amended in April 2026 an aggregate principal amount of up to $130.0 million, under which no borrowings were outstanding as of June 30, 2026. The June 23, 2021 Credit Agreement was amended on June 29, 2023 to implement a benchmark replacement of SOFR for LIBOR. The Initial Term Loan under the June 23, 2021 Credit Agreement has a seven-year term expiring in June 2028 and subsequent to the benchmark replacement amendment, bears interest, at the Company’s option, at a per annum rate equal to either (i) a base rate equal to the highest of (x) the federal funds rate, plus 0.50%, (y) the prime rate then in effect and (z) an adjusted SOFR rate

44

determined on the basis of a one-month interest period plus 1.00%, in each case, plus an applicable margin of 1.25% or (ii) an adjusted SOFR rate, subject to a floor of 0.50%, plus an applicable margin of 2.25%. Loans under the Revolving Facility initially bear interest, at a per annum rate equal to either (i) a base rate (as calculated above) plus an applicable margin of 0.00%, or (ii) an adjusted SOFR rate (as calculated above) plus an applicable margin of 1.00%. Following delivery of financial statements for the Company’s fiscal quarter ending June 30, 2021, the applicable margin for loans under the Revolving Facility ranged from 0.00% to 0.75% in the case of base rate loans and 1.00% to 1.75% in the case of SOFR rate loans, in each case, depending on the Company’s secured net leverage ratio as of the most recently ended fiscal quarter. The June 23, 2021 Credit Agreement was again amended on April 22, 2026 to among other things, (i) provide for $30 million in incremental revolving commitments under MaxLinear’s senior secured revolving credit facility (the “Revolving Facility”), (ii) increase the applicable margin for loans under the Revolving Facility to (x) 2.25% per annum for Term SOFR loans, and (y) 1.25% per annum for base rate loans, and (iii) extend the maturity date applicable to the Revolving Facility from June 23, 2026 to March 23, 2028. The amendment also amends the applicable financial covenants to require that MaxLinear maintain (a) a total net leverage ratio of not greater than 3.50 to 1.00 and (b) unrestricted cash plus available and undrawn commitments under the Revolving Facility in an amount of no less than $80 million, in each case, tested as of the last day of any fiscal quarter of MaxLinear.

The Company is required to pay commitment fees of 0.25% per annum on the daily undrawn commitments under the Revolving Facility, depending on the Company’s secured net leverage ratio as of the most recently ended fiscal quarter.

The following is a summary of our cash flows used in operating activities, investing activities and financing activities for the periods indicated:

	Six Months Ended June 30,
	2026		2025
	(in thousands)
Net cash used in operating activities	$	(4,063)	$	(911)
Net cash used in investing activities	(7,387)		(9,368)
Net cash provided by (used in) financing activities	3,887		(61)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(117)		990
Decrease in cash, cash equivalents and restricted cash	$	(7,680)	$	(9,350)

Cash Flows from Operating Activities

Net cash used in operating activities was $4.1 million for the six months ended June 30, 2026, compared to net cash used in operating activities of $0.9 million for the six months ended June 30, 2025. The decrease in operating cash flows was impacted by changes in our working capital, which decreased $53.3 million. The change in working capital was driven by a prepayment for wafers supporting rising demand for certain data center products.

Cash Flows from Investing Activities

Our use of cash in investing activities decreased by $2.0 million. Net cash used in investing activities was $7.4 million for the six months ended June 30, 2026 and consisted of purchases of property and equipment of $3.7 million, proceeds from convertible notes receivable of $2.0 million and purchases of intangible assets of $1.7 million.

Net cash used in investing activities was $9.4 million for the six months ended June 30, 2025 and consisted of purchases of intangible assets of $6.2 million and purchases of property and equipment of $3.2 million.

Cash Flows from Financing Activities

Cash flows from financing activities increased by $3.9 million. Net cash provided by financing activities was $3.9 million for the six months ended June 30, 2026 and included proceeds from borrowings under revolving credit facility of $20.0 million, a funding arrangement of $8.0 million and net proceeds from issuance of common stock, net of costs of $3.8 million, partially offset by repayment of borrowings under revolving credit facility of $20.0 million, and minimum tax withholding paid on behalf of employees for restricted stock units of $7.4 million.

Warranties and Indemnifications

In connection with the sale of products in the ordinary course of business, we often make representations affirming, among other things, that our products do not infringe on the intellectual property rights of others, and agree to indemnify customers against third-party claims for such infringement. Further, our certificate of incorporation and bylaws require us to

45

indemnify our officers and directors against any action that may arise out of their services in that capacity, and we have also entered into indemnification agreements with respect to all of our directors and certain controlling persons.

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in foreign currency exchange rates and interest rates.

Foreign Currency Risk

To date, our international customer and vendor agreements have been denominated mostly in United States dollars. Accordingly, we have limited exposure to foreign currency exchange rates and do not enter into foreign currency hedging transactions. The functional currency of certain foreign subsidiaries is the local currency. Accordingly, the effects of exchange rate fluctuations on the net assets of these foreign subsidiaries’ operations are accounted for as translation gains or losses in accumulated other comprehensive income (loss) within stockholders’ equity. A hypothetical change of 100 basis points in such foreign currency exchange rates during the six months ended June 30, 2026 would result in a change to translation gain in accumulated other comprehensive income (loss) of approximately $0.9 million.

Interest Rate Risk

We are subject to a variable amount of interest on the principal balance of our credit agreements described above and could be adversely impacted by high interest rates in the future. If SOFR interest rates had increased by 10% during the six months ended June 30, 2026, the rate increase would have resulted in an immaterial increase to interest expense. We currently believe our operating cash held primarily for working capital purpose is sufficient to cover our interest obligations, but we are monitoring the impact of high interest rates on our ability to service our interest and debt obligations, obtain financing, and on our business in general.

ITEM 4.    CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic reports filed with the SEC is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and no evaluation of controls and procedures can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. Management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

As required by Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, prior to filing this Quarterly Report, we carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this Quarterly Report. Based on their evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

An evaluation was performed under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, to determine whether any change in our internal control over financial reporting occurred during the fiscal quarter ended June 30, 2026 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. There were no changes in our internal control over financial reporting

46

identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or Rule 15d-15 of the Securities Exchange Act of 1934, as amended, that occurred during the fiscal quarter ended June 30, 2026 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

47

PART II — OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

See Note 14, Commitments and Contingencies of the Notes to Consolidated Financial Statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for a description of our material legal proceedings which are incorporated by reference herein.

ITEM 1A.    RISK FACTORS

The discussion under the heading “Risk Factors” in Part I, Item 1A of our 2025 Annual Report on Form 10-K provides information concerning the material risks and uncertainties that we have identified and believe may adversely affect our business, our financial condition and our results of operations. Before you decide whether to invest in our securities, you should carefully consider these risk factors together with all of the other information included in this Quarterly Report on Form 10-Q, and in our other public filings, which could materially affect our business, financial condition or future results. Our risk factors are not guarantees that no such conditions exist as of the date of this report and should not be interpreted as an affirmative statement that such risks or conditions have not materialized, in whole or in part.

Unless set forth below, there have been no material changes to those risk factors.

ITEM 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Recent Sales of Unregistered Securities

None.

Recent Repurchases of Equity Securities

None.

ITEM 3.    DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.    MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.    OTHER INFORMATION

Securities Trading Plans of Directors and Executive Officers

During our last fiscal quarter, no director or officer, as defined in Rule 16a-1(f), adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” each as defined in Regulation S-K Item 408.

48

ITEM 6.    EXHIBITS

Exhibit Number	Exhibit Title
10.1	MaxLinear, Inc. Amended and Restated 2010 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K filed on May 21, 2026 (File No. 001-34666)).
10.2	MaxLinear, Inc. Amended and Restated 2010 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.2 of the Registrant’s Current Report on Form 8-K filed on May 21, 2026 (File No. 001-34666)).
10.3	Amendment No. 2 to Credit Agreement, date as of April 22, 2026, by and among MaxLinear, Inc., the lenders from time to time party thereto, and Wells Fargo Bank, National Association, as administrative agent and collateral agent (incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K filed on April 23, 2026 (File No. 001-34666)).
31.1	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1(*)	Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	Inline XBRL Instance Document - the instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

(*) In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 33-8238 and 34-47986, Final Rule: Management’s Reports on Internal Control Over Financial Reporting and Certification of Disclosure in Exchange Act Periodic Reports, the certifications furnished pursuant to this item will not be deemed “filed” for purposes of Section 18 of the Exchange Act (15 U.S.C. 78r), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.

49

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		MAXLINEAR, INC.
		(Registrant)
Date:	July 23, 2026	By:	/s/ Steven G. Litchfield
			Steven G. Litchfield
			Chief Financial Officer and Chief Corporate Strategy Officer (Principal Financial Officer and Duly Authorized Officer)

50

EX-31.1

EXHIBIT 31.1

Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Kishore Seendripu, Ph.D., certify that:

1.I have reviewed this Form 10-Q of MaxLinear, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	July 23, 2026	/s/ Kishore Seendripu, Ph.D.
		Kishore Seendripu, Ph.D.
		President and Chief Executive Officer
		(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Steven G. Litchfield, certify that:

1.I have reviewed this Form 10-Q of MaxLinear, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	July 23, 2026	/s/ Steven G. Litchfield
		Steven G. Litchfield
		Chief Financial Officer and Chief Corporate Strategy Officer
		(Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

I, Kishore Seendripu, Ph.D., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of MaxLinear, Inc. on Form 10-Q for the fiscal quarter ended June 30, 2026 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of MaxLinear, Inc.

Date:	July 23, 2026	By:	/s/ Kishore Seendripu, Ph.D.
		Name:	Kishore Seendripu, Ph.D.
		Title:	President and Chief Executive Officer

I, Steven G. Litchfield, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of MaxLinear, Inc. on Form 10-Q for the fiscal quarter ended June 30, 2026 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of MaxLinear, Inc.

Date:	July 23, 2026	By:	/s/ Steven G. Litchfield
		Name:	Steven G. Litchfield
		Title:	Chief Financial Officer and Chief Corporate Strategy Officer

XML

Cover - shares	6 Months Ended
	Jun. 30, 2026	Jul. 16, 2026
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2026
Document Transition Report	false
Entity File Number	001-34666
Entity Registrant Name	MaxLinear, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	14-1896129
Entity Address, Address Line One	5966 La Place Court, Suite 100,
Entity Address, City or Town	Carlsbad
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92008
City Area Code	760
Local Phone Number	692-0711
Title of 12(b) Security	Common stock
Trading Symbol	MXL
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		90,693,191
Entity Central Index Key	0001288469
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2026
Document Fiscal Period Focus	Q2
Amendment Flag	false

XML

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 64,814	$ 72,806
Short-term restricted cash	1,492	1,419
Accounts receivable, net	51,037	46,122
Inventory	105,490	78,104
Prepaid expenses and other current assets	75,829	50,390
Total current assets	298,662	248,841
Long-term restricted cash	27,426	27,187
Property and equipment, net	41,207	48,873
Leased right-of-use assets	19,724	15,506
Intangible assets, net	43,780	48,892
Goodwill	318,588	318,588
Deferred tax assets	62,361	77,268
Other long-term assets	10,823	11,241
Total assets	822,571	796,396
Current liabilities:
Accounts payable	40,401	37,916
Accrued price protection liability	31,192	26,493
Accrued expenses and other current liabilities	58,244	72,392
Accrued compensation	38,287	49,219
Total current liabilities	168,124	186,020
Long-term lease liabilities	15,465	12,313
Long-term debt	123,926	123,618
Other long-term liabilities	30,216	22,550
Total liabilities	337,731	344,501
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding	0	0
Common stock, $0.0001 par value; 550,000 shares authorized; 90,692 shares issued and outstanding at June 30, 2026 and 86,451 shares issued and outstanding at December 31, 2025	9	9
Additional paid-in capital	1,027,265	951,262
Accumulated other comprehensive income	1,349	1,030
Accumulated deficit	(543,783)	(500,406)
Total stockholders’ equity	484,840	451,895
Total liabilities and stockholders’ equity	$ 822,571	$ 796,396

XML

Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2026	Dec. 31, 2025
Statement of Financial Position [Abstract]
Preferred stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	25,000,000	25,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in usd per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	550,000,000	550,000,000
Common stock, shares issued (in shares)	90,692,000	86,451,000
Common stock, shares outstanding (in shares)	90,692,000	86,451,000

XML

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Net revenue	$ 168,847	$ 108,813	$ 306,035	$ 204,746
Cost of net revenue	71,184	47,288	129,488	89,390
Gross profit	97,663	61,525	176,547	115,356
Operating expenses:
Research and development	56,033	47,199	109,195	102,656
Selling, general and administrative	45,751	33,361	88,208	69,950
Restructuring charges	64	5,580	538	13,459
Total operating expenses	101,848	86,140	197,941	186,065
Loss from operations	(4,185)	(24,615)	(21,394)	(70,709)
Interest income	474	812	1,107	1,676
Interest expense	(2,269)	(2,512)	(4,466)	(5,016)
Other income (expense), net	(570)	(4,386)	(449)	(5,654)
Total other income (expense), net	(2,365)	(6,086)	(3,808)	(8,994)
Loss before income taxes	(6,550)	(30,701)	(25,202)	(79,703)
Income tax provision (benefit)	(8,310)	(4,115)	18,175	(3,404)
Net income (loss)	$ 1,760	$ (26,586)	$ (43,377)	$ (76,299)
Net income (loss) per share:
Basic (in usd per share)	$ 0.02	$ (0.31)	$ (0.49)	$ (0.89)
Diluted (in usd per share)	$ 0.02	$ (0.31)	$ (0.49)	$ (0.89)
Shares used to compute net income (loss) per share:
Basic (in shares)	90,043	86,626	88,826	85,952
Diluted (in shares)	97,333	86,626	88,826	85,952

XML

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 1,760	$ (26,586)	$ (43,377)	$ (76,299)
Other comprehensive income, net of tax:
Foreign currency translation adjustments, net of tax benefit of $10 and $34 for the three and six months ended June 30, 2026, respectively, and net of tax expense of $264 for the three months ended June 30, 2025 and net of tax benefit of $259 for the six months ended June 30, 2025, respectively.	1,228	6,300	319	7,157
Total comprehensive income (loss)	$ 2,988	$ (20,286)	$ (43,058)	$ (69,142)

XML

Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Statement of Comprehensive Income [Abstract]
Foreign currency translation adjustment, tax expense (benefit)	$ (10)	$ 264	$ (34)	$ (259)

XML

Consolidated Statement of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2024		84,613
Balance at beginning of period at Dec. 31, 2024	$ 516,283	$ 8	$ 886,823	$ (6,823)	$ (363,725)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued pursuant to equity awards, net (in shares)		1,761
Common stock issued pursuant to equity awards, net	2,877	$ 1	2,876
Stock-based compensation	22,871		22,871
Other comprehensive income (loss)	857			857
Net income (loss)	(49,713)				(49,713)
Balance at end of period (in shares) at Mar. 31, 2025		86,374
Balance at end of period at Mar. 31, 2025	493,175	$ 9	912,570	(5,966)	(413,438)
Balance at beginning of period (in shares) at Dec. 31, 2024		84,613
Balance at beginning of period at Dec. 31, 2024	516,283	$ 8	886,823	(6,823)	(363,725)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(76,299)
Balance at end of period (in shares) at Jun. 30, 2025		86,907
Balance at end of period at Jun. 30, 2025	488,331	$ 9	928,012	334	(440,024)
Balance at beginning of period (in shares) at Mar. 31, 2025		86,374
Balance at beginning of period at Mar. 31, 2025	493,175	$ 9	912,570	(5,966)	(413,438)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued pursuant to equity awards, net (in shares)		331
Employee stock purchase plan (in shares)		202
Employee stock purchase plan	2,178		2,178
Stock-based compensation	13,264		13,264
Other comprehensive income (loss)	6,300			6,300
Net income (loss)	(26,586)				(26,586)
Balance at end of period (in shares) at Jun. 30, 2025		86,907
Balance at end of period at Jun. 30, 2025	$ 488,331	$ 9	928,012	334	(440,024)
Balance at beginning of period (in shares) at Dec. 31, 2025	86,451	86,451
Balance at beginning of period at Dec. 31, 2025	$ 451,895	$ 9	951,262	1,030	(500,406)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued pursuant to equity awards, net (in shares)		3,078
Common stock issued pursuant to equity awards, net	28,360		28,360
Stock-based compensation	19,982		19,982
Other comprehensive income (loss)	(909)			(909)
Net income (loss)	(45,137)				(45,137)
Balance at end of period (in shares) at Mar. 31, 2026		89,529
Balance at end of period at Mar. 31, 2026	$ 454,191	$ 9	999,604	121	(545,543)
Balance at beginning of period (in shares) at Dec. 31, 2025	86,451	86,451
Balance at beginning of period at Dec. 31, 2025	$ 451,895	$ 9	951,262	1,030	(500,406)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ (43,377)
Balance at end of period (in shares) at Jun. 30, 2026	90,692	90,692
Balance at end of period at Jun. 30, 2026	$ 484,840	$ 9	1,027,265	1,349	(543,783)
Balance at beginning of period (in shares) at Mar. 31, 2026		89,529
Balance at beginning of period at Mar. 31, 2026	454,191	$ 9	999,604	121	(545,543)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued pursuant to equity awards, net (in shares)		989
Common stock issued pursuant to equity awards, net	(1,758)		(1,758)
Employee stock purchase plan (in shares)		174
Employee stock purchase plan	1,961		1,961
Stock-based compensation	27,458		27,458
Other comprehensive income (loss)	1,228			1,228
Net income (loss)	$ 1,760				1,760
Balance at end of period (in shares) at Jun. 30, 2026	90,692	90,692
Balance at end of period at Jun. 30, 2026	$ 484,840	$ 9	$ 1,027,265	$ 1,349	$ (543,783)

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating Activities
Net loss	$ (43,377)	$ (76,299)
Adjustments to reconcile net loss to cash provided by (used in) operating activities:
Amortization and depreciation	18,130	18,582
Amortization of debt issuance costs and accretion of discounts	839	1,001
Stock-based compensation	47,506	36,024
Deferred income taxes	14,902	(6,355)
Loss on disposal of property and equipment	200	900
Reduction in the carrying amount of leased right-of-use assets	3,615	3,784
Impairment of leased right-of-use assets	233	427
Gain on extinguishment of lease liabilities	(328)	0
Loss on foreign currency	247	5,461
Excess tax benefits on stock-based awards	(10,615)	(2,274)
Changes in operating assets and liabilities:
Accounts receivable	(4,915)	(20,354)
Inventory	(27,386)	4,312
Prepaid expenses and other assets	(22,501)	4,480
Accounts payable, accrued expenses and other current liabilities	(709)	29,141
Accrued compensation	21,211	11,849
Accrued price protection liability	4,699	(3,881)
Lease liabilities	(5,485)	(5,777)
Other long-term liabilities	(329)	(1,932)
Net cash used in operating activities	(4,063)	(911)
Investing Activities
Purchases of property and equipment	(3,722)	(3,161)
Purchases of intangible assets	(1,665)	(6,207)
Proceeds from convertible notes receivable	(2,000)	0
Net cash used in investing activities	(7,387)	(9,368)
Financing Activities
Proceeds from borrowings under revolving credit facility	20,000	0
Repayment of borrowings under revolving credit facility	(20,000)	0
Payment of debt issuance costs	(479)	0
Proceeds from funding arrangement	8,000	0
Net proceeds from issuance of common stock, net of costs	3,804	2,140
Minimum tax withholding paid on behalf of employees for restricted stock units	(7,438)	(2,201)
Net cash provided by (used in) financing activities	3,887	(61)
Effect of exchange rate changes on cash and cash equivalents	(117)	990
Decrease in cash, cash equivalents and restricted cash	(7,680)	(9,350)
Cash, cash equivalents and restricted cash at beginning of period	101,412	119,603
Cash, cash equivalents and restricted cash at end of period	93,732	110,253
Supplemental disclosures of cash flow information:
Cash paid for interest	3,984	4,322
Cash paid for income taxes, net of refunds	(2,116)	2,994
Supplemental disclosures of non-cash activities:
Issuance of shares for payment of bonuses	$ 32,205	$ 5,163

XML

Organization and Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2026

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization and Summary of Significant Accounting Policies

Organization and Summary of Significant Accounting Policies

Description of Business

MaxLinear, Inc. was incorporated in Delaware in September 2003. MaxLinear, Inc., together with its directly and indirectly wholly-owned subsidiaries, collectively referred to as MaxLinear, or the Company, is a provider of communications systems-on-chips, or SoCs, solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. MaxLinear is a fabless integrated circuit design company whose products integrate all or substantial portions of a high-speed communication system, including radio frequency, or RF, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management. MaxLinear’s customers primarily include electronics distributors, module makers, original equipment manufacturers, or OEMs, and original design manufacturers, or ODMs, which incorporate the Company’s products in a wide range of electronic devices. Examples of such devices include radio transceivers and modems for 4G/5G base-station and backhaul infrastructure; optical transceivers targeting hyperscale data centers; Wi-Fi and wireline routers for home networking; broadband modems compliant with Data Over Cable Service Interface Specifications, or DOCSIS, passive optical network, or PON, and digital subscriber line, or DSL; as well as power management and interface products used in these and many other markets.

Basis of Presentation and Principles of Consolidation

The accompanying unaudited consolidated financial statements include the accounts of MaxLinear, Inc. and its directly and indirectly wholly-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. All intercompany transactions and investments have been eliminated in consolidation.

In the opinion of management, the Company’s unaudited consolidated interim financial statements contain adjustments, including normal recurring accruals necessary to present fairly the Company’s consolidated financial position, results of operations, comprehensive loss, stockholders’ equity, and cash flows.

The consolidated balance sheet as of December 31, 2025 was derived from the Company’s audited consolidated financial statements at that date. The accompanying unaudited consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2025 included in the Company’s Annual Report on Form 10-K filed by the Company with the Securities and Exchange Commission, or the SEC, on January 29, 2026, or the Annual Report. Interim results for the six months ended June 30, 2026 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2026.

The functional currency of certain foreign subsidiaries is the local currency. Accordingly, assets and liabilities of these foreign subsidiaries are translated at the current exchange rate at the balance sheet date and historical rates for equity. Revenue and expense components are translated at weighted average exchange rates in effect during the period. Gains and losses resulting from foreign currency translation are included as a component of stockholders’ equity. Foreign currency transaction gains and losses are included in the results of operations, and to date, have not been material.

Use of Estimates and Significant Risks and Uncertainties

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes to the consolidated financial statements. Actual results could differ from those estimates.

The Company is not aware of any specific event or circumstance that would require an update to its estimates or adjustments to the carrying value of its assets and liabilities as of July 23, 2026, the issuance date of this Quarterly Report on Form 10-Q. Actual results could differ from those estimates.

Summary of Significant Accounting Policies

Refer to the Company’s Annual Report for a summary of significant accounting policies. There have been no material changes to the Company’s significant accounting policies during the six months ended June 30, 2026.

Recently Adopted Accounting Pronouncements

In September 2025, the FASB issued ASU No. 2025-07, Derivatives and Hedging (Topic 815) and Revenue from Contracts with Customers (Topic 606)—Derivatives Scope Refinements and Scope Clarification for Share-Based Noncash Consideration from a Customer in a Revenue Contract, or ASU No. 2025-07. The amendments in this update exclude from derivative accounting non-exchange-traded contracts with underlyings that are based on operations or activities specific to one of the parties to the contract and clarify the accounting for receipt of share-based noncash consideration from a customer for the transfer of goods or services. These amendments are effective for the Company for annual and interim periods in 2027 and may be applied prospectively to new contracts entered into on or after the date of adoption, or on a modified retrospective basis via a cumulative-effect adjustment to the opening balance of retained earnings for existing contracts, with early adoption permitted. The Company adopted the amendments in this update prospectively in 2026. The impact of the adoption of the amendments in this update was not material to the Company’s consolidated financial position and results of operations as of and for the three and six months ended June 30, 2026.

In July 2025, the FASB issued ASU No. 2025-05, Financial Instruments – Credit Losses (Topic 326), to allow entities to elect a practical expedient that assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset when estimating expected credit losses for current accounts receivable and current contract assets. These amendments are effective for the Company for annual and interim periods in 2026 applied prospectively, with early adoption permitted. The Company adopted the amendments in this update prospectively in 2026. The impact of the adoption of the amendments in this update was not material to the Company’s consolidated financial position and results of operations.

Recently Issued, Not Yet Adopted Accounting Pronouncements

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements, to clarify and reorganize GAAP interim reporting guidance to improve navigability, applicability, and consistency without changing the fundamental nature or volume of required interim disclosures. This amendment clarifies when ASC 270 is applicable, establishes a disclosure principle requiring disclosure of material events or changes occurring since the most recent annual reporting period, and consolidates into ASC Topic 270 a comprehensive list of interim disclosures required by other Codification Topics. The amendment also clarifies the form and content of interim financial statements, including guidance for condensed interim reporting. The amendment is effective for the Company for interim periods in 2028, with early adoption permitted. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations.

In December 2025, the FASB issued ASU 2025‑10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities, to establish specific guidance for the recognition, measurement, presentation, and disclosure of government grants received to reduce diversity and increase consistency amongst business entities in accounting for such grants. This amendment amends ASC Topic 832 to require that a government grant received by a business entity should not be recognized as income until it is probable that a business entity will comply with the conditions attached to the grant and the grant will be received, with any grant related to an asset to be purchased, constructed or acquired such as long-lived assets or inventory to be recognized on the balance sheet as either deferred income or as an adjustment to the cost basis of the related asset, or the cost accumulation approach, as such costs are incurred. Any grant income or deferred income shall be recognized in earnings on a systematic and rational basis over the periods in which a business entity recognizes as expenses the costs for which the grant is intended to compensate, whereas any grants accounted for using the cost accumulation approach will not have a direct subsequent recognition in earnings, but rather reduced depreciation or amortization in accounting for the related asset. Entities are also required to present grants recognized in earnings separately under other income or deducted from the related expense, and provide disclosures of the nature of the government grant received, the accounting policies used to account for the grant, and the significant terms and conditions of the grant.

The amendment is effective for the Company for annual and interim periods in 2029, with early adoption and multiple transition methods permitted. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations as it does not differ materially from the Company’s current practice in accounting for government grants.

In September 2025, the FASB issued ASU No. 2025-06, Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, to update the accounting for software developed for internal use to better align with software development as it has evolved from a sequential development method to incremental and iterative development methods. The amendments in this update require an entity to begin capitalizing internal-use software costs when management has authorized and committed to funding the software project and it is probable that the project will be completed and the software will be used to perform the function intended. These amendments are effective for the Company for annual and interim periods in 2028, applied either prospectively, retrospectively, or by a modified approach,

with early adoption permitted. As the Company does not currently have a material amount of software developed for internal use, the impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations.

In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses, to improve the disclosures about a public business entity’s expenses and address requests from investors for more detailed information about the types of expenses including purchases of inventory, employee compensation, depreciation and intangible asset amortization in commonly presented expense captions such as cost of sales, selling, general and administrative expense, and research and development. These amendments are effective for the Company for annual periods in 2027, applied prospectively, with early adoption permitted, and interim periods beginning in 2028. The Company intends to adopt the amendments in this update prospectively in 2027 for annual periods and in 2028 for interim periods. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations, as the requirements only require more detailed disclosures in the footnotes to the Company’s consolidated financial statements.

XML

Net Income (Loss) Per Share

6 Months Ended

Jun. 30, 2026

Earnings Per Share [Abstract]

Net Income (Loss) Per Share

Net Income (Loss) Per Share

Basic earnings per share, or EPS, is calculated by dividing net income (loss) by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted EPS is computed by dividing net income (loss) by the weighted-average number of common shares outstanding for the period and the weighted-average number of dilutive common stock equivalents outstanding for the period determined using the treasury-stock method. For purposes of this calculation, stock options and restricted stock units are considered to be common stock equivalents and are only included in the calculation of diluted EPS when their effect is dilutive. In periods in which the Company has a net loss, dilutive common stock equivalents are excluded from the calculation of diluted EPS.

The table below presents the computation of basic and diluted EPS:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
	(in thousands, except per share amounts)
Numerator:
Net income (loss)	$	1,760	$	(26,586)	$	(43,377)	$	(76,299)
Denominator:
Weighted average common shares outstanding—basic	90,043		86,626		88,826		85,952
Dilutive common stock equivalents	7,290		—		—		—
Weighted average common shares outstanding—diluted	97,333		86,626		88,826		85,952
Net income (loss) per share:
Basic	$	0.02	$	(0.31)	$	(0.49)	$	(0.89)
Diluted	$	0.02	$	(0.31)	$	(0.49)	$	(0.89)

For the three months ended June 30, 2026 and 2025, the Company excluded common stock equivalents for outstanding stock-based awards, which represented potentially dilutive securities of 144 thousand and 7.8 million, respectively, from the calculation of diluted net income (loss) per share due to their anti-dilutive nature.

For the six months ended June 30, 2026 and 2025, the Company excluded common stock equivalents for outstanding stock-based awards, which represented potentially dilutive securities of 7.4 million and 6.4 million, respectively, from the calculation of diluted net loss per share due to their anti-dilutive nature.

XML

Business Combinations

6 Months Ended

Jun. 30, 2026

Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]

Business Combinations

Business Combinations

Terminated Silicon Motion Merger

On May 5, 2022, MaxLinear entered into an Agreement and Plan of Merger, or the Merger Agreement, with Silicon Motion Technology Corporation, or Silicon Motion, an exempted company with limited liability incorporated under the laws of the Cayman Islands, pursuant to which, among other things and subject to the terms and conditions thereof, MaxLinear agreed to acquire Silicon Motion pursuant to a statutory merger, under the laws of the Cayman Islands, of Shark Merger Sub, a wholly-owned subsidiary of MaxLinear, with and into Silicon Motion, with Silicon Motion surviving the merger as a wholly-owned

subsidiary of MaxLinear. Silicon Motion is a provider of NAND flash controllers for solid state drives, or SSDs, and other solid state storage devices.

On July 26, 2023, MaxLinear terminated the Merger Agreement and notified Silicon Motion that MaxLinear was relieved of its obligations to close because, among other reasons, (i) certain conditions to closing set forth in the Merger Agreement were not satisfied and were incapable of being satisfied, (ii) Silicon Motion had suffered a Material Adverse Effect that was continuing, (iii) Silicon Motion was in material breach of representations, warranties, covenants, and agreements in the Merger Agreement that gave rise to the right of the Company to terminate, and (iv) in any event, the First Extended Outside Date had passed and was not automatically extended because certain conditions in Article 6 of the Merger Agreement were not satisfied or waived as of May 5, 2023. For these same reasons, under the terms of the Merger Agreement, MaxLinear was not required to pay a break-up fee or other fee to Silicon Motion as a result of the termination of the Merger Agreement. Undefined capitalized terms in this paragraph have the same meaning as in the Merger Agreement. On August 16, 2023, Silicon Motion delivered to MaxLinear a notice, which Silicon Motion publicly disclosed, that it was purporting to terminate the Merger Agreement and that Silicon Motion would be commencing an arbitration to seek damages from MaxLinear arising from MaxLinear's alleged breaches of the Merger Agreement.

On October 5, 2023, Silicon Motion filed a Notice of Arbitration with the Singapore International Arbitration Centre alleging that MaxLinear breached the Merger Agreement. See Note 14 for more information on legal matters related to the termination of the Merger Agreement.

XML

Restructuring Activity

6 Months Ended

Jun. 30, 2026

Restructuring and Related Activities [Abstract]

Restructuring Activity

Restructuring Activity

From time to time, the Company approves and implements restructuring plans as a result of internal resource alignment and cost saving measures. Such restructuring plans may include terminating employees, vacating certain leased facilities, and cancelling certain contracts.

The following table presents the activity related to the restructuring plans, which is included in restructuring charges in the consolidated statements of operations:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
	(in thousands)
Employee separation expenses	$	218	$	4,561	$	323	$	6,158
Lease related charges	(176)		933		182		935
Other	22		86		33		6,366
	$	64	$	5,580	$	538	$	13,459

The following table presents a roll-forward of the Company’s restructuring liability for the six months ended June 30, 2026. The restructuring liability is included in accrued expenses and other current liabilities and other long-term liabilities in the consolidated balance sheets.

	Employee Separation Expenses		Lease Related Charges		Other		Total
	(in thousands)
Liability as of December 31, 2025	$	2,857	$	858	$	11,243	$	14,958
Restructuring charges	323		182		33		538
Cash payments	(2,707)		(172)		(8,818)		(11,697)
Non-cash charges and adjustments	(254)		101		138		(15)
Liability as of June 30, 2026	219		969		2,596		3,784
Less: current portion as of June 30, 2026	(219)		(969)		(1,175)		(2,363)
Long-term portion as of June 30, 2026	$	—	$	—	$	1,421	$	1,421

XML

Goodwill and Intangible Assets

6 Months Ended

Jun. 30, 2026

Intangible Asset, Goodwill and Other [Abstract]

Goodwill and Intangible Assets

Goodwill and Intangible Assets

Goodwill

Goodwill arises from the acquisition method of accounting for business combinations and represents the excess of the purchase price over the fair value of the net assets and other identifiable intangible assets acquired. The fair values of net tangible assets and intangible assets acquired are based upon preliminary valuations and the Company’s estimates and assumptions are subject to change within the measurement period (potentially up to one year from the acquisition date).

There were no changes in the carrying amount of goodwill for the six months ended June 30, 2026 and 2025.

The Company performs an annual goodwill impairment assessment on October 31st each year, using a quantitative assessment comparing the fair value of each reporting unit, which the Company has determined to be the entity itself, with its carrying amount, including goodwill. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recorded. As a result of the Company’s impairment assessment, no goodwill impairment was recognized as of October 31, 2025.

In addition to its annual review, the Company performs a test of impairment when indicators of impairment are present. During the six months ended June 30, 2026 and 2025, there were no indications of impairment of the Company’s goodwill balances.

Acquired Intangibles

Finite-lived Intangible Assets

The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which are amortized over their estimated useful lives:

		June 30, 2026						December 31, 2025
	Weighted Average Useful Life (in Years)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
		(in thousands)
Licensed technology	6.9	$	33,523	$	(4,917)	$	28,606	$	31,858	$	(3,663)	$	28,195
Developed technology	6.9	311,261		(298,872)		12,389		311,261		(293,761)		17,500
Trademarks and trade names	6.2	14,800		(14,633)		167		14,800		(14,562)		238
Patents	7.0	4,780		(2,162)		2,618		4,780		(1,821)		2,959
	6.0	$	364,364	$	(320,584)	$	43,780	$	362,699	$	(313,807)	$	48,892

The following table sets forth amortization expense associated with finite-lived intangible assets, which is included in the consolidated statements of operations as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
	(in thousands)
Cost of net revenue	$	3,213	$	2,844	$	6,342	$	5,673
Selling, general and administrative	229		591		435		1,183
	$	3,442	$	3,435	$	6,777	$	6,856

Amortization of finite-lived intangible assets in cost of net revenue in the consolidated statements of operations results primarily from acquired developed technology.

The following table sets forth the activity related to finite-lived intangible assets:

	Six Months Ended June 30,
	2026		2025
	(in thousands)
Beginning balance	$	48,892	$	55,008
Additions	1,665		6,207
Amortization	(6,777)		(6,856)
Ending balance	$	43,780	$	54,359

The Company regularly reviews the carrying amount of its long-lived assets subject to depreciation and amortization, as well as the related useful lives, to determine whether indicators of impairment may exist that warrant adjustments to carrying values or estimated useful lives. An impairment loss is recognized when the sum of the expected future undiscounted net cash flows is less than the carrying amount of the asset. Should impairment exist, the impairment loss is measured based on the excess of the carrying amount of the asset over the asset’s fair value.

During each of the three and six months ended June 30, 2026 and 2025, no impairment losses related to finite-lived intangible assets were recognized.

The following table presents future amortization of the Company’s finite-lived intangible assets at June 30, 2026:

	Amount
	(in thousands)
2026 (6 months)	$	7,427
2027	11,834
2028	6,388
2029	5,297
2030	4,167
Thereafter	8,667
Total	$	43,780

XML

Financial Instruments

6 Months Ended

Jun. 30, 2026

Fair Value Disclosures [Abstract]

Financial Instruments

Financial Instruments

The composition of financial instruments is as follows:

	Fair Value
	June 30, 2026		December 31, 2025
	(in thousands)
Liabilities
Contingent consideration	$	2,600	$	2,600

The fair value of the Company’s financial instruments is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants and is recorded using a hierarchical disclosure framework based upon the level of subjectivity of the inputs used in measuring assets and liabilities. The levels are described below:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.

Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

Level 3: Unobservable inputs are used when little or no market data is available.

The Company classifies its financial instruments that are categorized within Level 1 or Level 2 of the fair value hierarchy on the basis of valuations using quoted market prices or alternate pricing sources and models utilizing market observable inputs, respectively.

The contingent consideration liability of $2.6 million as of June 30, 2026 and December 31, 2025 is associated with an acquisition in January 2023. The contingent consideration liability is classified as a Level 3 (significant unobservable inputs) financial instrument. The contingent consideration as it relates to the acquisition was subject to the acquired business’ satisfaction of certain personnel objectives by June 17, 2024, but remains unpaid pending resolution of certain matters. The fair value of the contingent consideration was based on (1) applying the Monte Carlo simulation method, with underlying forecast mathematics based on Geometric Brownian motion in a risk-neutral framework, to forecast achievement of the acquired business’ financial objectives, if applicable, under various possible contingent consideration events and (2) a probability based methodology using management’s inputs and assumptions to forecast achievement of the acquired business’ personnel objectives which included an assumption of total payments up to $2.6 million to the acquiree. Key inputs in the valuation include forecasted revenue, revenue volatility, discount rate and discount term as it relates to the financial objectives and probability of achievement, discount term and discount rate as it relates to the personnel objectives.

There was no activity in the Level 3 fair value hierarchy categories of financial instruments for the six months ended June 30, 2026 and 2025.

There were no transfers between Level 1, Level 2, or Level 3 fair value hierarchy categories of financial instruments for the six months ended June 30, 2026 and 2025.

Financial Instruments Not Recorded at Fair Value on a Recurring Basis

Some of the Company’s financial instruments are recorded at amounts that approximate fair value due to their liquid or short-term nature. Such financial assets and financial liabilities include: cash and cash equivalents, restricted cash, net receivables, certain other assets, accounts payable, accrued price protection liability, accrued expenses, accrued compensation costs, and other current liabilities.

The Company’s long-term debt is not recorded at fair value on a recurring basis but is measured at fair value for disclosure purposes (Note 8).

XML

Balance Sheet Details

6 Months Ended

Jun. 30, 2026

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Details

Balance Sheet Details

Cash, cash equivalents and restricted cash consist of the following:

	June 30, 2026		December 31, 2025
	(in thousands)
Cash and cash equivalents	$	64,814	$	72,806
Short-term restricted cash	1,492		1,419
Long-term restricted cash	27,426		27,187
Total cash, cash equivalents and restricted cash	$	93,732	$	101,412

As of June 30, 2026 and December 31, 2025, cash and cash equivalents included money market funds of approximately $2.0 million and $19.2 million, respectively. As of June 30, 2026 and December 31, 2025, the Company had restricted cash of approximately $28.9 million and $28.6 million, respectively. The cash is restricted in connection with guarantees for certain import duties, office leases and purchase obligations.

Inventory consists of the following:

	June 30, 2026		December 31, 2025
	(in thousands)
Work-in-process	$	79,012	$	47,598
Finished goods	26,478		30,506
	$	105,490	$	78,104

Property and equipment, net consists of the following:

	Useful Life (in Years)	June 30, 2026		December 31, 2025
		(in thousands)
Furniture and fixtures	5	$	4,101	$	4,006
Machinery and equipment	3-5	88,929		87,043
Masks and production equipment	5	68,028		66,044
Software	3	11,253		11,498
Leasehold improvements	1-5	36,127		35,632
Construction in progress	N/A	1,315		2,516
		209,753		206,739
Less: accumulated depreciation and amortization		(168,546)		(157,866)
		$	41,207	$	48,873

Depreciation expense for the three months ended June 30, 2026 and 2025 was $5.6 million and $5.9 million, respectively. Depreciation expense for the six months ended June 30, 2026 and 2025 was $11.4 million and $11.7 million, respectively.

As of June 30, 2026, the Company held a note receivable from a supplier of $8.0 million with annual repayments of $2.0 million per year due annually by March 31, from 2027 through 2030, provided that certain production utilization targets are met. The long-term portion of the note receivable of $6.0 million is included in other long-term assets as of June 30, 2026 and December 31, 2025, respectively.

On January 5, 2026, the Company entered into a convertible note receivable of $2.0 million with a privately-held entity. The convertible note receivable bears interest at an annual rate of 3.87%, compounded annually. The note is due and payable at any time on or after the maturity date of January 5, 2029, unless earlier converted. The outstanding principal and any unpaid accrued interest are convertible into shares of the entity or repayable under certain conditions. Conversion occurs automatically upon the closing of the investee’s next equity financing of at least $10.0 million, provided the entity has achieved a specified milestone prior to such financing, or conversion may be elected by the Company under certain conditions. If the entity fails to achieve the milestone prior to the maturity date, the Company may, at any time on or after maturity, elect either repayment of the outstanding principal and accrued interest or conversion into shares of the entity. The convertible note receivable of $2.0 million is included in other long-term assets as of June 30, 2026.

The following table sets forth activity related to the accrued price protection liability:

	Six Months Ended June 30,
	2026		2025
	(in thousands)
Beginning balance	$	26,493	$	43,401
Charged as a reduction of revenue	15,890		14,353
Revisions to accrued rebates	(2,440)		(12,170)
Payments	(8,751)		(6,064)
Ending balance	$	31,192	$	39,520

Accrued expenses and other current liabilities consist of the following:

	June 30, 2026		December 31, 2025
	(in thousands)
Accrued technology license payments	$	3,627	$	3,687
Accrued professional fees	5,198		6,882
Accrued engineering and production costs	11,496		8,469
Accrued restructuring	2,363		13,390
Short-term lease liabilities	8,806		9,096
Accrued customer credits	5,197		6,398
Income tax liability	432		511
Customer contract liabilities	397		4,222
Accrued obligations to customers for price adjustments	10,420		11,922
Accrued obligations to customers for stock rotation rights	247		222
Contingent consideration - current portion	2,600		2,600
Other	7,461		4,993
	$	58,244	$	72,392

The following table summarizes the change in balances of accumulated other comprehensive income (loss) by component:

	Cumulative Translation Adjustments		Pension and Other Defined Benefit Plan Obligation		Total
	(in thousands)
Balance at December 31, 2025	$	(327)	$	1,357	$	1,030
Other comprehensive loss before reclassifications, net of tax	319		—		319
Balance at June 30, 2026	$	(8)	$	1,357	$	1,349

XML

Debt and Other Long-Term Liabilities

6 Months Ended

Jun. 30, 2026

Debt Disclosure [Abstract]

Debt and Other Long-Term Liabilities

Debt and Other Long-Term Liabilities

Debt

The carrying amount of the Company’s long-term debt consists of the following:

	June 30, 2026		December 31, 2025
	(in thousands)
Principal balance:
Initial term loan under the June 23, 2021 credit agreement	$	125,000	$	125,000
Total principal balance	125,000		125,000
Less:
Unamortized debt discount	(258)		(320)
Unamortized debt issuance costs	(816)		(1,062)
Net carrying amount of long-term debt	123,926		123,618
Less: current portion of long-term debt	—		—
Long-term debt, non-current portion	$	123,926	$	123,618

As of June 30, 2026 and December 31, 2025, the weighted average effective interest rate on aggregate debt was approximately 6.4% and 6.9%, respectively.

During the three months ended June 30, 2026 and 2025, the Company recognized total amortization of debt discount and debt issuance costs of $0.2 million and $0.2 million, respectively, to interest expense. During the six months ended June 30,

2026 and 2025, the Company recognized total amortization of debt discount and debt issuance costs of $0.3 million and $0.3 million, respectively, to interest expense.

The approximate aggregate fair value of the term loans outstanding as of June 30, 2026 and December 31, 2025 was $123.3 million and $124.7 million, respectively, which was estimated on the basis of inputs that are observable in the market and which is considered a Level 2 measurement method in the fair value hierarchy (Note 6).

As of June 30, 2026, the outstanding principal balance of $125.0 million is due in full on June 23, 2028, upon maturity of the loan.Initial Term Loan and Revolving Facility under the June 23, 2021 Credit Agreement

On June 23, 2021, the Company entered into a Credit Agreement, or the June 23, 2021 Credit Agreement, by and among the Company, the lenders from time to time party thereto, and Wells Fargo Bank, National Association, as administrative agent and collateral agent, or “Agent”, that provides for a senior secured term B loan facility, or the Initial Term Loan under the June 23, 2021 Credit Agreement, in an aggregate principal amount of $350.0 million and a senior secured revolving credit facility, or the Revolving Facility, in an aggregate principal amount of up to $100.0 million. The proceeds of the Initial Term Loan under the June 23, 2021 Credit Agreement were used (i) to repay in full all outstanding indebtedness under that certain Credit Agreement dated May 12, 2017, by and among the Company, MUFG Bank Ltd., as administrative agent and MUFG Union Bank, N.A., as collateral agent and the lenders from time to time party thereto (as amended by Amendment No. 1, dated July 31, 2020) and (ii) to pay fees and expenses incurred in connection therewith. The remaining proceeds of the Initial Term Loan under the June 23, 2021 Credit Agreement are available for general corporate purposes and the proceeds of the Revolving Facility may be used to finance the working capital needs and other general corporate purposes of the Company and its subsidiaries. Under the terminated amended and restated commitment letter with Wells Fargo Bank and other lenders entered into in connection with the previously pending (now terminated) merger with Silicon Motion (Note 3), the Company had expected to repay the remaining outstanding term loans under such agreement upon closing of the merger.

The June 23, 2021 Credit Agreement permits the Company to request incremental loans in an aggregate principal amount not to exceed the sum of an amount equal to the greater of (x) $175.0 million and (y) 100% of consolidated EBITDA, plus the amount of certain voluntary prepayments, plus an unlimited amount that is subject to pro forma compliance with certain first lien net leverage ratio, secured net leverage ratio and total net leverage ratio tests. Incremental loans are subject to certain additional conditions, including obtaining additional commitments from the lenders then party to the June 23, 2021 Credit Agreement or new lenders.

Under the June 23, 2021 Credit Agreement, the Initial Term Loan bears interest, at the Company’s option, at a per annum rate equal to either (i) a base rate equal to the highest of (x) the federal funds rate, plus 0.50%, (y) the prime rate then in effect and (z) an adjusted Term SOFR rate determined on the basis of a one-month interest period plus 1.00%, in each case, plus an applicable margin of 1.25% or (ii) an adjusted Term SOFR rate, subject to a floor of 0.50%, plus an applicable margin of 2.25%. Loans under the Revolving Facility initially bear interest, at a per annum rate equal to either (i) a base rate (as calculated above) plus an applicable margin of 0.00%, or (ii) an adjusted Term SOFR rate (as calculated above) plus an applicable margin of 1.00%. Following delivery of financial statements for the Company’s fiscal quarter ending June 30, 2021, the applicable margin for loans under the Revolving Facility will range from 0.00% to 0.75% in the case of base rate loans and 1.00% to 1.75% in the case of Term SOFR rate loans, in each case, depending on the Company’s secured net leverage ratio as of the most recently ended fiscal quarter. The Company is required to pay commitment fees of 0.25% per annum on the daily undrawn commitments under the Revolving Facility, depending on the Company’s secured net leverage ratio as of the most recently ended fiscal quarter. The Initial Term Loan under the June 23, 2021 Credit Agreement was initially set to amortize in equal quarterly installments from September 30, 2021 equal to 0.25% of the original principal amount of the Initial Term Loan under the June 23, 2021 Credit Agreement, with the balance payable on the maturity date. Due to prepayments of the principal made to date, the remaining principal balance of $125.0 million is payable on the June 23, 2028 maturity date. The June 23, 2021 Credit Agreement was amended on June 29, 2023 to implement a benchmark replacement.

On April 22, 2026, the Company entered into an amendment with the lenders party thereto and the Agent, or the Second Amendment. The Second Amendment amended the June 23, 2021 Credit Agreement to, among other things, (i) extend the maturity date applicable to the Revolving Facility from June 23, 2026 to March 23, 2028, (ii) provide for $30 million in incremental revolving commitments under the Revolving Facility and a $10.0 million Letter of Credit Commitment,, (iii) increase the applicable margin for loans under the Revolving Facility to (x) 2.25% per annum for Term SOFR loans, and (y) 1.25% per annum for base rate loans, and (iv) increase the applicable commitment fee rate to 0.25% per annum. Further, the financial covenant was modified to require that the Company maintain (a) a total net leverage ratio of not greater than 3.50:1.00

and (b) unrestricted cash plus available and undrawn commitments under the Revolving Facility in an amount not to exceed 100% of the Consolidated EBITDA for the most recently ended Test Period, in each case, tested as of the last day of any fiscal quarter of the Company. The proceeds of the Revolving Facility may be used to finance the working capital needs and other general corporate purposes of the Company and its subsidiaries. As of June 30, 2026, there were no borrowings outstanding under the Revolving Facility.

The Company is required to make mandatory prepayments of the outstanding principal amount of term loans under the June 23, 2021 Credit Agreement, or as amended by the Second Amendment, the Amended Credit Agreement, with the net cash proceeds from the disposition of certain assets and the receipt of insurance proceeds upon certain casualty and condemnation events, in each case, to the extent not reinvested within a specified time period, from excess cash flow beyond stated threshold amounts, and from the incurrence of certain indebtedness. The Company has the right to prepay its term loans under the Amended Credit Agreement, in whole or in part, at any time without premium or penalty, subject to certain limitations and a 1.0% soft call premium applicable during the first six months following the closing date of the Amended Credit Agreement. The Initial Term Loan under the June 23, 2021 Credit Agreement will mature on June 23, 2028, at which time all outstanding principal and accrued and unpaid interest on the Initial Term Loan under the June 23, 2021 Credit Agreement must be repaid. The Revolving Facility will mature on March 23, 2028, at which time all outstanding principal and accrued and unpaid interest under the Revolving Facility must be repaid. The Company is also obligated to pay fees customary for a credit facility of this size and type.

The Company’s obligations under the Amended Credit Agreement are required to be guaranteed by certain of its domestic subsidiaries meeting materiality thresholds set forth in the Amended Credit Agreement. Such obligations, including the guaranties, are secured by substantially all of the assets of the Company and the subsidiary guarantors pursuant to a Security Agreement, dated as of June 23, 2021, by and among the Company, the subsidiary guarantors from time to time party thereto, and Wells Fargo Bank, National Association, as collateral agent.

The Amended Credit Agreement contains customary affirmative and negative covenants, including covenants limiting the ability of the Company and its restricted subsidiaries to, among other things, incur debt, grant liens, undergo certain fundamental changes, make investments, make certain restricted payments, and sell assets, in each case, subject to limitations and exceptions set forth in the Amended Credit Agreement. The Revolving Facility also prohibits the Company from having a secured net leverage ratio in excess of 3.50:1.00 (subject to a temporary increase to 3.75:1.00 following the consummation of certain material permitted acquisitions) as of the last day of any fiscal quarter of the Company (commencing with the fiscal quarter ending September 30, 2021) if the aggregate borrowings under the Revolving Facility exceed 1% of the aggregate commitments thereunder (subject to certain exceptions set forth in the Amended Credit Agreement) as of such date. As of June 30, 2026, the Company was in compliance with such covenants. The Amended Credit Agreement also contains customary events of default that include, among other things, certain payment defaults, cross defaults to other indebtedness, covenant defaults, change in control defaults, judgment defaults, and bankruptcy and insolvency defaults. If an event of default exists, the lenders may require immediate payment of all obligations under the Amended Credit Agreement and may exercise certain other rights and remedies provided for under the Amended Credit Agreement, the other loan documents and applicable law.

The debt is carried at its principal amount, net of unamortized debt discount and issuance costs, and is not adjusted to fair value each period. The issuance date fair value of the liability component of the debt in the amount of $350.2 million was determined using a discounted cash flow analysis, in which the projected interest and principal payments were discounted back to the issuance date of the term loan at a market interest rate for nonconvertible debt of 3.4%, which represents a Level 2 fair value measurement. The debt discount of $0.9 million and debt issuance costs of $2.9 million associated with the Initial Term Loan under the Amended Credit Agreement are being amortized to interest expense using the effective interest method over its seven-year term through June 23, 2028. Debt issuance costs of $0.4 million associated with the Revolving Facility are being amortized to interest expense over its five-year original term through June 23, 2026, with the portion for incremental debt issuance costs of $0.5 million associated with the Second Amendment amortized to interest expense over the period from the date incurred through March 23, 2028.

Sale Arrangement

In March 2026, the Company entered into an agreement to sell an interest in certain claims for an amount not to exceed $10.0 million. The proceeds of this sale of $8.0 million were used to pay certain costs and expenses in connection with such claims, and are reflected as a long-term liability as of June 30, 2026. This liability is expected to be derecognized upon settlement or other resolution of the specified claims. Management does not believe that any additional potential payments that are contingent on the outcome of the claims are estimable as of June 30, 2026.

XML

Stock-Based Compensation

6 Months Ended

Jun. 30, 2026

Share-Based Payment Arrangement [Abstract]

Stock-Based Compensation

Stock-Based Compensation

Common Stock

Each share of common stock is entitled to one vote per share and holders of the common stock vote as a single class of stock on any matter that is submitted to a vote of stockholders.

Employee Stock-Based Compensation Plans

At June 30, 2026, the Company had stock-based compensation awards outstanding under the following plans: the 2010 Equity Incentive Plan, as amended, or 2010 Plan, the 2010 Employee Stock Purchase Plan, or ESPP, and the 2024 Inducement Equity Incentive Plan, or the Inducement Plan. Refer to the Company’s Annual Report for a summary of these plans.

On May 20, 2026, an amendment and restatement of the 2010 Plan, or the Restated 2010 Plan, and an amendment and restatement of the ESPP, or the Restated ESPP, became effective upon approval by the Company’s stockholders. Concurrently, on May 20, 2026, the Company terminated the Inducement Plan. The Restated Incentive Plan reserves an aggregate of 18,791,651 shares of the Company’s common stock for issuance under the plan, expires in May 2036, and (1) requires stockholder approval to increase the maximum number of shares reserved and available for issuance under the Restated 2010 Plan, (2) prohibits share recycling, or add back to shares available for issuance under the Restated 2010 Plan, of shares of stock used to pay the exercise or purchase price of an award or to satisfy tax withholding obligations, (3) prohibits option exchanges, re-pricings or cash buyouts of out-of-the money stock options. The Restated ESPP will remain in effect until it is terminated. The amendment and restatement of the ESPP also removes the annual automatic increase of the number of shares reserved and available for sale thereunder. As of June 30, 2026, the number of shares of common stock available for future issuance under the Restated 2010 Plan was 17,032,561 shares, including stock options and restricted stock unit awards outstanding at June 30, 2026 of 11,910,556 shares.

As of June 30, 2026, the number of shares of common stock available for future issuance under the ESPP was 7,766,912 shares.

As of June 30, 2026, the 713,220 shares subject to restricted stock unit awards outstanding as of June 30, 2026 remain available for future issuance under the terminated Inducement Plan.

Employee Incentive Bonus

The Company’s Executive Incentive Bonus Plan permits the settlement of awards under the plan in any combination of cash or shares of its common stock. The Company settles a majority of bonus awards for its employees, including executives, in shares of common stock under the Restated 2010 Plan. When bonus awards are settled in common stock issued under the Restated 2010 Plan, the number of shares issuable to plan participants is determined based on the closing price of the Company’s common stock as determined in trading on the applicable stock exchange, on a date approved by the Board of Directors. In connection with the Company’s bonus programs, in February 2026, the Company issued 1.5 million freely-tradable (subject to certain restrictions for affiliates) shares of the Company’s common stock in settlement of bonus awards to employees, including executives, for the 2025 performance period. At June 30, 2026, the Company has an accrual of $18.0 million for bonus awards for employees for year-to-date achievement in the 2026 performance period, which the Company intends to settle primarily in shares of its common stock, unless otherwise required to be settled in cash due to local laws or agreements. The Company’s compensation committee retains discretion to effect payment of employee bonus awards in cash, stock, or a combination of cash and stock.

Stock-Based Compensation

The Company recognizes stock-based compensation in the consolidated statements of operations, based on the department to which the related employee reports, as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
	(in thousands)
Cost of net revenue	$	131	$	155	$	281	$	437
Research and development	10,535		7,625		20,210		22,281
Selling, general and administrative	16,813		5,333		27,015		13,306
	$	27,479	$	13,113	$	47,506	$	36,024

The total unrecognized compensation cost related to unvested restricted stock units as of June 30, 2026 was $99.7 million, and the weighted average period over which these equity awards are expected to vest is 2.15 years.

The total unrecognized compensation cost related to unvested performance-based restricted stock units as of June 30, 2026 was $9.2 million, and the weighted average period over which these equity awards are expected to vest is 1.35 years. Actual levels of future performance under performance-based restricted stock units for the unvested periods may differ from the Company’s current estimates.

The total unrecognized compensation cost related to unvested stock options as of June 30, 2026 was $12.9 million, and the weighted average period over which these equity awards are expected to vest is 1.64 years.

Restricted Stock Units

A summary of the Company’s restricted stock unit activity for all equity plans is as follows:

	Number of Shares (in thousands)	Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 2025	7,649	$	19.89
Granted1	4,096	21.06
Vested2	(4,127)	19.99
Canceled3	(389)	18.92
Outstanding at June 30, 2026	7,229	$	20.55

____________
(1) Includes approximately 148 thousand shares granted under the Inducement Plan at a weighted-average grant-date fair value per share of $18.47.

(2) Includes approximately 38 thousand shares vested under the Inducement Plan at a weighted-average grant-date fair value per share of $14.00.

(3) Includes approximately 70 thousand shares canceled under the Inducement Plan at a weighted-average grant-date fair value per share of $15.35.

Performance-Based Restricted Stock Units

Performance-based restricted stock units are eligible to vest at the end of each year in a three-year performance period based on certain financial metrics as defined in the underlying agreement.

2025 and Subsequent Performance-Based Restricted Stock Units

For performance-based restricted stock units granted in 2025 and 2026, the award is divided into four approximately equal tranches each representing 25% of the target number of performance-based restricted stock units subject to the award. Each tranche has one or more performance goals that must be achieved in order for any restricted stock units subject to the tranche to become eligible to vest. For the first tranche, which covers one fiscal year in a three-year period, restricted stock units are eligible to vest based upon the achievement of certain net revenue and non-GAAP operating income targets. For two

of the four tranches, each of which cover one fiscal year in a three-year period, restricted stock units are eligible to vest when the Company’s annual growth rate in net revenue and non-GAAP operating income over baseline results equal or exceed target growth rates, as defined in the underlying agreement. For each of these three tranches, 50% of each performance-based award is subject to the net revenue metric for the performance period and 50% is subject to the non-GAAP operating income metric for the respective performance period. If the Company’s baseline results, or growth rate in each of these metrics relative to the baseline results, are below a determined threshold for a performance period for a particular performance metric and tranche, no shares in the performance metric and tranche will vest. The number of shares vesting is based on meeting minimum threshold, target, or maximum pre-determined baseline for the first year, and growth rate relative to the baseline thereafter, up to a maximum 200% of target; however, any shares above target (100%) will only become eligible to vest with continued service through the end of year three.

The fourth tranche of performance-based restricted stock units is measured over a three-year performance period, and shares are eligible to vest for this tranche based on the Company’s relative percentile rank in growth rate in net revenue for the third year over baseline results relative to the growth rates for companies in the Russell 3000 index for the same metric and periods. The Company’s relative percentile rank in net revenue is determined by ranking the individual companies in the Russell 3000 (including MaxLinear) in order of largest to smallest according to their revenue growth for the third year over baseline results, then calculating the percentile ranking of MaxLinear relative to other Russell 3000 companies. If the Company’s relative percentile rank for revenue growth at the end of the third year versus baseline is less than the predetermined threshold, as defined in the underlying agreement, no shares will vest. The target number of shares are eligible to vest when the Company’s relative percentile rank equals or exceeds the 50th percentile. The maximum shares that may be achieved is 200% of target shares for performance at or above the 75th percentile.

2024 and Prior Performance-Based Restricted Stock Units

For previous performance-based restricted stock units granted prior to 2025, the target number of units (100%) are eligible to vest when the annual growth rate in net revenue and non-GAAP diluted earnings per share (subject to certain adjustments) over baseline results relative to the growth rates for a peer group of companies for the same metrics and periods, equals or exceeds the 50th percentile.

The Company’s relative percentile rank in net revenue and non-GAAP diluted earnings per share is determined by ranking the designated peer group companies (including MaxLinear) from the highest to the lowest according to their annual growth rate in each metric for the performance year, then calculating the percentile ranking of MaxLinear relative to other companies in the designated peer group. If the Company’s relative percentile rank for each metric at year-end is less than the 25th percentile, no shares will vest. If the Company’s relative percentile rank for these metrics is greater than or equal to the 25th percentile, vesting may range from 50% up to a maximum 250% of target; such maximum may only vest at the end of year three for performance achieved at or above the 75th percentile.

For the performance-based restricted stock units granted prior to 2025, 60% of each performance-based award is subject to the net revenue metric for the performance period and 40% is subject to the non-GAAP diluted earnings per share metric for the performance period. The maximum percentage for a particular metric is 250% of the target number of units subject to the award related to that metric, however, vesting of the performance stock units is capped at 30% and 100%, respectively, of the target number of units subject to the award in years one and two, respectively, of the three-year performance period. The number of shares granted is based on the maximum percentage achievable (250%) in the performance-based restricted stock unit award, in order to reserve an adequate number of shares for any potential future vesting.

As of June 30, 2026, achievement to date under the performance metrics specified in the respective award agreements are based on its expected metric results over the performance periods and calculated growth rates relative to baseline based on data available, as defined in the respective award agreements. To the extent any prior achievement levels are no longer probable, any compensation expense recorded is adjusted to the revised achievement levels.

A summary of the Company’s performance-based restricted stock unit activity is as follows:

	Number of Shares (in thousands)	Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 2025	3,333	$	19.58
Granted	623	18.47
Released	(83)	15.19
Canceled1	(1,021)	25.46
Outstanding at June 30, 2026	2,852	$	17.36

________________

(1) Includes shares canceled due to achievement below threshold amounts from shares granted which were previously reserved at the maximum achievable (250%). No shares were eligible to vest for the 2025 performance period under the 2023 and 2024 performance-based restricted stock unit grants due to achievement below the 25th percentile.

Employee Stock Purchase Rights and Stock Options

Employee Stock Purchase Rights

During the six months ended June 30, 2026 and 2025, there were 174,470 and 201,877 shares of common stock purchased under the ESPP at a weighted average price of $11.24 and $10.79, respectively.

The fair values of employee stock purchase rights were estimated using the Black-Scholes option pricing model at their respective grant date using the following assumptions:

	Six Months Ended June 30,
	2026		2025
Weighted-average grant date fair value per share	$4.22 to $43.36		$5.24 to $6.00
Risk-free interest rate	3.77% to 3.81%		4.29% to 4.44%
Dividend yield	—	%	—	%
Expected life (in years)	0.49 to 0.51		0.50 to 0.51
Volatility	59.07% to 113.93%		92.19% to 95.74%

The risk-free interest rate assumption was based on rates for United States (U.S.) Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued. The assumed dividend yield was based on the Company’s expectation of not paying dividends in the foreseeable future. The expected term is the duration of the offering period for each grant date. In addition, the estimated volatility incorporates the historical volatility over the expected term based on the Company’s daily closing stock prices.

Stock Options

A summary of the Company’s stock options activity is as follows:

	Number of Options (in thousands)	Weighted-Average Exercise Price		Weighted-Average Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2025	2,718	$	19.39
Exercised	(100)	18.76
Canceled	(200)	$	18.76
Outstanding at June 30, 2026	2,418	$	19.48	6.9	$	262,464
Vested and expected to vest at June 30, 2026	2,330	$	19.47	6.9	$	252,979
Exercisable at June 30, 2026	949	$	19.22	5.7	$	103,303

No options were granted during the six months ended June 30, 2026 and 2025.

The intrinsic value of stock options exercised was $2.9 million and $0 in the three months ended June 30, 2026 and 2025, respectively. The intrinsic value of stock options exercised was $2.9 million and $0 in the six months ended June 30, 2026 and 2025, respectively.

Cash received from exercise of stock options was $3.1 million during each of the three and six months ended June 30, 2026 and negligible during each of the three and six months ended June 30, 2025.

The tax benefit from stock options exercised was $0.6 million and $0 during the three months ended June 30, 2026 and 2025, respectively. The tax benefit from stock options exercised was $0.6 million and $0 during the six months ended June 30, 2026 and 2025, respectively.

XML

Income Taxes

6 Months Ended

Jun. 30, 2026

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

The provision for income taxes primarily relates to projected federal, state, and foreign income taxes. To determine the quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is generally based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates. In addition, the tax effects of certain significant or unusual items are recognized discretely in the quarter during which they occur and can be a source of variability in the effective tax rates from quarter to quarter.

The Company utilizes the asset and liability method of accounting for income taxes, under which deferred tax assets and liabilities are determined based on temporary differences between the financial statement and tax basis of assets and liabilities using enacted tax rates expected to be in effect during the years in which the temporary differences reverse. The Company records a valuation allowance to reduce its deferred taxes to the amount it believes is more likely than not to be realized. In making such determination, the Company considers all available positive and negative evidence quarterly, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, and recent financial performance. Forming a conclusion that a valuation allowance is not required is difficult when there is negative evidence such as cumulative losses in recent years. Based upon the Company’s review of all positive and negative evidence, the Company continues to have a valuation allowance on its state deferred tax assets, certain of its federal deferred tax assets, and certain foreign deferred tax assets in jurisdictions where the Company has cumulative losses or otherwise is not expected to utilize certain tax attributes. The Company does not incur expense or benefit in certain tax-free jurisdictions in which it operates.

The Company recorded an income tax benefit of $8.3 million in the three months ended June 30, 2026 and an income tax benefit of $4.1 million in the three months ended June 30, 2025. The Company recorded an income tax provision of $18.2 million in the six months ended June 30, 2026 and an income tax benefit of $3.4 million in the six months ended June 30, 2025.

The difference between the Company’s effective tax rate and the 21.0% United States federal statutory rate for the six months ended June 30, 2026 primarily related to the mix of pre-tax income among jurisdictions, permanent tax items including a tax on net controlled foreign corporation tested income, or NCTI, stock-based compensation, and the impact of the valuation allowance against the Company’s Singapore deferred tax assets.

The difference between the Company’s effective tax rate and the 21.0% U.S. federal statutory rate for the six months ended June 30, 2025 primarily related to the mix of pre-tax income among jurisdictions, permanent tax items, and stock-based compensation and the impact of the valuation allowance against the Company's Singapore deferred tax assets.

Income tax positions must meet a more-likely-than-not threshold to be recognized. Income tax positions that previously failed to meet the more-likely-than-not threshold are recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not threshold are de-recognized in the first financial reporting period in which that threshold is no longer met. The Company records potential penalties and interest accrued related to unrecognized tax benefits within the consolidated statements of operations as income tax expense.

During the six months ended June 30, 2026, the Company’s unrecognized tax benefits increased by $1.0 million. The Company does not expect its unrecognized tax benefits to change significantly over the next 12 months. Accrued interest and penalties associated with uncertain tax positions as of June 30, 2026 were approximately $0 and $0, respectively.

The Company is subject to federal and state income tax in the United States and is also subject to income tax in certain other foreign tax jurisdictions. At June 30, 2026, the statutes of limitations for the assessment of federal, state, and foreign income taxes are closed for the years before 2022, 2021, and 2018, respectively.

The Company’s subsidiary in Singapore operates under certain tax incentives in Singapore, which are generally effective through March 2027, and are conditional upon meeting certain employment and investment thresholds in Singapore. Under the incentives, qualifying income derived from certain sales of the Company’s integrated circuits is taxed at a concessionary rate over the incentive period, and there are reduced Singapore withholding taxes on certain intercompany royalties during the incentive period. During the quarter ended December 31, 2024, the Company recorded a full valuation allowance against its Singapore deferred tax assets. No deferred tax benefit was recognized on the Singapore net loss and deductible temporary differences for the three and six months ended June 30, 2026 and 2025 due to the valuation allowance.

XML

Concentration of Credit Risk, Significant Customers and Geographic Information

6 Months Ended

Jun. 30, 2026

Risks and Uncertainties [Abstract]

Concentration of Credit Risk, Significant Customers and Geographic Information

Concentration of Credit Risk, Significant Customers and Geographic Information

Concentration of Credit Risk

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents and accounts receivable. Collateral is generally not required for customer receivables. The Company limits its exposure to credit loss by placing its cash with high credit quality financial institutions. At times, such deposits may be in excess of insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents.

Significant Customers

The Company markets its products and services to manufacturers of a wide range of electronic devices (Note 1). The Company sells its products both directly to end-customers and through third-party distributors, both of which are referred to as the Company’s customers (Note 12). Revenue is also generated from sales of intellectual property, and the recipients of such intellectual property are also referred to as the Company’s customers. The Company makes periodic evaluations of the credit worthiness of its customers.

Customers comprising 10% or greater of net revenues for each of the periods presented are as follows:

	Three Months Ended June 30,			Six Months Ended June 30,
	2026	2025		2026		2025
Percentage of total net revenue
Customer A	*	16	%	11	%	16	%
Customer B	*	16	%	*		14	%

____________________________

*    Represents less than 10% of the net revenue for the respective period.

The following table presents balances that are 10% or greater of gross accounts receivable, based on the Company’s billings to its customers.

	June 30, 2026		December 31, 2025
Percentage of gross accounts receivable
Customer C	20	%	*
Customer D	12	%	26	%
Customer E	12	%	*
Customer F	*		14	%
Customer G	*		10	%
Customer H	*		10	%

____________________________

*    Represents less than 10% of the gross accounts receivable for the respective period.

Significant Suppliers

Suppliers comprising 10% or greater of total inventory purchases are as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Vendor A	57	%	29	%	54	%	32	%
Vendor B	13	%	23	%	15	%	21	%
Vendor C	*		14	%	*		14	%

____________________________

*    Represents less than 10% of the total inventory purchases for the respective period.

Geographic Information

The Company’s consolidated net revenues by geographic area based on ship-to location are as follows (dollars in thousands):

	Three Months Ended June 30,								Six Months Ended June 30,
	2026				2025				2026				2025
	Amount		% of total net revenue		Amount		% of total net revenue		Amount		% of total net revenue		Amount		% of total net revenue
Asia	$	143,795	85	%	$	87,118	80	%	$	249,180	81	%	$	162,379	80	%
Europe	15,028		9	%	16,101		15	%	31,317		10	%	31,055		15	%
United States	9,498		6	%	5,223		5	%	23,489		8	%	10,752		5	%
Rest of world	526		—	%	371		—	%	2,049		1	%	560		—	%
Total	$	168,847	100	%	$	108,813	100	%	$	306,035	100	%	$	204,746	100	%

The products shipped to individual countries or territories representing 10% or greater of total net revenue for each of the periods presented are as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Percentage of total net revenue
Hong Kong	48	%	50	%	48	%	49	%
Mainland China	13	%	*		12	%	*
Vietnam	13	%	10	%	10	%	10	%

____________________________

*    Represents less than 10% of total net revenue for the respective period.

The determination of which country a particular sale is allocated to is based on the destination of the product shipment. No other individual country accounted for more than 10% of net revenue during these periods. Although a large percentage of the Company’s products is shipped to Asia, and in particular, Hong Kong, mainland China, and Vietnam, the Company believes that a significant number of the systems designed by customers and incorporating the Company’s semiconductor products are subsequently sold outside Asia to Europe, Middle East, and Africa markets and North American markets.

Long-lived assets, which consist of property and equipment, net, leased right-of-use assets, intangible assets, net, and goodwill by geographic area are as follows (dollars in thousands):

	June 30, 2026				December 31, 2025
	Amount		% of total		Amount		% of total
United States	$	320,820	75	%	$	319,478	74	%
Singapore	83,142		20	%	92,519		21	%
Rest of world	19,337		5	%	19,862		5	%
Total	$	423,299	100	%	$	431,859	100	%

XML

Revenue from Contracts with Customers

6 Months Ended

Jun. 30, 2026

Revenue from Contract with Customer [Abstract]

Revenue from Contracts with Customers

Revenue from Contracts with Customers

Revenue by Market

The table below presents disaggregated net revenues by market (dollars in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
Infrastructure	$	85,016		$	34,709		$	147,830		$	61,270
% of net revenue	50		%	32		%	48		%	30		%
Broadband	44,882			47,556			88,508			88,439
% of net revenue	27		%	44		%	29		%	43		%
Connectivity	23,968			20,741			42,563			40,976
% of net revenue	14		%	19		%	14		%	20		%
Industrial and multi-market	14,981			5,807			27,134			14,061
% of net revenue	9		%	5		%	9		%	7		%
Total net revenue	$	168,847		$	108,813		$	306,035		$	204,746

Revenues from sales through the Company’s distributors accounted for 48% and 31% of net revenue for the three months ended June 30, 2026 and 2025, respectively. Revenues from sales through the Company’s distributors accounted for 47% and 33% of net revenue for the six months ended June 30, 2026 and 2025, respectively.

Contract Liabilities

As of June 30, 2026 and December 31, 2025, customer contract liabilities were approximately $0.4 million and $4.2 million, respectively, and consisted primarily of advance payments received for which performance obligations have not been completed. The decrease in customer contract liabilities was due to recognition of revenue in the six months ended June 30, 2026, which was previously in the contract liability balance as of the beginning of the period.

Obligations to Customers for Price Adjustments and Returns and Assets for Right-of-Returns

As of June 30, 2026 and December 31, 2025, obligations to customers consisting of estimates of price protection rights offered to the Company’s end customers totaled $31.2 million and $26.5 million, respectively, and are included in accrued price protection liability in the consolidated balance sheets. For activity in this account, including amounts included in net revenue, refer to Note 7.

Other obligations to customers representing estimates of price adjustments to be claimed by distributors upon sell-through of their inventory to their end customer and estimates of stock rotation returns to be claimed by distributors on products sold as of June 30, 2026 were $10.4 million and $0.2 million, respectively, and as of December 31, 2025 were $11.9 million and $0.2 million, respectively, and are included in accrued expenses and other current liabilities in the consolidated balance sheets (Note 7).

As of June 30, 2026 and December 31, 2025, right of return assets under customer contracts representing the estimates of product inventory the Company expects to receive from customers in stock rotation returns were approximately $0.1 million and $0.1 million, respectively. Right of return assets are included in inventory in the consolidated balance sheets.

As of June 30, 2026 and December 31, 2025, there were no credit losses recorded on customer accounts receivable.

XML

Leases

6 Months Ended

Jun. 30, 2026

Leases [Abstract]

Leases

Leases

Operating Leases

Operating lease arrangements primarily consist of office leases expiring in various years through 2033. These leases have original terms of approximately 2 to 8 years and some contain options to extend the lease up to 5 years or terminate the lease, which are included in right-of-use assets and lease liabilities when the Company is reasonably certain it will renew the underlying leases. Since the implicit rate of such leases is unknown and the Company is not reasonably certain to renew its leases, the Company has elected to apply a collateralized incremental borrowing rate to facility leases on the original lease term in calculating the present value of future lease payments. As of June 30, 2026 and December 31, 2025, the weighted average

discount rate for operating leases was 4.3% and 4.6%, respectively, and the weighted average remaining lease term for operating leases was 3.6 years and 2.7 years, respectively, as of the end of each of these periods.

The table below presents aggregate future minimum payments due under leases, reconciled to total lease liabilities included in the consolidated balance sheet as of June 30, 2026:

	Operating Leases
	(in thousands)
2026 (6 months)	$	5,000
2027	8,937
2028	4,850
2029	3,660
2030	1,939
Thereafter	2,650
Total minimum payments	27,036
Less: imputed interest	(2,763)
Less: unrealized translation loss	(2)
Total lease liabilities	24,271
Less: short-term lease liabilities	(8,806)
Long-term lease liabilities	$	15,465

Operating lease cost was $2.1 million and $2.2 million for the three months ended June 30, 2026 and 2025, respectively. Operating lease cost was $4.3 million and $4.6 million for the six months ended June 30, 2026 and 2025, respectively.

Short-term lease costs for the three and six months ended June 30, 2026 and 2025 were not material.

There were $0 and $0.3 million of right-of-use assets obtained in exchange for new lease liabilities for the three months ended June 30, 2026 and 2025, respectively. There were $8.1 million and $2.0 million of right-of-use assets obtained in exchange for new lease liabilities for the six months ended June 30, 2026 and 2025, respectively.

XML

Commitments and Contingencies

6 Months Ended

Jun. 30, 2026

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Inventory Purchase and Other Contractual Obligations

As of June 30, 2026, future minimum payments under inventory purchase and other obligations are as follows (in thousands):

	Inventory Purchase Obligations		Other Obligations		Total
2026 (6 months)	$	165,109	$	22,424	$	187,533
2027	56,227		25,925		82,152
2028	—		21,846		21,846
2029	—		10,898		10,898
2030	—		647		647
Thereafter	—		2,790		2,790
Total minimum payments	$	221,336	$	84,530	$	305,866

Other obligations consist primarily of contractual payments due for software licenses. Total inventory purchase and other contractual obligations increased from $209.6 million as of December 31, 2025 to $305.9 million as of June 30, 2026 driven by increased sales demand, which resulted in incremental purchase orders, and incremental software licenses.

Jointly Funded Research and Development

From time to time, the Company enters into contracts for jointly funded research and development projects to develop technology that may be commercialized into a product in the future and receives payments as milestones under the contracts are

met. If the Company is required to repay all or a portion of the funds provided by the other parties under certain conditions, the Company defers such funds in other long-term liabilities. As of June 30, 2026, funds of $15.0 million received from the other parties have been deferred in other long-term liabilities. The Company de-recognizes the liabilities when the contingencies associated with the repayment conditions have been resolved.

Dispute with Silicon Motion

As previously disclosed, on July 26, 2023, MaxLinear terminated the Merger Agreement on multiple grounds (Note 3). On August 16, 2023, Silicon Motion delivered to MaxLinear a notice, which Silicon Motion publicly disclosed, that it was purporting to terminate the Merger Agreement and that Silicon Motion would be commencing an arbitration before the Singapore International Arbitration Centre to seek damages from MaxLinear arising from MaxLinear’s alleged breaches of the Merger Agreement. Silicon Motion’s position is that MaxLinear’s Willful and Material Breaches (as such term is defined in the Merger Agreement) of the Merger Agreement prevented the Merger from being completed by August 7, 2023, and that MaxLinear is consequently liable for substantial monetary damages in excess of the termination fee as provided in the Merger Agreement.

On October 5, 2023, Silicon Motion filed a Notice of Arbitration with the Singapore International Arbitration Centre alleging that MaxLinear breached the Merger Agreement. Silicon Motion seeks payment of the termination fee, additional damages, fees, and costs. The arbitration is confidential.

MaxLinear believes that it properly terminated the Merger Agreement. MaxLinear remains confident in its decision and will vigorously defend its right to terminate the Silicon Motion transaction without penalty.

Silicon Motion Stockholder Litigation

MaxLinear and certain of its officers have been named as defendants in three lawsuits brought by stockholders of Silicon Motion.

On August 31, 2023, a Silicon Motion stockholder filed a putative class action complaint in the United States District Court for the Southern District of California captioned Water Island Event-Driven Fund v. MaxLinear, Inc., No. 23-cv-01607 (S.D. Cal.), against MaxLinear and certain of its current officers. The complaint included two claims: (1) an alleged violation of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder; and (2) an alleged violation of Section 20(a) of the Exchange Act. On December 20, 2023, the court appointed the lead plaintiffs, who filed the Consolidated Complaint on February 15, 2024. The Consolidated Complaint alleged that the defendants made false and misleading statements and/or omitted material facts that MaxLinear had a duty to disclose, concerning the Company’s intention to close the merger with Silicon Motion. On August 28, 2024, the court granted the defendants’ motion to dismiss, holding that the plaintiffs lacked standing to sue MaxLinear and its officers. The case was dismissed without prejudice.

On September 18, 2024, the plaintiffs filed an Amended Consolidated Complaint, or the Amended Complaint. The Amended Complaint includes the same two claims as alleged in the Consolidated Complaint and makes similar factual allegations against the MaxLinear defendants, but added Silicon Motion and certain of its officers as additional defendants. On July 15, 2025, the court dismissed the Amended Complaint, “with prejudice”. The plaintiffs cannot amend the Amended Complaint.

On August 8, 2025, the plaintiffs filed a Notice of Appeal to the United States Court of Appeals for the Ninth Circuit. On November 6, 2025, the plaintiffs filed their opening brief with the Court of Appeals, and on January 22, 2026, the MaxLinear defendants filed their answering brief with the Court of Appeals. The plaintiffs filed their reply brief on April 13, 2026.

On June 13, 2024, HBK Master Fund L.P. and HBK Merger Strategies Master Fund L.P., stockholders of Silicon Motion, or collectively, the HBK Plaintiffs, filed an additional complaint in the United States District Court for the Southern District of California captioned HBK Master Fund L.P. v. MaxLinear, Inc., No. 24-cv-01033 (S.D. Cal.), against MaxLinear and certain of its current officers, which also alleges violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder, and Section 20(a) of the Exchange Act, and other violations. The complaint alleges that the defendants concealed their intention to terminate the merger with Silicon Motion from Silicon Motion’s shareholders. The complaint seeks compensatory damages, including interest, costs and expenses, punitive damages, and such other equitable or injunctive relief that the court deems appropriate. On January 2, 2025, the court granted the defendants’ motion to dismiss holding that the plaintiffs lacked standing to sue MaxLinear and its officers. The case was dismissed without prejudice.

On January 17, 2025, the HBK Plaintiffs filed an amended complaint, including the same two claims as alleged previously with similar factual allegations. The amended complaint seeks compensatory damages, including interest, costs and expenses, punitive damages, and such other relief that the court deems appropriate. On February 18, 2025, the MaxLinear

defendants filed a motion to dismiss this amended complaint. On September 17, 2025, the court dismissed all but one claim under the plaintiffs' amended complaint. MaxLinear intends to continue to vigorously defend its position.

On May 14, 2026, the HBK Plaintiffs filed a complaint and jury demand in the Superior Court of California, County of San Diego captioned HBK Master Fund L.P. and HBK Merger Strategies Master Fund L.P. vs. MaxLinear, Inc., Kishore Seendripu, Steven Litchfield, and Leslie Green, Case No. 26CL026719N (Superior Court of CA). These are the same plaintiffs suing based on the same set of facts as the case that was filed in the United States District Court for the Southern District of California, arising from the terminated merger with Silicon Motion. The complaint alleges that the defendants falsely assured the plaintiffs and other investors that they would complete the merger upon regulatory approval despite their internal plans otherwise. The complaint alleges common law fraud, statutory fraud pursuant to Civil Code sections 1709, 1710, and 1711, negligent misrepresentation, tortious interference with prospective economic advantage, and negligent interference with prospective economic advantage. The plaintiffs request compensatory damages, punitive damages, attorneys' fees and costs, and such other relief as the court may deem just and proper. MaxLinear intends to vigorously defend these claims.

MaxLinear Stockholder Litigation

On February 12, 2025, the plaintiff, Joshua M. Steffens, brought a shareholder derivative action on behalf of MaxLinear in the United States District Court for the Southern District of California, against current and former members of MaxLinear’s Board of Directors and certain of its executive officers. The complaint alleges breach of fiduciary duties and violation of federal securities laws. This is a follow-on derivative lawsuit alleging that the defendants concealed their intention to terminate the merger with Silicon Motion, leading to the filing of the Silicon Motion stockholder lawsuits referenced above, thereby causing harm to MaxLinear. The complaint seeks money damages, directing the individual defendants to account for all damages caused by them and all profits, special benefits and unjust enrichment they have obtained as a result of their unlawful conduct, including all salaries, bonuses, fees, stock award, options and common stock sale proceeds, and imposing a constructive trust thereon, punitive damages, costs and expenses, and such other relief that the court deems appropriate. This matter is stayed pending resolution of the Silicon Motion stockholder lawsuits referenced above.

Comcast Litigation

On December 1, 2023, MaxLinear filed claims against Comcast Management, LLC and Comcast Cable Communications, LLC, or together, Comcast, in the United States District Court for the Southern District of New York. MaxLinear alleges that in 2020, MaxLinear shared its proprietary design and know-how for a full-duplex, or FDX, amplifier with Comcast in the hope of securing future business with Comcast. MaxLinear shared its design and know-how on several occasions, all pursuant to a non-disclosure agreement between MaxLinear and Comcast, with the expectation that Comcast would keep the information confidential. MaxLinear alleges that Comcast needed this technology in order to effectively compete with fiber-optic internet providers. Instead of engaging MaxLinear to develop the FDX amplifier, Comcast allegedly shared MaxLinear’s proprietary designs with MaxLinear’s direct competitor. Comcast allegedly then worked with MaxLinear’s competitor to develop the FDX-amplifier technology. MaxLinear brought claims for trade secret misappropriation, unfair competition, and breach of the parties’ non-disclosure agreement, and it sought an unspecified amount of compensatory damages, punitive damages, pre-judgment and post-judgment interest, costs, expenses, and attorney fees as well as an injunction against Comcast’s use or disclosure of MaxLinear’s trade secrets.

On March 19, 2024, Comcast amended its claims for declaratory judgments, indemnification, and breach of the implied covenant of good faith and fair dealing, and on April 3, 2024, MaxLinear moved to dismiss all claims against it. On September 19, 2024, the court granted the motion to dismiss with respect to certain claims for declaratory judgment claim and denied the motion to dismiss with respect to the remaining claims. On September 23, 2024, Comcast filed amended claims for declaratory judgment, indemnification, and breach of the implied covenant of good faith and fair dealing, and on October 14, 2024, MaxLinear amended and refiled its trade secret and related claims. MaxLinear intends to continue to vigorously prosecute its claims and defend its position.

Dish Litigation

On February 10, 2023, Entropic Communications, LLC, or Entropic, filed claims for patent infringement against Dish Network Corporation, Dish Network LLC, Dish Network Service, LLC, and Dish Network California Service Corporation in the United States District Court for the Central District of California. At that time, MaxLinear was not a party to the action. On September 21, 2023, Dish Network California Service Corporation, or Dish California, filed four counterclaims against MaxLinear. The four claims are declaratory judgment, breach of contract, fraud and negligent misrepresentation, and civil conspiracy.

On January 31, 2024, the Dish defendants, together with DISH Technologies L.L.C., or collectively, Dish, filed eight counterclaims (amended counterclaims for Dish California) against MaxLinear. The eight counterclaims were (1) breach of

contract, (2) fraud and negligent misrepresentation, (3) fraud arising from a civil conspiracy, (4) quasi-contract for restitution/unjust enrichment, (5) combination in restraint of trade, (6) violation of the Cartwright Act (by Dish California only), (7) patent misuse, and (8) violation of Cal. Bus. & Prof. Code § 17200 et seq. Dish’s eight counterclaims revolve around a core allegation that MaxLinear is a member of the Multimedia over Coax Alliance (MoCA) and that MaxLinear violated its obligation under MoCA’s Intellectual Property Rights Policy, or IPR Policy, by acting with Entropic to rid the asserted patents of the RAND encumbrances. Dish seeks an unspecified amount of compensatory damages, disgorgement, attorneys’ fees, experts’ fees, and costs.

On February 14, 2025, the court dismissed with prejudice six of the eight counterclaims against MaxLinear, as follows: (1) fraud arising from a civil conspiracy, (2) quasi-contract for restitution/unjust enrichment, (3) combination in restraint of trade, (4) violation of the Cartwright Act (by Dish California only), (5) patent misuse, and (6) violation of Cal. Bus. & Prof. Code § 17200 et seq.

On July 2, 2026, Dish filed a Notice of Bankruptcy Filing and Automatic Stay of Proceedings in this pending litigation. The bankruptcy filing automatically stays Entropic's claims against Dish, but not Dish's counterclaims against MaxLinear.

MaxLinear intends to continue to vigorously defend its position against Dish’s remaining two counterclaims.

Cox Litigations

On February 10, 2023, Entropic sued Cox Communications, Inc., CoxCom, LLC, and Cox Communications California, LLC, or together, Cox, in two separate actions in the United States District Court for the Central District of California. On October 6, 2023, Cox filed counterclaims against MaxLinear in each of the two actions.

In the first action, Cox alleges that when MaxLinear assigned certain patents to Entropic, MaxLinear violated its obligations under MoCA’s IPR Policy by assigning these patents and by allegedly failing to ensure that Cox would be offered a FRAND license for these patents. Cox amended its counterclaims on January 9, 2024 and asserted claims of breach of contract, unjust enrichment, and declaratory judgment against MaxLinear. Cox seeks an unspecified amount of compensatory damages, equitable relief, attorneys’ fees, expenses, and costs. MaxLinear moved to dismiss Cox’s amended counterclaims on February 6, 2024.

On February 14, 2025, the court dismissed with prejudice the unjust enrichment counterclaim against MaxLinear.

In the second action, in response to Entropic suing Cox for patent infringement, Cox filed counterclaims against MaxLinear. Cox alleges that MaxLinear granted CableLabs a non-exclusive, royalty-free license to all patents essential for compliance with DOCSIS specifications. It further alleges that MaxLinear breached this agreement when MaxLinear assigned certain patents to Entropic. Cox amended its counterclaims on January 9, 2024 and asserted claims for breach of contract, unjust enrichment, and declaratory judgment. Cox seeks an unspecified amount of compensatory damages, equitable relief, attorneys’ fees, expenses, and costs. MaxLinear moved to dismiss Cox’s amended counterclaims on February 6, 2024.

On February 14, 2025, the court dismissed with prejudice all the counterclaims against MaxLinear in this matter.

MaxLinear intends to continue to vigorously defend its position against Cox’s remaining two counterclaims.

DIRECTV Litigation

On November 7, 2023, Entropic filed an amended complaint against DIRECTV, LLC, AT&T, Inc., AT&T Services, Inc., and AT&T Communications, LLC, in the Central District of California, for infringement of twelve patents. DIRECTV, LLC, or DIRECTV, filed its answer to the amended complaint on March 28, 2025. DIRECTV’s answer asserted five counterclaims against MaxLinear. The counterclaims against MaxLinear include two separate breach of contract claims, failure to negotiate in good faith, and declaratory judgment that MaxLinear’s transfer of patents to Entropic was void. MaxLinear intends to vigorously defend its position against these counterclaims.

*    *    *

The Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. As of June 30, 2026, no material loss contingencies have been accrued for litigation and other legal claims in the consolidated financial statements, since the Company’s management currently does not believe that the ultimate outcome of any of the matters described above is probable. An unfavorable outcome of these matters may be reasonably possible in excess of recorded amounts; however, a reasonable estimate of the amount or range of such loss cannot be made at this time.

Other Matters

From time to time, the Company is subject to threats of litigation or actual litigation in the ordinary course of business as described above, some of which may be material. Results of litigation and claims are inherently unpredictable. Regardless of the outcome, litigation and claims can have an adverse impact on the Company because of defense and settlement costs, diversion of management resources, and other factors.

XML

Segment Reporting

6 Months Ended

Jun. 30, 2026

Segment Reporting [Abstract]

Segment Reporting

Segment Reporting

The following table presents segment revenue, gross profit, and net income (loss) for the periods presented (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Net revenue	$	168,847	$	108,813	$	306,035	$	204,746
Cost of net revenue	71,184		47,288		129,488		89,390
Gross profit	97,663		61,525		176,547		115,356
Less:
Employee related	76,501		55,643		143,670		122,746
Depreciation and amortization	3,853		4,541		7,869		9,004
Design and prototype expenses	12,866		10,177		24,700		19,848
Professional fees	4,494		5,983		12,984		12,494
Occupancy expenses	4,070		4,216		8,180		8,514
Restructuring expenses	64		5,580		538		13,459
Interest and other (income) expense, net	2,365		6,086		3,808		8,994
Income tax expense (benefit)	(8,310)		(4,115)		18,175		(3,404)
Segment net income (loss)	$	1,760	$	(26,586)	$	(43,377)	$	(76,299)

XML

Stock Repurchases

6 Months Ended

Jun. 30, 2026

Equity [Abstract]

Stock Repurchases

Stock Repurchases

On November 20, 2025, the Company’s board of directors authorized a plan to repurchase up to $75.0 million of the Company’s common stock over a period ending November 20, 2028. The amount and timing of repurchases are subject to a variety of factors including liquidity, share price, market conditions, and legal requirements. Any purchases have been and will be funded from available working capital and may be effected through open market purchases, block transactions, and privately negotiated transactions. The share repurchase program does not obligate the Company to make any repurchases and may be modified, suspended, or terminated by the Company at any time without prior notice.

During the year ended December 31, 2025, the Company repurchased and retired 1,143,891 shares of its common stock at a weighted average price of $17.46 per share at an aggregate value of approximately $20.0 million under the repurchase program. During the six months ended June 30, 2026, the Company did not repurchase any of its common stock under the repurchase program. As of June 30, 2026, approximately $55.0 million remained available for repurchase under the program.

XML

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2026
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

Organization and Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2026

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation and Principles of Consolidation

Basis of Presentation and Principles of Consolidation

The accompanying unaudited consolidated financial statements include the accounts of MaxLinear, Inc. and its directly and indirectly wholly-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. All intercompany transactions and investments have been eliminated in consolidation.

In the opinion of management, the Company’s unaudited consolidated interim financial statements contain adjustments, including normal recurring accruals necessary to present fairly the Company’s consolidated financial position, results of operations, comprehensive loss, stockholders’ equity, and cash flows.

The consolidated balance sheet as of December 31, 2025 was derived from the Company’s audited consolidated financial statements at that date. The accompanying unaudited consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2025 included in the Company’s Annual Report on Form 10-K filed by the Company with the Securities and Exchange Commission, or the SEC, on January 29, 2026, or the Annual Report. Interim results for the six months ended June 30, 2026 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2026.

The functional currency of certain foreign subsidiaries is the local currency. Accordingly, assets and liabilities of these foreign subsidiaries are translated at the current exchange rate at the balance sheet date and historical rates for equity. Revenue and expense components are translated at weighted average exchange rates in effect during the period. Gains and losses resulting from foreign currency translation are included as a component of stockholders’ equity. Foreign currency transaction gains and losses are included in the results of operations, and to date, have not been material.

Use of Estimates and Significant Risks and Uncertainties

Use of Estimates and Significant Risks and Uncertainties

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes to the consolidated financial statements. Actual results could differ from those estimates.

The Company is not aware of any specific event or circumstance that would require an update to its estimates or adjustments to the carrying value of its assets and liabilities as of July 23, 2026, the issuance date of this Quarterly Report on Form 10-Q. Actual results could differ from those estimates.

Recently Adopted Accounting Pronouncements and Recently Issued, Not Yet Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements

In September 2025, the FASB issued ASU No. 2025-07, Derivatives and Hedging (Topic 815) and Revenue from Contracts with Customers (Topic 606)—Derivatives Scope Refinements and Scope Clarification for Share-Based Noncash Consideration from a Customer in a Revenue Contract, or ASU No. 2025-07. The amendments in this update exclude from derivative accounting non-exchange-traded contracts with underlyings that are based on operations or activities specific to one of the parties to the contract and clarify the accounting for receipt of share-based noncash consideration from a customer for the transfer of goods or services. These amendments are effective for the Company for annual and interim periods in 2027 and may be applied prospectively to new contracts entered into on or after the date of adoption, or on a modified retrospective basis via a cumulative-effect adjustment to the opening balance of retained earnings for existing contracts, with early adoption permitted. The Company adopted the amendments in this update prospectively in 2026. The impact of the adoption of the amendments in this update was not material to the Company’s consolidated financial position and results of operations as of and for the three and six months ended June 30, 2026.

In July 2025, the FASB issued ASU No. 2025-05, Financial Instruments – Credit Losses (Topic 326), to allow entities to elect a practical expedient that assumes that current conditions as of the balance sheet date do not change for the remaining life of the asset when estimating expected credit losses for current accounts receivable and current contract assets. These amendments are effective for the Company for annual and interim periods in 2026 applied prospectively, with early adoption permitted. The Company adopted the amendments in this update prospectively in 2026. The impact of the adoption of the amendments in this update was not material to the Company’s consolidated financial position and results of operations.

Recently Issued, Not Yet Adopted Accounting Pronouncements

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements, to clarify and reorganize GAAP interim reporting guidance to improve navigability, applicability, and consistency without changing the fundamental nature or volume of required interim disclosures. This amendment clarifies when ASC 270 is applicable, establishes a disclosure principle requiring disclosure of material events or changes occurring since the most recent annual reporting period, and consolidates into ASC Topic 270 a comprehensive list of interim disclosures required by other Codification Topics. The amendment also clarifies the form and content of interim financial statements, including guidance for condensed interim reporting. The amendment is effective for the Company for interim periods in 2028, with early adoption permitted. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations.

In December 2025, the FASB issued ASU 2025‑10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities, to establish specific guidance for the recognition, measurement, presentation, and disclosure of government grants received to reduce diversity and increase consistency amongst business entities in accounting for such grants. This amendment amends ASC Topic 832 to require that a government grant received by a business entity should not be recognized as income until it is probable that a business entity will comply with the conditions attached to the grant and the grant will be received, with any grant related to an asset to be purchased, constructed or acquired such as long-lived assets or inventory to be recognized on the balance sheet as either deferred income or as an adjustment to the cost basis of the related asset, or the cost accumulation approach, as such costs are incurred. Any grant income or deferred income shall be recognized in earnings on a systematic and rational basis over the periods in which a business entity recognizes as expenses the costs for which the grant is intended to compensate, whereas any grants accounted for using the cost accumulation approach will not have a direct subsequent recognition in earnings, but rather reduced depreciation or amortization in accounting for the related asset. Entities are also required to present grants recognized in earnings separately under other income or deducted from the related expense, and provide disclosures of the nature of the government grant received, the accounting policies used to account for the grant, and the significant terms and conditions of the grant.

The amendment is effective for the Company for annual and interim periods in 2029, with early adoption and multiple transition methods permitted. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations as it does not differ materially from the Company’s current practice in accounting for government grants.

In September 2025, the FASB issued ASU No. 2025-06, Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, to update the accounting for software developed for internal use to better align with software development as it has evolved from a sequential development method to incremental and iterative development methods. The amendments in this update require an entity to begin capitalizing internal-use software costs when management has authorized and committed to funding the software project and it is probable that the project will be completed and the software will be used to perform the function intended. These amendments are effective for the Company for annual and interim periods in 2028, applied either prospectively, retrospectively, or by a modified approach,

with early adoption permitted. As the Company does not currently have a material amount of software developed for internal use, the impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations.

In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses, to improve the disclosures about a public business entity’s expenses and address requests from investors for more detailed information about the types of expenses including purchases of inventory, employee compensation, depreciation and intangible asset amortization in commonly presented expense captions such as cost of sales, selling, general and administrative expense, and research and development. These amendments are effective for the Company for annual periods in 2027, applied prospectively, with early adoption permitted, and interim periods beginning in 2028. The Company intends to adopt the amendments in this update prospectively in 2027 for annual periods and in 2028 for interim periods. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations, as the requirements only require more detailed disclosures in the footnotes to the Company’s consolidated financial statements.

XML

Net Income (Loss) Per Share (Tables)

6 Months Ended

Jun. 30, 2026

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Earnings Per Share

The table below presents the computation of basic and diluted EPS:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
	(in thousands, except per share amounts)
Numerator:
Net income (loss)	$	1,760	$	(26,586)	$	(43,377)	$	(76,299)
Denominator:
Weighted average common shares outstanding—basic	90,043		86,626		88,826		85,952
Dilutive common stock equivalents	7,290		—		—		—
Weighted average common shares outstanding—diluted	97,333		86,626		88,826		85,952
Net income (loss) per share:
Basic	$	0.02	$	(0.31)	$	(0.49)	$	(0.89)
Diluted	$	0.02	$	(0.31)	$	(0.49)	$	(0.89)

XML

Restructuring Activity (Tables)

6 Months Ended

Jun. 30, 2026

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Related Costs

The following table presents the activity related to the restructuring plans, which is included in restructuring charges in the consolidated statements of operations:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
	(in thousands)
Employee separation expenses	$	218	$	4,561	$	323	$	6,158
Lease related charges	(176)		933		182		935
Other	22		86		33		6,366
	$	64	$	5,580	$	538	$	13,459

Schedule of Restructuring Liability

The following table presents a roll-forward of the Company’s restructuring liability for the six months ended June 30, 2026. The restructuring liability is included in accrued expenses and other current liabilities and other long-term liabilities in the consolidated balance sheets.

	Employee Separation Expenses		Lease Related Charges		Other		Total
	(in thousands)
Liability as of December 31, 2025	$	2,857	$	858	$	11,243	$	14,958
Restructuring charges	323		182		33		538
Cash payments	(2,707)		(172)		(8,818)		(11,697)
Non-cash charges and adjustments	(254)		101		138		(15)
Liability as of June 30, 2026	219		969		2,596		3,784
Less: current portion as of June 30, 2026	(219)		(969)		(1,175)		(2,363)
Long-term portion as of June 30, 2026	$	—	$	—	$	1,421	$	1,421

XML

Goodwill and Intangible Assets (Tables)

6 Months Ended

Jun. 30, 2026

Intangible Asset, Goodwill and Other [Abstract]

Intangible Asset, Finite-Lived, Acquired

The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which are amortized over their estimated useful lives:

		June 30, 2026						December 31, 2025
	Weighted Average Useful Life (in Years)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
		(in thousands)
Licensed technology	6.9	$	33,523	$	(4,917)	$	28,606	$	31,858	$	(3,663)	$	28,195
Developed technology	6.9	311,261		(298,872)		12,389		311,261		(293,761)		17,500
Trademarks and trade names	6.2	14,800		(14,633)		167		14,800		(14,562)		238
Patents	7.0	4,780		(2,162)		2,618		4,780		(1,821)		2,959
	6.0	$	364,364	$	(320,584)	$	43,780	$	362,699	$	(313,807)	$	48,892

Schedule of Finite-lived Intangible Assets Amortization Expense

The following table sets forth amortization expense associated with finite-lived intangible assets, which is included in the consolidated statements of operations as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
	(in thousands)
Cost of net revenue	$	3,213	$	2,844	$	6,342	$	5,673
Selling, general and administrative	229		591		435		1,183
	$	3,442	$	3,435	$	6,777	$	6,856

Intangible Asset, Finite-Lived

The following table sets forth the activity related to finite-lived intangible assets:

	Six Months Ended June 30,
	2026		2025
	(in thousands)
Beginning balance	$	48,892	$	55,008
Additions	1,665		6,207
Amortization	(6,777)		(6,856)
Ending balance	$	43,780	$	54,359

Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense

The following table presents future amortization of the Company’s finite-lived intangible assets at June 30, 2026:

	Amount
	(in thousands)
2026 (6 months)	$	7,427
2027	11,834
2028	6,388
2029	5,297
2030	4,167
Thereafter	8,667
Total	$	43,780

XML

Financial Instruments (Tables)

6 Months Ended

Jun. 30, 2026

Fair Value Disclosures [Abstract]

Schedule of Composition of Financial Instruments

The composition of financial instruments is as follows:

	Fair Value
	June 30, 2026		December 31, 2025
	(in thousands)
Liabilities
Contingent consideration	$	2,600	$	2,600

XML

Balance Sheet Details (Tables)

6 Months Ended

Jun. 30, 2026

Balance Sheet Related Disclosures [Abstract]

Schedule of Cash and Cash Equivalents

Cash, cash equivalents and restricted cash consist of the following:

	June 30, 2026		December 31, 2025
	(in thousands)
Cash and cash equivalents	$	64,814	$	72,806
Short-term restricted cash	1,492		1,419
Long-term restricted cash	27,426		27,187
Total cash, cash equivalents and restricted cash	$	93,732	$	101,412

Schedule of Restriction Cash

Cash, cash equivalents and restricted cash consist of the following:

	June 30, 2026		December 31, 2025
	(in thousands)
Cash and cash equivalents	$	64,814	$	72,806
Short-term restricted cash	1,492		1,419
Long-term restricted cash	27,426		27,187
Total cash, cash equivalents and restricted cash	$	93,732	$	101,412

Schedule of Inventory

Inventory consists of the following:

	June 30, 2026		December 31, 2025
	(in thousands)
Work-in-process	$	79,012	$	47,598
Finished goods	26,478		30,506
	$	105,490	$	78,104

Schedule of Property and Equipment

Property and equipment, net consists of the following:

	Useful Life (in Years)	June 30, 2026		December 31, 2025
		(in thousands)
Furniture and fixtures	5	$	4,101	$	4,006
Machinery and equipment	3-5	88,929		87,043
Masks and production equipment	5	68,028		66,044
Software	3	11,253		11,498
Leasehold improvements	1-5	36,127		35,632
Construction in progress	N/A	1,315		2,516
		209,753		206,739
Less: accumulated depreciation and amortization		(168,546)		(157,866)
		$	41,207	$	48,873

Schedule of Price Protection Liability

The following table sets forth activity related to the accrued price protection liability:

	Six Months Ended June 30,
	2026		2025
	(in thousands)
Beginning balance	$	26,493	$	43,401
Charged as a reduction of revenue	15,890		14,353
Revisions to accrued rebates	(2,440)		(12,170)
Payments	(8,751)		(6,064)
Ending balance	$	31,192	$	39,520

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

	June 30, 2026		December 31, 2025
	(in thousands)
Accrued technology license payments	$	3,627	$	3,687
Accrued professional fees	5,198		6,882
Accrued engineering and production costs	11,496		8,469
Accrued restructuring	2,363		13,390
Short-term lease liabilities	8,806		9,096
Accrued customer credits	5,197		6,398
Income tax liability	432		511
Customer contract liabilities	397		4,222
Accrued obligations to customers for price adjustments	10,420		11,922
Accrued obligations to customers for stock rotation rights	247		222
Contingent consideration - current portion	2,600		2,600
Other	7,461		4,993
	$	58,244	$	72,392

Schedule of Accumulated Other Comprehensive Income (Loss) by Component

The following table summarizes the change in balances of accumulated other comprehensive income (loss) by component:

	Cumulative Translation Adjustments		Pension and Other Defined Benefit Plan Obligation		Total
	(in thousands)
Balance at December 31, 2025	$	(327)	$	1,357	$	1,030
Other comprehensive loss before reclassifications, net of tax	319		—		319
Balance at June 30, 2026	$	(8)	$	1,357	$	1,349

XML

Debt and Other Long-Term Liabilities (Tables)

6 Months Ended

Jun. 30, 2026

Debt Disclosure [Abstract]

Schedule of Debt

The carrying amount of the Company’s long-term debt consists of the following:

	June 30, 2026		December 31, 2025
	(in thousands)
Principal balance:
Initial term loan under the June 23, 2021 credit agreement	$	125,000	$	125,000
Total principal balance	125,000		125,000
Less:
Unamortized debt discount	(258)		(320)
Unamortized debt issuance costs	(816)		(1,062)
Net carrying amount of long-term debt	123,926		123,618
Less: current portion of long-term debt	—		—
Long-term debt, non-current portion	$	123,926	$	123,618

XML

Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2026

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-Based Compensation Expense

The Company recognizes stock-based compensation in the consolidated statements of operations, based on the department to which the related employee reports, as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
	(in thousands)
Cost of net revenue	$	131	$	155	$	281	$	437
Research and development	10,535		7,625		20,210		22,281
Selling, general and administrative	16,813		5,333		27,015		13,306
	$	27,479	$	13,113	$	47,506	$	36,024

Schedule of Restricted Stock Unit Activity

A summary of the Company’s restricted stock unit activity for all equity plans is as follows:

	Number of Shares (in thousands)	Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 2025	7,649	$	19.89
Granted1	4,096	21.06
Vested2	(4,127)	19.99
Canceled3	(389)	18.92
Outstanding at June 30, 2026	7,229	$	20.55

____________
(1) Includes approximately 148 thousand shares granted under the Inducement Plan at a weighted-average grant-date fair value per share of $18.47.

(2) Includes approximately 38 thousand shares vested under the Inducement Plan at a weighted-average grant-date fair value per share of $14.00.

(3) Includes approximately 70 thousand shares canceled under the Inducement Plan at a weighted-average grant-date fair value per share of $15.35.

Schedule of Performance-Based Restricted Stock Unit Activity

A summary of the Company’s performance-based restricted stock unit activity is as follows:

	Number of Shares (in thousands)	Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 2025	3,333	$	19.58
Granted	623	18.47
Released	(83)	15.19
Canceled1	(1,021)	25.46
Outstanding at June 30, 2026	2,852	$	17.36

________________

(1) Includes shares canceled due to achievement below threshold amounts from shares granted which were previously reserved at the maximum achievable (250%). No shares were eligible to vest for the 2025 performance period under the 2023 and 2024 performance-based restricted stock unit grants due to achievement below the 25th percentile.

Schedule of Employee Stock Purchase Plan, Valuation Assumptions

The fair values of employee stock purchase rights were estimated using the Black-Scholes option pricing model at their respective grant date using the following assumptions:

	Six Months Ended June 30,
	2026		2025
Weighted-average grant date fair value per share	$4.22 to $43.36		$5.24 to $6.00
Risk-free interest rate	3.77% to 3.81%		4.29% to 4.44%
Dividend yield	—	%	—	%
Expected life (in years)	0.49 to 0.51		0.50 to 0.51
Volatility	59.07% to 113.93%		92.19% to 95.74%

Schedule of Stock Option Activity

A summary of the Company’s stock options activity is as follows:

	Number of Options (in thousands)	Weighted-Average Exercise Price		Weighted-Average Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2025	2,718	$	19.39
Exercised	(100)	18.76
Canceled	(200)	$	18.76
Outstanding at June 30, 2026	2,418	$	19.48	6.9	$	262,464
Vested and expected to vest at June 30, 2026	2,330	$	19.47	6.9	$	252,979
Exercisable at June 30, 2026	949	$	19.22	5.7	$	103,303

XML

Concentration of Credit Risk, Significant Customers and Geographic Information (Tables)

6 Months Ended

Jun. 30, 2026

Risks and Uncertainties [Abstract]

Schedule of Concentration of Risk, by Risk Factor

Customers comprising 10% or greater of net revenues for each of the periods presented are as follows:

	Three Months Ended June 30,			Six Months Ended June 30,
	2026	2025		2026		2025
Percentage of total net revenue
Customer A	*	16	%	11	%	16	%
Customer B	*	16	%	*		14	%

____________________________

*    Represents less than 10% of the net revenue for the respective period.

The following table presents balances that are 10% or greater of gross accounts receivable, based on the Company’s billings to its customers.

	June 30, 2026		December 31, 2025
Percentage of gross accounts receivable
Customer C	20	%	*
Customer D	12	%	26	%
Customer E	12	%	*
Customer F	*		14	%
Customer G	*		10	%
Customer H	*		10	%

____________________________

*    Represents less than 10% of the gross accounts receivable for the respective period.

Significant Suppliers

Suppliers comprising 10% or greater of total inventory purchases are as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Vendor A	57	%	29	%	54	%	32	%
Vendor B	13	%	23	%	15	%	21	%
Vendor C	*		14	%	*		14	%

____________________________

*    Represents less than 10% of the total inventory purchases for the respective period.

Schedule of Revenue from External Customers by Geographic Areas

The Company’s consolidated net revenues by geographic area based on ship-to location are as follows (dollars in thousands):

	Three Months Ended June 30,								Six Months Ended June 30,
	2026				2025				2026				2025
	Amount		% of total net revenue		Amount		% of total net revenue		Amount		% of total net revenue		Amount		% of total net revenue
Asia	$	143,795	85	%	$	87,118	80	%	$	249,180	81	%	$	162,379	80	%
Europe	15,028		9	%	16,101		15	%	31,317		10	%	31,055		15	%
United States	9,498		6	%	5,223		5	%	23,489		8	%	10,752		5	%
Rest of world	526		—	%	371		—	%	2,049		1	%	560		—	%
Total	$	168,847	100	%	$	108,813	100	%	$	306,035	100	%	$	204,746	100	%

The products shipped to individual countries or territories representing 10% or greater of total net revenue for each of the periods presented are as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Percentage of total net revenue
Hong Kong	48	%	50	%	48	%	49	%
Mainland China	13	%	*		12	%	*
Vietnam	13	%	10	%	10	%	10	%

____________________________

*    Represents less than 10% of total net revenue for the respective period.

Schedule of Long-lived Assets by Geographic Areas

Long-lived assets, which consist of property and equipment, net, leased right-of-use assets, intangible assets, net, and goodwill by geographic area are as follows (dollars in thousands):

	June 30, 2026				December 31, 2025
	Amount		% of total		Amount		% of total
United States	$	320,820	75	%	$	319,478	74	%
Singapore	83,142		20	%	92,519		21	%
Rest of world	19,337		5	%	19,862		5	%
Total	$	423,299	100	%	$	431,859	100	%

XML

Revenue from Contracts with Customers (Tables)

6 Months Ended

Jun. 30, 2026

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregated Net Revenues

The table below presents disaggregated net revenues by market (dollars in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
Infrastructure	$	85,016		$	34,709		$	147,830		$	61,270
% of net revenue	50		%	32		%	48		%	30		%
Broadband	44,882			47,556			88,508			88,439
% of net revenue	27		%	44		%	29		%	43		%
Connectivity	23,968			20,741			42,563			40,976
% of net revenue	14		%	19		%	14		%	20		%
Industrial and multi-market	14,981			5,807			27,134			14,061
% of net revenue	9		%	5		%	9		%	7		%
Total net revenue	$	168,847		$	108,813		$	306,035		$	204,746

XML

Leases (Tables)

6 Months Ended

Jun. 30, 2026

Leases [Abstract]

Schedule of Aggregate Future Minimum Payments Due

The table below presents aggregate future minimum payments due under leases, reconciled to total lease liabilities included in the consolidated balance sheet as of June 30, 2026:

	Operating Leases
	(in thousands)
2026 (6 months)	$	5,000
2027	8,937
2028	4,850
2029	3,660
2030	1,939
Thereafter	2,650
Total minimum payments	27,036
Less: imputed interest	(2,763)
Less: unrealized translation loss	(2)
Total lease liabilities	24,271
Less: short-term lease liabilities	(8,806)
Long-term lease liabilities	$	15,465

XML

Commitments and Contingencies (Tables)

6 Months Ended

Jun. 30, 2026

Commitments and Contingencies Disclosure [Abstract]

Schedule of Future Minimum Payments Under Inventory Purchase Obligations

As of June 30, 2026, future minimum payments under inventory purchase and other obligations are as follows (in thousands):

	Inventory Purchase Obligations		Other Obligations		Total
2026 (6 months)	$	165,109	$	22,424	$	187,533
2027	56,227		25,925		82,152
2028	—		21,846		21,846
2029	—		10,898		10,898
2030	—		647		647
Thereafter	—		2,790		2,790
Total minimum payments	$	221,336	$	84,530	$	305,866

Schedule of Future Minimum Payments Under Other Obligations

As of June 30, 2026, future minimum payments under inventory purchase and other obligations are as follows (in thousands):

	Inventory Purchase Obligations		Other Obligations		Total
2026 (6 months)	$	165,109	$	22,424	$	187,533
2027	56,227		25,925		82,152
2028	—		21,846		21,846
2029	—		10,898		10,898
2030	—		647		647
Thereafter	—		2,790		2,790
Total minimum payments	$	221,336	$	84,530	$	305,866